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Abstract 
The major challenge currently facing human in vitro fertilization (IVF) programs is the prevention of 
multiple gestation pregnancies. The replacement of multiple embryos to fertility patients is common 
practice to increase pregnancy rates. However this introduces a significant risk of a resultant multiple 
pregnancy (25-50%), with associated increased complications such as perinatal morbidity, mortality and 
long-term disabilities, as well as significant maternal complications. The transfer of a single embryo 
during IVF treatment is the only acceptable way to overcome the issues related to multiple gestation 
pregnancies. To encourage the replacement of only one embryo, pregnancy rates must be able to be 
maintained. There is therefore a great need for clinical laboratories to use markers that can identify 
highly viable embryos. 
Current laboratory embryo selection techniques involve selecting an embryo based on its appearance. 
However it is well established that this is only weakly linked to pregnancy success. Therefore other less 
subjective quantitative markers are required to select embryos that are the most viable within a patient‟s 
cohort.  Any  quantitative  techniques  which  provide  additional  information  to  combine  with  current 
morphological assessment protocols must be rapid, simple, non-invasive and highly discriminating. This 
thesis  describes  the  investigations  of  candidate  non-invasive  viability  markers  to  assess  the 
competence of the oocyte/embryo. 
In  order  to  track  investigations  of  individual  oocytes  and  embryos,  single  embryo  culture  is  a 
prerequisite. Mouse and human embryo development and implantation were studied as a prelude to 
investigations of biomarkers of human embryo viability. No differences were observed in human embryo 
development or viability after single or group culture. Mouse embryos cultured singly were found to have 
a reduced cell number, however this did not affect implantation or fetal viability. Interestingly, mouse 
placental weights were reduced. This and a lack of power in the human studies suggest that single 
embryo culture in the human needs further long-term examination. 
Following preliminary investigations of single embryo culture, morphological, biochemical and metabolic 
studies were undertaken as potential biomarkers of oocyte/embryo viability in the human. Firstly, a new 
morphological scoring system was described for day 4 human embryos, a stage of embryo development 
that has previously been overlooked. This morphological scoring system was easy to implement in the 
clinic and able to improve implantation rates over morphological scoring of cleavage stage embryos. It 
has subsequently been adopted in several clinics. Secondly, the reduction-oxidation (REDOX) state of 
cumulus  cells  surrounding  oocytes  retrieved  for  IVF  was  measured  and  retrospectively  found  to 
correlate  with  subsequent  embryo  viability.  Finally,  a  direct  measure  of  metabolism  was  also 
investigated in cumulus-oocyte complexes as well as cleavage stage embryos with determination of Abstract 
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metabolic turnover of glucose, lactate, pyruvate and alanine, with pyruvate uptake by the early embryo 
and pyruvate: alanine turnover of the cumulus-oocyte complex being related to viability.  
Overall, these experiments showed that some metabolic parameters were correlated with subsequent 
viability. Biochemical markers in combination with current morphological measures show promise in 
selecting the most viable embryo for replacement. Further validations of these markers in randomized 
controlled trials are the next step in the introduction of these technologies to improve success rates of 
single embryo transfers in fertility treatment. 
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1.1  INTRODUCTION 
A major challenge in human assisted reproductive technologies (ART) is the selection of embryos with the 
highest implantation potential. This ability to identify the most viable embryo for replacement is essential to 
both maintain pregnancy rates but also to reduce the number of embryos transferred and the number of 
resultant multiple gestation pregnancies. Current protocols to select embryos for transfer are based on 
either single or a combination of morphological parameters (Edwards et al. 1984, Cummins et al. 1986, Hill 
et al. 1989, Steer et al. 1992). In general, the number and quality of cells in an embryo are assessed as well 
as the absence of fragmentation and multinucleation (Gerris et al. 1999, Van Royen et al. 2003). Additional 
observations have been more recently integrated into the clinical assessment of human embryos with the 
recognition that a single static observation is likely not indicative of the developmental potential of an 
embryo (Bavister 1995). These inclusions have been based on the initiation of key events during gamete 
and embryo development, in a time-dependent fashion, and incorporate; oocyte morphology (Ebner et al. 
2000,  Shen  et  al.  2005,  Ebner  et  al.  2006,  Montag  et  al.  2006,  Madaschi  et  al.  2008),  pronuclear 
morphology (Tesarik and Greco 1999, Scott et al. 2000) early cleavage assessment (Shoukir et al. 1997, 
Sakkas et al. 1998, Sakkas et al. 2001) and blastocyst development (Gardner et al. 2000a, Gardner et al. 
2002). However, maximal implantation rates have likely been reached using an „observation only‟ approach, 
and have been deemed unacceptable by both clinicians and patients, as demonstrated by the continuing 
practice of replacing multiple embryos in a treatment cycle to increase pregnancy rates. Given the known 
risks associated with multiple pregnancies (Dare et al. 2004), the ultimate goal of ART should be to achieve 
singleton pregnancies. The only way to reliably achieve this (other than selective fetal reduction) is by the 
transfer of a single embryo. Therefore other indicators of viability as defined by the ability to establish and 
maintain pregnancy need to be explored.  
 
ART procedures, including in vitro fertilization (IVF) and gamete intrafallopian tube transfer (GIFT), were 
established prior to the ability to manipulate a menstrual cycle. As such, these procedures were performed 
during a woman‟s own natural menstrual cycle, aspirating the dominant follicle from the ovary following the 
luteinizing  hormone  (LH)  ovulatory  surge.  As  generally  single  oocytes  were  collected,  single  oocytes 
(GIFT)/embryos (IVF) were replaced, and therefore multiple gestations were rare. The ability to stimulate a 
woman‟s ovaries to produce multiple oocytes for collection was a major breakthrough in fertility treatments 
(Trounson  et  al.  1981),  which  also  created  the  circumstance  of  having  surplus  oocytes/embryos. 
Cryopreservation was a viable option for surplus reproductive material (Trounson and Mohr 1983), however 
the preferred choice was to transfer a higher number of oocytes/embryos to maximize the chances of Chapter 1: Introduction 
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achieving pregnancy. Due to the low pregnancy rates in the early stages of IVF, transferring more embryos 
was an acceptable practice as high order multiple gestations were uncommon.  
 
Historically GIFT was introduced as it allows for in vivo fertilization, providing a physiological environment 
i.e. the fallopian tube, for gametes to be placed for normal fertilization to occur (McLaughlin et al. 1987). 
GIFT was introduced in Australia in 1985 and was initially preferred to IVF as it was simpler and more 
successful, and few clinics had the technology and personnel able to perform IVF (Seibel 2004). This 
technique is still preferred by some patients today for religious reasons. However, GIFT requires at least 
one normal fallopian tube to be present, and for patients with bi-lateral tubal occlusion, IVF was their only 
option to become pregnant (Seibel 2004). Today, IVF is more routine, less invasive, applies to a greater 
range of infertility diagnoses and is more successful than GIFT, and thus the demand for GIFT has sharply 
declined in recent years and now only accounts for a small proportion of ART cycles ((Wang et al. 2009), 
see Figure 1.1). In addition, GIFT usually involves transfer of multiple oocytes into the fallopian tube with 
processed spermatozoa and thus has a high risk of multiple pregnancy, with one in four pregnancies in 
2006 being a multiple pregnancy in Australia and New Zealand (Wang et al. 2008).  
  
       
 
 
Figure 1.1 Number of GIFT and IVF cycles performed and live birth rates in Australia and New Zealand assisted conception 1992-2007. 
Constructed from AIHW NPSU reports (Lancaster et al. 1995, Hurst et al. 1997, Lancaster et al. 1997, Hurst et al. 1999, Hurst and Lancaster 2001a, Hurst and 
Lancaster 2001b, Dean and Sullivan 2003, Bryant et al. 2004, Wang et al. 2006, Waters et al. 2006, Wang et al. 2007, Wang et al. 2008, Wang et al. 2009). 
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From its first successes in 1978, IVF embryos were replaced into the uterus soon after the first cleavage 
cycles were observed, as in vitro culture techniques were too primitive to maintain embryo viability (Gardner 
et al. 1996a). Improvements in embryo culture systems through investigations into oviduct and uterine fluids 
and the nutritional requirements of a developing embryo (Gardner et al. 1996a) led to the inception of 
sequential culture media to support the growth of embryos in vitro to the blastocyst stage (Gardner and 
Lane  1997,  Gardner  and  Lane  1999,  Schoolcraft  and  Gardner  2000,  Pool  2002).  The  introduction  of 
blastocyst stage embryo replacements into clinical IVF programs resulted, in many units, in an increase in 
pregnancy rates (Gardner et al. 2000a, Wilson et al. 2002). The ability to develop to the blastocyst stage in 
vitro provides a tool to select the most competent embryo from a cohort, as an extended period in vitro 
allows further differentiation between embryos, in particular embryos with little developmental potential. The 
replacement of blastocysts played a significant role in improving IVF pregnancy rates, for which the number 
of embryos being replaced was not compensated, contributing further to the increase in multiple pregnancy 
rates (Gardner et al. 2000a). 
 
IVF pregnancy rates have improved with the advancement of technology and techniques, while the transfer 
of multiple embryos has remained common practice. This resulted in a large increase in the proportion of 
multiple pregnancies following IVF (Callahan et al. 1994, Wilcox et al. 1996). Many clinicians and patient 
couples underestimate the negative consequences associated with multiple pregnancies, including twins 
(Gleicher et al. 1995, Olivennes 2000). A higher rate of prematurity and low birth weights in babies born 
following a multiple pregnancy contribute to significant perinatal morbidity and mortality (Baird et al. 1998, 
Senat et al. 1998, Russell et al. 2003, Wang et al. 2009) including: admission to neonatal intensive care and 
extended length of care; respiratory distress; cerebral palsy and developmental delay (Williams and O'Brien 
1998, Dani et al. 1999, Ross et al. 1999, Stromberg et al. 2002). Increased rates of maternal hypertension 
and pre-eclampsia are also associated with multiple as opposed to singleton pregnancies  (Tallo et al. 
1995), all of which significantly contribute to health costs (Ledger et al. 2006). In addition, there is now 
significant  evidence  that  low  birth  weight  singletons  have  increased  risk  of  long-term  adverse  health 
outcomes,  particularly  cardiovascular  disease,  type  2  diabetes,  hypertension  and  metabolic  syndrome 
(Barker 1998). Although this phenomenon is yet to be investigated in multiple births, it suggests that the 
96.1% of triplets and 61.4% of ART twins that are born prematurely in Australia and New Zealand will have 
considerable health and economic consequences.  
A variety of methods have been proposed as potentially useful to evaluate embryo viability in human IVF 
programs (Ebner et al. 2003). Ultimately, for practical purposes, the techniques involved need to be non-
invasive, timely and require simple operation as well as being highly discriminating. The employment of Chapter 1: Introduction 
 
Feil    Page 25  
   
such techniques to assist in selection of the most viable embryo from a cohort can only improve pregnancy 
rates, which would lead to the much anticipated reduction in the number of multiple embryo transfers and 
therefore the number of multiple pregnancies and births. The following review of the literature describes 
parameters that have been investigated to assess the viability of an embryo and the barriers of those 
parameters to date and for implementation in human IVF programs in the future. 
 
1.2  CURRENT STATUS OF SINGLE EMBRYO TRANSFERS 
The number of embryos replaced during an IVF treatment cycle has reduced from 3-4 to 2-3 since the 
publication of the International Federation of Fertility Societies (IFFS) Surveillance 01 (Jones and Cohen 
2001, Cohen and Jones 2004).  Legislation in countries such as Denmark, Hong Kong, Saudi Arabia, the 
United Kingdom, Switzerland and Brazil limits the number of embryos for replacement, with potentially 
severe penalties if violated. In countries without legislation limiting the number of embryos for replacement, 
national  guidelines  are  generally  in  place,  however  there  are  a  small  number  of  countries  which  are 
regulated by neither legislation nor guidelines (Jones and Cohen 2001). In Australia and New Zealand, the 
number of embryos replaced during IVF has steadily decreased over the last decade (see Figure 1.2), with 
63.7% of all embryo replacements in 2007 being of single embryos, 35.9% being of two embryos and <1% 
being of three or more embryos (Wang et al. 2009). The reduction in the number of embryos replaced is 
often  a  result  of  prolonged  high  pregnancy  rates  and  a  high  proportion  of  multiple  gestations  within 
individual clinics (if not legislated). The change can clearly be seen in Australia and New Zealand (see 
Figure 1.2) where the proportion of patients having three or more embryos replaced between 1998 and 
1999 was reduced, and similarly the proportion of patients having two embryos replaced between 2001 and 
2002 reduced to a greater proportion of single embryo transfers (see Figure 1.2, (Wang et al. 2008)). 
Although explanations for the shift in the number of embryos transferred are not discussed in the Australia 
and New Zealand ART report (Wang et al. 2008), these two time periods were greatly influenced by the 
improvement in embryo culture systems (Gardner et al. 1996a, Gardner and Lane 1999, Pool 2002) and the 
introduction of blastocyst transfer as a selection tool (Gardner and Lane 1997, Schoolcraft and Gardner 
2000), which resulted in an improvement in pregnancy rates and also an increase in the incidence of 
multiple gestations (see Figure 1.3). Despite the reduction in the number of embryos being transferred to 
patients in some countries, there is still a need to further reduce the number of embryos being replaced, in 
the  pursuit  for  the  majority  of  patients  to  have  a  single  embryo  replaced  during  fertility  treatment. 
Investigations into improved embryo selection methods will allow this goal to be achieved, with patients, 
their pregnancy and child being the ultimate beneficiaries.  











Figure 1.2 Proportion of embryo transfer cycles transferring one, two and three or more embryos in Australia and New Zealand. 
Adapted from (Wang et al. 2006, Waters et al. 2006, Wang et al. 2007, Wang et al. 2008, Wang et al. 2009). 
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Figure 1.3 Pregnancy rates in Australia and New Zealand 1997-2006. 
  Data obtained from (Bryant et al. 2004, Wang et al. 2009). 
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1.3  EMBRYO ASSESSMENT 
As mentioned earlier, the ability to generate multiple oocytes for IVF treatments resulted in multiple embryos 
available for utilisation. Hormonal stimulation of the ovary to produce many oocytes bypasses the natural 
atresia which a large number of oocytes undergo (Chun et al. 1996) prior to ovulation of the dominant 
follicle. Fertility treatments generate a heterogeneous cohort of meiotically mature sibling oocytes with 
differing levels of developmental competence (Pellicer et al. 1987, Stouffer and Zelinski-Wooten 2004, May-
Panloup et al. 2005, Scott et al. 2008). Therefore resultant embryos in a cohort are highly variable in quality. 
 
1.3.1  Morphological Parameters  
Observational criteria are currently the only existing routine measures available to estimate embryo quality, 
excluding pre-implantation genetic diagnosis (PGD). Relatively low implantation rates worldwide result from 
the current use of morphological assessment of embryos, with the most likely explanation for the failure of 
this system being  that  the  quality  of  an  embryo  at a  single  point  in  time  is not  representative  of  the 
developmental history of the gametes and resultant embryo and can therefore be misleading with regard to 
embryo  viability.  In  addition,  “on  time” cleavage  gives  a  measure  of  how successful an  embryo  is at 
overcoming any stressors it is exposed to and not the toll that those stressors are taking physiologically, 
which may not be observed until cleavage arrest or implantation failure result. Attempts around the world to 
improve human IVF pregnancy rates have led to the investigation of additional morphological markers 
including oocyte and pronuclear morphology, early cleavage status and blastocyst culture (Scott 2003a, 
Scott 2003b, Rienzi et al. 2005, Sakkas and Gardner 2005). 
 
1.3.1.1  Cleavage Stage Embryos  
Traditional  criteria  commonly  used  to  assess  a  cohort  of  cleavage  stage  embryos  (day  2  or  3  of 
development)  incorporate  cell  number,  integrity  of  cell  membranes,  quality  of  the  cytoplasm,  and  the 
absence of both fragmentation and multinucleation (Gerris et al. 1999, Racowsky et al. 2000, Van Royen et 
al. 2003). Of these parameters it has long been known that cleavage speed (the appropriate cell divisions 
occurring at the correct rate) is of paramount importance to animal (Van Soom et al. 1992, Grisart et al. 
1994, Gonzales et al. 1995) and human embryo competence (Cummins et al. 1986, Van Royen et al. 1999, 
Racowsky  et  al.  2000).  When  human  embryos  containing  4  blastomeres  on  day  2  (40  hours  post-
insemination) are transferred, a pregnancy rate can be obtained which is 2-fold higher than the combined 
pregnancy rate in cases where embryos containing 2, 3, 5 and 6 blastomeres are transferred (15.6% v Chapter 1: Introduction 
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7.4%, (Giorgetti et al. 1995)). Similarly, on day 3 (64 hours post-insemination), when human embryos with 
greater than 7 blastomeres are replaced, implantation rates have been shown to significantly improve (49% 
v 12%, see Table 1.1, (Van Royen et al. 1999)). These windows of assessment for „on-time‟ development 
are a critical component of the only tool that embryologists have available to assess the quality of embryos.   
 
In addition to the number of blastomeres present during assessment, the degree of fragmentation in an 
embryo is an important morphological factor of embryo scoring systems to select the most suitable embryos 
for transfer. Cellular fragmentation is common in human embryos, with the presence of up to 20% small 
scattered fragments within the zona pellucida not impacting on further development or implantation rates 
(Ziebe et al. 1997, Alikani et al. 1999). However, a high proportion of fragmentation (>35%) is associated 
with chromosomal abnormalities such as mosaicism, polyploidy and haploidy in 70-90% of embryos (Munne 
et al. 1995, Magli et al. 2001). The detrimental effect of fragmentation on embryo quality originates from the 
loss of large volumes of cytoplasm from the remaining, viable blastomeres. In particular, the release of large 
fragments  at  an  early  stage  of  pre-implantation  embryo  development  depletes  the  embryo  of  critical 
organelles such as mitochondria (Trounson and Sathananthan 1984), essential for energy generation for 
further  development.  Microsurgical  removal  of  fragmentation  has  been  performed  and  it  has  been 
hypothesised  that  removal  of  extracellular  fragments  reinstates  the  spatial  communication  between 
blastomeres, facilitating compaction, cavitation and blastocyst formation. In addition, a second hypothesis 
suggests that removal of degenerating cellular material from the embryo prevents the degeneration of 
adjacent blastomeres (Sathananthan et al. 1990). Fragment removal in embryos affected by up to 35% 
fragmentation,  has  been  shown  to  alleviate  the  reduced  implantation  rates  of  these  embryos,  to  be 
equivalent  to  the  implantation  rate  of  embryos  without  fragmentation.  However  embryos  with  >35% 
fragmentation do not show improved developmental competence from this technique, most likely due to the 
high incidence of chromosome abnormalities in these embryos (Alikani et al. 1999). Observations using 
time-lapse  photography  have  shown  creation,  as  well  as  evidence  for  the  resorption  of  fragments 
(Hardarson et al. 2002), supporting the concept that low levels of fragmentation are a healthy indication, 
and do not affect the viability of the embryo. In addition, embryos that develop in vitro with a low to 
moderate degree of fragmentation have been shown to extrude those fragments when the blastocyst forms, 
with the fragments being retained in the zona pellucida when the blastocyst undergoes hatching (see Figure 
1.4, (Veeck and Zaninovic 2003)).  This is evidence that the embryo itself is able to manage low level 
fragmentation without compromising its developmental potential.   
 
             
 
Table 1.1 Morphological measures used as assessment tools to select embryos. 
Reference  Assessment Tool  Selected Patients 
(Y / N) 
Implantation Rates 
(measure v comparison)* 
Significant 
Improvement in 
Implantation Rates  
(Y / N) 
(Scott and Smith 1998) 
(Ludwig et al. 2000) 
(Scott et al. 2000) 
(Tesarik et al. 2000) 
(Wittemer et al. 2000) 
(De Placido et al. 2002) 
(Balaban et al. 2001) 
(Montag and van der Ven 2001) 








28% v 2% 
22% v 4% 
31% v 19% 
30.2% v 11.2% 
25.8% v 11.8% 
15.7% v 7.1% 
42.2% v 8.3% 









(Shoukir et al. 1997) 
(Bos-Mikich et al. 2001) 
(Lundin et al. 2001) 
(Petersen et al. 2001) 
(Sakkas et al. 2001) 
(Fenwick et al. 2002) 
(Salumets et al. 2003)† 
Early cleavage  Y (n = 143) 
N (n = 74) 
N (n = 727) 
Y (n = 200) 
N (n = 230) 
Y (n = 70) 
Y (n = 178) 
23.6% v 7.5% 
18% v 8% 
28% v 19.5% 
17.5% v 5.9% 
26.1% v 17.3% 
21.4% v 6.0% 








(Steer et al. 1992) 
(Van Royen et al. 1999) 
(Desai et al. 2000) 
(De Placido et al. 2002) 
Day 3 morphology  Y (n = 390) 
Y (n = 221) 
N (n = 93) 
Y (n = 154) 
33% v 8% 
49% v 12% 
35% v 12% 





(Hardarson et al. 2001)  Even cell division  N (n = 378)  36.4% v 23.9%  Y 
(Ziebe et al. 1997) 
(Alikani et al. 1999) 
Fragmentation  Y (n = 1001) 
N (n = 1727) 
21% v 5% 





             
Table 1.1 continued 
 
Reference  Assessment Tool  Selected Patients 
(Y / N) 
Implantation Rates 
(measure v comparison)* 
Significant 
Improvement in 
Implantation Rates  
(Y / N) 
(Racowsky et al. 2000) 
(Shapiro et al. 2000) 
Rate of development  Y (n = 362) 
N (n = 93) 
24.2% v 7.9% 
43% v 17% 
Y 
Y 
(Rijnders and Jansen 1998) 
(Scholtes and Zeilmaker 1998) 
(Balaban et al. 2000) 
(Balaban et al. 2001) 




N (n = 1532) 
Y (n = 350) 
N (n = 320) 
Y (n = 100) 
30.1% v 0% 
23% v 6% 
44.9% v 7.1% 
21% v 11.6% 






(Fisch et al. 2001) 
(De Placido et al. 2002) 
Combined morphlogy 
scores 
Y (n = 109) 
Y (n = 154) 
39% v 24% 




* test measures were only occasionally compared to standard practice, and often compared implantation rates between more than 2 groups, 
therefore  the  highest  and  lowest  implantation  rates  are  reported  in  this  summary  for  each  study.  Implantation  rates  presented  may  be  a 
comparison between high and low scores of different parameters e.g. pronuclear score or blastocyst score.  
†Significantly, this study is the only study reported above that was performed using single embryo transfers. 
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More  recently,  blastomere  size  has  been  recognised  as  an  important  measure  of  embryo  viability. 
Blastomeres of uneven size result when cells do not divide equally, and embryos with disproportionate cell 
cleavage have been shown to have a lower developmental capacity when compared to evenly cleaved 
embryos (Giorgetti et al. 1995, Hardarson et al. 2001). The reduced viability of embryos with unevenly 
cleaved blastomeres can in part be explained by unequal division of cellular organelles, which increases the 
likelihood of fragmentation as well as a higher degree of both multinucleation and aneuploidy (Hnida et al. 
2004). 
 
The  criteria  outlined  above  are  measures  that  are  common  in  most  all  IVF  laboratories  that  transfer 
cleavage stage embryos. This system is valuable in the elimination of embryos with little developmental 
potential but is limited in its ability to predict viability (see Figure 1.5, (Langley et al. 2001). This is evidenced 
by the large number of high morphological quality cleavage stage embryos transferred that do not establish 
a  pregnancy.  As  a  result  there  have  been  attempts  to  increase  the  discriminatory  nature  of  the 
morphological  scoring  system  by  including  one  or  more  additional  observations  such  as  pronuclear 
morphology, assessment of the timing of the first cleavage (early cleavage) and ability to develop to the 
blastocyst stage, in an attempt to gain additional information to assist in the selection of the most viable 

















Figure 1.4 Hatching human blastocyst with fragmentation and cellular debris remaining in the zona 
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Figure 1.5 Relationship between day 3 cell number and blastocyst development. 
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1.3.1.2  Pronuclear Morphology  
Pronuclear  morphology  is  the  earliest  point  at  which  the  newly  formed  embryo  can  be  assessed. 
Assessment of normal oocyte fertilization 16-19 hours following insemination involves the visualisation of 
two  pronuclei  (PN)  and  two  polar  bodies.  The  appearance,  pattern  and  polarity  of  the  pronuclei  and 
nucleolar precursor bodies (NPBs, see Figure 1.6) has been suggested to be an important indicator of 
zygote quality and therefore predictive of embryo quality and viability (see Table 1.1, (Scott and Smith 1998, 
Tesarik and Greco 1999, Tesarik et al. 2000, Wittemer et al. 2000, Balaban et al. 2001, Montag and van der 
Ven 2001). The number of NPBs and the presence or absence of NPB polarisation has been retrospectively 
linked to the developmental fate of human embryos (Tesarik and Greco 1999). However, the sequence and 
timing of the morphological events of fertilization have been observed with time lapse imaging and vary 
between  and  within  good  and  poor  morphology  embryos  (Payne  et  al.  1997).  Payne  et  al.  (1997) 
demonstrated that in the majority of cases, asynchronous pronuclei development does not occur, which 
suggests  that  the  assessment  window  for  pronuclear  morphology  predicting  implantation  potential  is 
extremely fluid. Other laboratories have been unable to demonstrate any value in determining nucleolar 
distribution or alignment after assessing more than 2000 fertilized oocytes (Clarke et al. 2001). In addition, 
Veeck and Zaninovic (2003) in another large study of 258 patients and more than 2000 zygotes observed 
few differences in the different classifications of pronuclear score. A zygote sub-type with scattered NPBs 
was more likely to undergo early cleavage, while a sub-type with aligned NPBs was more likely to result in a 
good quality embryo on day 3 of development. Furthermore, no zygote morphology classification was 
correlated with development to blastocyst stage, however as no embryo transfers were reported in this 
study, implantation ability is unknown (Veeck and Zaninovic 2003). As a result, some clinics have deemed 
pronuclear morphology to confer no benefit for the selection for transfer or prediction of subsequent in vitro 
development.  
 
1.3.1.3  Early Cleavage  
The rate at which the first cleavage division in human embryos occurs has also been used as an added 
measure to morphological scoring systems. Human embryos which have undergone the first cell division by 
24-27 hours following insemination, show improved implantation rates (see Table 1.1, (Shoukir et al. 1997, 
Sakkas et al. 1998, Bos-Mikich et al. 2001, Lundin et al. 2001, Salumets et al. 2003)). Furthermore, this 
parameter is one of the few markers of viability that has been assessed in an elective single embryo 
transfer program which showed a near 2-fold increase in implantation rates when an embryo which had 
undergone the first cleavage by 25-27 hours post-insemination was transferred, compared to an embryo 
which had not cleaved at that time point (Salumets et al. 2003). A significant barrier to the application of Chapter 1: Introduction 
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„early cleavage‟ as a predictive parameter is the susceptibility of the embryo to its culture system. For 
example:    the  gonadotrophin  stimulation  regime;  the  use  of  different  commercial  culture  media; 
maintenance of correct temperature and pH during and following oocyte retrieval and handling between 
retrieval, insemination and fertilization assessment, can greatly influence the rate of embryo development, 
rendering a standard „early cleavage‟ time point in one laboratory, ineffective in another. Differences in a 
laboratory‟s culture system, therefore require a new validation of the early cleavage „window‟, which may 
differ between clinics. This creates a significant logistic exercise in a clinical setting.  
 
1.3.1.4  Blastocyst Culture  
The majority of embryos in the first two decades of IVF were transferred at the pronucleate or cleavage 
stage  of  development.  This  stems  from  the  poor  capacity  of  embryo  culture  systems  to  support  the 
development of embryos beyond this point. However, with the advent of improved culture systems (Gardner 
et al. 1996a, Gardner and Lane 1997, Gardner and Schoolcraft 1999, Schoolcraft and Gardner 2000, Pool 
2002), extended culture of embryos to the blastocyst stage (day 5/6) has been employed as an alternative 
clinical procedure in many IVF clinics, with the goal of transferring fewer embryos of higher viability, to 
reduce multiple births (Gardner et al. 2000a, Wilson et al. 2002). The ability of an embryo to develop to the 
blastocyst stage in vitro has been proposed as an indicator of embryo viability (Gardner et al. 2002) and a 
valuable selection technique, as after 5 days in culture embryos begin to differentiate themselves within a 
cohort as  arrested or developmentally  slow,  with  on  average only 50%  of  embryos  developing  to  the 
blastocyst stage. In addition, the degree of expansion of the blastocyst and differentiation into the inner cell 
mass and trophectoderm cell types of the blastocyst allow for further discrimination into the quality of 
individual embryos. The transfer of blastocysts has shown improved implantation rates in many clinics (see 
Table 1.1, (Dokras et al. 1993, Gardner and Lane 1997, Milki et al. 2000, Schoolcraft and Gardner 2000, 
Langley et al. 2001)), which is a prerequisite in the pursuit towards single embryo transfers. In contrast, 
other clinics have reported no change in implantation rates (Coskun et al. 2000, Huisman et al. 2000), and 
one clinic reported a decrease in implantation rates (Levron et al. 2002). The reasons for the mixed results 
following blastocyst culture have been discussed in more detail elsewhere (Blake et al. 2002, Gardner and 






Figure 1.6 Z-scoring system for zygotes. 
Z scores describe the number, size and position of the nucleoli and the equality between the nucleoli. Z1 
zygotes have equal numbers of nucleoli which are aligned at the pronuclear junction. Z2 zygotes have an 
equal size and number of nucleoli that are not yet aligned. Z3 zygotes have nucleoli that are unequal in 
alignment, number or size. Z4 zygotes are grossly abnormal with unequal pronuclei and unequal nucleoli in 
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Blastocyst  culture  is  more  demanding  on  personnel  and  resources,  as  it  requires  a  multistep  culture 
regimen for optimal development.  This may explain some of the variations in results (Gardner et al. 1998a, 
Coskun et al. 2000, Karaki et al. 2002, Levron et al. 2002, Rienzi et al. 2002, Utsunomiya et al. 2002, Van 
der Auwera et al. 2002, Bungum et al. 2003, Emiliani et al. 2003, Frattarelli et al. 2003, Margreiter et al. 
2003). Furthermore, the introduction of extended culture has been met with some reluctance relating to the 
unknown long term effects of culturing human embryos for up to 6 days in the laboratory (Leese et al. 1998, 
Martin 2004) as there has been reports that mouse embryos cultured to the blastocyst stage in poor culture 
conditions, exhibited perturbed gene expression of imprinted genes (Doherty et al. 2000), and that longer 
time periods of in vitro culture result in an increase in aberrant imprinting (Rivera et al. 2008). Currently, the 
data collected on imprinted disorders in the human does not discriminate between cleavage or blastocyst 
stage transfers, however, as these studies incorporate cohorts of children born prior  to the year 2000 
(reviewed by (Manipalviratn et al. 2009)), it could be presumed that the effect of blastocyst culture and 
imprinting disorders has not yet been adequately investigated in children born following blastocyst transfer. 
However, studies to date have concluded that due to the low incidence of imprinting disorders (<1:12000 
births) large cohort studies are required to determine an association between imprinting disorders and ART.  
 
Blastocyst culture and transfer are expensive and labour intensive for both the patient and laboratory staff, 
and for this reason many clinics around the world are unable to provide extended culture as an option to 
patients for either legal or practical reasons. Therefore viability determinants that can be easily incorporated 
into any IVF clinic worldwide are highly desired.  
 
It is important to note that the majority of studies which have explored additional morphological measures to 
select the most viable embryo for transfer are confounded by the practice of multiple embryo transfer. Some 
studies manage this by analysing patients who have only embryos of one distinct description transferred. 
However, the intrauterine communication between multiple embryos and the endometrium compared with a 
single embryo is different and therefore single embryo transfers are the only true validation of independent 
embryo viability markers in human IVF (Matorras et al. 2005). 
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1.4  OOCYTE HEALTH 
Gamete quality is a crucial component of embryo health and therefore a viable pregnancy. As such the 
oocyte and its influencing factors are fundamental in the determination of viability markers (Hardy et al. 
1995).  The  cumulus-oocyte  complex  (COC)  is  contained  within  the  ovarian  follicle  where  growth  and 
development of the somatic cells and oocyte occur in a highly coordinated and mutually dependent fashion 
(see Figure 1.7, (Gilchrist et al. 2004)). A dynamic bi-directional communication exists between cumulus 
cells and the enclosed oocyte which is essential for oocyte viability.  The oocyte secretes growth factors 
such as growth differentiation factor-9 (GDF-9) and bone morphogenic protein-15 (BMP-15), which act on 
the surrounding cumulus cells to regulate gene expression and metabolism which, in turn, impact on oocyte 
function and viability (Eppig 2001, Gilchrist et al. 2004, Sugiura et al. 2005). As evidenced by mouse and 
sheep gene knockout models, oocyte derived factors are essential for fertility (Dong et al. 1996, Galloway et 
al. 2000, McNatty et al. 2005).  
The close proximity of the cumulus cells to the oocyte makes them an ideal candidate to investigate the 
potential viability of the oocyte. In addition, cumulus cells are not utilised during infertility treatments and are 
routinely removed and discarded during handling of oocytes. Researchers are now exploiting cumulus cells 
to discover markers of oocyte viability that can be implemented into infertility clinics to improve clinical 
outcomes. A marker of oocyte viability would have further additional value in countries where the number of 
embryos able to be created is restricted by legislation, as well as overcoming the moral dilemma of creating 















Figure 1.7 Follicle diagrammatic representing regulation of cumulus-oocyte complex health. 
Schematic of the regulatory loop between the cumulus cells and oocyte. Oocytes secrete soluble growth 
factors (GDF-9 and BMP-15) which regulate cumulus cell gene expression and key cumulus cell functions. 
In addition, cumulus cells pass regulatory growth factors and small metabolites back to the oocyte via 
paracrine and gap-junctional signalling, with the influence of maternal signals such as Follicle Stimulating 
Hormone (FSH, (Eppig 2001, Gilchrist et al. 2004, Sugiura et al. 2005)). Chapter 1: Introduction 
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1.5  FOLLICULAR FLUID 
Follicular fluid provides an important environment for oocyte development (Downs and Eppig 1984, Naito et 
al. 1989), and is readily available as part of IVF treatments as it is aspirated to recover the oocyte. It is 
therefore  a  reasonable  candidate  to  investigate  its  role  in  determining  oocyte  quality  and  subsequent 
developmental  potential.  It  is  known  that  altered  follicular  environments  can  influence  oocyte  quality 
(Nayudu et al. 1987, Nayudu et al. 1989, Artini et al. 1994, Gregory et al. 1994, Van Blerkom et al. 1997), 
however, to date no reliable biochemical factor able to determine oocyte viability has been identified. A 
recently published review has covered the parameters of follicular fluid that have been investigated as 
markers of oocyte quality in detail (reviewed by (Revelli et al. 2009)), including:  
  Hormones – follicle stimulating hormone (FSH), LH, human chorionic gonadotrophin (hCG), growth 
hormone, prolactin, oestrogen and progesterone, cortisol and cortisone. 
  Growth factors – Inhibin A and B, Activin A, Anti-Mullerian Hormone, BMP-15, Insulin-like Growth 
Factors  1  and  2  (IGF-1,  IGF-2)  and  their  binding  proteins  (IGFBP-1,  IGFBP-2),  amphiregulin 
(AREG) and vascular endothelial growth factor (VEGF). 
  Interleukins  –  interleukin-1β,  interleukin-2,  interleukin-10  and  interferon-γ,  granulocyte  colony-
stimulating factor, interleukin-1α, tumor necrosis factor alpha (TNF-α) and leukotriene B4. 
  Reactive  Oxygen  Species  and  antioxidants  –  reactive  oxygen  species  (ROS),  superoxide 
dismutase, selenium-dependent glutathione peroxidase, melatonin, 8-hydroxy-2-deoxy-guanosine 
(8-OHdG), total antioxidant capacity (TAC) and nitric oxide.  
  Anti-apoptotic factors – tumor necrosis factor and its receptor and Fas-ligand and its receptor. 
  Proteins – α-fetoprotein, carcinoembryonic antigen (CEA), cancer antigen 125 (Ca-125), antigen 
CD44, α-1-antitrypsin, leptin, endothelin-2, oocyte maturation inhibitor, homocysteine, β-endorphin, 
lactoferrin, angiotensin II and prorenin. 
  Amino acids – glycine, alanine and aspartic acid. 
  Sugars – hyaluronan and myo-inositol. 
  Prostanoids – prostaglandin F2α and prostaglandin E2. 
 
Despite the large number of biochemical factors that have been evaluated in the pursuit to identify a marker 
of oocyte quality, very few of these studies have correlated potential markers to the ultimate developmental 
competence  of  the  oocyte  and  resultant  embryo.  Rather,  many  studies  had  endpoints  of  maturation, 
fertilization and occasionally embryo morphology (reviewed by (Revelli et al. 2009)). Follicular fluid factors 
that have correlated to pregnancy in human following IVF include increased LH (Mendoza et al. 2002), Chapter 1: Introduction 
 
Feil    Page 42  
         
decreased as well as increased levels of growth hormone (Tarlatzis et al. 1993, Mendoza et al. 2002) 
respectively), higher prolactin levels (Laufer et al. 1984, Mendoza et al. 2002), specific ranges of oestrogen 
and progesterone (Botero-Ruiz et al. 1984, Kreiner et al. 1987), increased cortisol/cortisone ratio (Keay et 
al. 2002, Lewicka et al. 2003), elevated inhibin A and B (Ocal et al. 2004), increased IGF-1/IGFBP-1 ratio 
(Fried et al. 2003), decreased interleukins (Mendoza et al. 2002, Ledee et al. 2008), increased ROS and 
TAC (Attaran et al. 2000, Pasqualotto et al. 2004), lowered VEGF (Ocal et al. 2004) and decreased leptin 
levels (Mantzoros et al. 2000). Many of these factors are controversial as predictors of IVF pregnancy 
establishment as observations were not able to be confirmed in other studies (Revelli et al. 2009). In recent 
years,  the  research  in  this  area  has  progressed  toward  metabolomics  i.e.  analysis  of  all  substances 
contained in a biological fluid. Thomas and colleagues (2000) demonstrated differences in oestrogen and 
progesterone levels between small and large antral follicles with this technique, however further analysis on 
oocyte developmental fate was not included in the study (Thomas et al. 2000). A subsequent investigation 
of follicular fluid demonstrated reliably produced unique „fingerprints‟ that may be predictive of oocyte quality 
and successive pregnancy (Agarwal et al. 2006).  
 
It is important to note that for follicular fluid to be related to resultant oocyte and embryo quality, follicles 
must be aspirated individually. This method requires flushing of the needle used for oocyte aspiration to 
ensure  retrieval  of  the  oocyte,  if  any,  from  each  follicle,  and  requires  multiple  vaginal punctures  with 
associated increased risk of vaginal bleeding and discomfort for the patient. In addition, it is not clear if 
follicular fluid parameters are a variable related to the quality of the follicle and potentially reflective of 
oocyte quality, or to the clinical characteristics of the patient, such as age, smoking habit or etiology. 
Therefore,  the  introduction  of  new  techniques  in  this  field  require  further  analysis  and  validation  to 
determine if a viable follicular fluid biomarker can be discovered. 
 
1.6  CUMULUS CELLS 
1.6.1  Cumulus Cell Gene Expression  
Oocyte  secreted  factors are  essential  for  appropriate  cumulus  cell  gene  expression  in  animal  models 
(Gilchrist et al. 2004). In the final stages of oocyte maturation, the expression of several critical periovulatory 
cumulus cell genes are induced by oocyte secreted factors, which regulate the mucification of the cumulus-
oocyte matrix, particularly in mouse and sheep (Dong et al. 1996, Juengel et al. 2002). These genes are 
crucial for cumulus expansion, ovulation and fertilization, which has been demonstrated by gene deletion Chapter 1: Introduction 
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studies in mice and sheep, including tumour necrosis factor alpha inducible protein 6 (Tnfαip6), pentraxin-3 
(Ptx-3) and prostaglandin-endoperoxide synthase 2 (Ptgs2) (Lim et al. 1997, Varani et al. 2002, Fulop et al. 
2003, Ochsner et al. 2003, Salustri et al. 2004). The ability of cumulus cell gene expression to reflect oocyte 
competence in the human has been investigated by a small number of recent studies. Initially, McKenzie 
and colleagues (2004) retrieved cumulus cells from 8 patients undergoing intra-cytoplasmic sperm injection 
(ICSI) and determined that PTGS2, gremlin 1 (GREM1) and hyaluronan synthase 2 (HAS2) have increased 
expression in cleavage stage embryos with good morphological scores compared to embryos with a poor 
morphological score. This result was subsequently confirmed in 45 patients for HAS2 and GREM1 (Cillo et 
al. 2007). In contrast, it has been found that there was no predictive value of cumulus cell gene expression 
when  investigating  cleavage  stage  embryo  quality,  however  those  oocytes  that  went  on  to  develop 
blastocysts  were  found  to  have  reduced  expression  of  steroidogenic acute  regulatory  protein  (STAR), 
PTGS2, gap junctional α1 (CX43), AREG and delta-9 desaturase 1 and 5 (SCD1 and SCD5) in cumulus 
cells (Feuerstein et al. 2007). These observations, although of interest, are of limited value in a clinical 
setting. Embryo morphology can be determined in a timely manner by a simple observation without the 
requirement for the examination of gene expression levels. However, to further investigate the potential of 
such a technique, correlation of the findings to pregnancy establishment would be an extremely valuable 
study to undertake. Anderson and colleagues (2009) attempted to investigate this, though with the majority 
of patients in their study having two embryos transferred, clear analysis of pregnancy outcome was difficult. 
Despite this, PTGS2 expression was increased in cumulus cells that resulted in a good morphological 
quality  embryo,  a  further  validation  of  earlier  results  (McKenzie  et  al.  2004,  Anderson  et  al.  2009). 
Furthermore, brain-derived neurotrophic factor (BDNF) expression of was also increased in cumulus cells 
that resulted in good quality cleavage stage embryos  (Anderson et al. 2009). In another evaluation of 
cumulus  cell  gene  expression,  a  microarray  of  pooled  cumulus  samples  from  20  patients  comparing 
resultant good morphological quality embryos to resultant poor quality embryos and unfertilized oocytes 
following  IVF,  160  genes  involved  in  cell  cycle,  cell  proliferation,  apoptosis,  oncogenesis,  energy 
metabolism and mitochondrial proteins were found to be differentially expressed (Zhang et al. 2005). A 
subsequent study determined by microarray that BCL2-like 11 (BCL2L11, an apoptosis promoting factor), 
phosphoenolpyruvate carboxykinase 1 (PCK1, an enzyme involved in gluconeogenesis) and nuclear factor 
IB  (NFIB, a transcription factor) in cumulus cells were correlated with pregnancy, and importantly that the 
gene expression profiles of embryos with a good morphology on day 3 of development were different to the 
expression profiles of embryos which resulted in pregnancy (Assou et al. 2008). Multiple embryos were 
transferred  in  this  study  and  thus  to  date  the  lack  of  single  embryo  transfer  studies  in  this  area  of 
investigation mean the ability of cumulus cell gene expression markers to predict embryo competence, 
although promising still remains unanswered. Chapter 1: Introduction 
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1.6.2  COC Metabolism  
A vital function of the cumulus cells is to control the nutrient balance of the developing oocyte (reviewed by 
(Sutton et al. 2003a, Sutton et al. 2003b)). Glucose is the principal substrate of cumulus cells, which is 
metabolised to lactate and pyruvate, the predominant energy source of the oocyte (Gardner et al. 1996a). 
Oocytes utilise glucose poorly as an energy substrate and rely on cumulus cells to provide the products of 
glycolysis, such as pyruvate, by either secreting them or passing them through gap junctions that couple the 
two cell types (Biggers et al. 1967, Donahue and Stern 1968, Leese and Barton 1985, Sugiura et al. 2007). 
Paracrine factors secreted by the oocyte promote expression of glycolytic enzymes to regulate glycolysis in 
cumulus cells (Sugiura et al. 2005). A disruption in the balance of the consumption and production of 
carboxylic acids alters the metabolites available to the oocyte to support growth and maturation. Despite the 
cumulus cells playing such an important role in the utilisation of energy substrates by the oocyte, there is 
minimal information regarding the metabolic profile of the COC, with most studies focusing on the denuded 
oocyte.  
 
Disruption of the carbohydrate balance in metabolism in mouse, pig and cow COCs perturbs resultant 
embryo developmental competence indicating that metabolic balance in the cumulus cells is essential for 
oocyte competence (Sutton-McDowall et al. 2004). It is however, likely that a disruption in the balance of 
glucose metabolism to pyruvate in human cumulus cells may similarly effect the viability of  the human 
oocyte. While this has not been assessed directly, a study by Rice et al. (2005), demonstrated that cumulus 
cells from anovulatory women with polycystic ovary syndrome (PCOS) have perturbed levels of glucose 
conversion to lactate and the resultant oocytes produced embryos of lower morphological score (Rice et al. 
2005). Therefore, it is possible that measurement of cumulus cell metabolism, especially the change in 
substrate levels found in medium used for short-term incubation of COCs, may be a useful marker of the 
conditions that the cumulus cells have developed under within the follicle. 
 
1.6.3  COC Oxidative State  
Oxidative stress results when an elevation in the level of reactive oxygen species (ROS) which exceeds a 
cell‟s level of antioxidant defence mechanisms (see Figure 1.8). The oxidative status of a cell can be a 
marker of both normal physiological processes and cellular stress. ROS result from external environmental 
factors as well as normal cellular metabolism (see Figure 1.8).  Excessive ROS result in damage to lipids, 
proteins and DNA causing cellular damage and reducing viability. Bovine and human cumulus cells have 
antioxidant activity through enzymatic measures such as glutathione peroxidase, catalase and superoxide 
dismutases (SODs, (Cetica et al. 2001, Matos et al. 2009). Thus as the cumulus cells have the ability to 
regulate their oxidative state, this has potential as a marker of health of the follicular environment and Chapter 1: Introduction 
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cumulus cells and subsequently the oocyte. The protective effect of the cumulus cells from ROS has been 
clearly demonstrated with denuded oocytes undergoing meiotic arrest and degenerating when exposed to 
ROS  without  the  protective  buffer  of  the  cumulus  cells  (Tatemoto  et  al.  2000).  Eight-hydroxy-2-
deoxyguanosine (8-OHdG) is produced as a byproduct of DNA damage caused by reactive oxygen species 
(Floyd 1990), and is therefore a measure of oxidative stress in biological systems (Beckman and Ames 
1997). In granulosa cells of patients undergoing IVF, 8-OHdG was found to adversely affect fertilization and 
subsequent embryo quality (Seino et al. 2002). Although granulosa and cumulus cells were separately 
investigated in this study, within patients the follicular aspirates were pooled so cumulus and granulosa cells 
from  individual  follicles  and  associated  oocytes  were  not  tracked.  This  is  a  technically  and  resource 
demanding  task  which  is  unlikely  to  be  implemented  in  a  clinical  setting  and  therefore  alternative 
methodology for such investigations would need to be explored.  
 
Cumulus cells are a promising candidate as a marker of oocyte health as they are surplus to the  IVF 
process. However, methods of collection and tracking need to be employed, that enable a single oocyte to 
be traced throughout the process and subsequently single embryo transfer assessment is required for the 













Figure 1.8 REDOX imbalance in mitochondria of cumulus cells. 
Normal cellular metabolism and external factors produce reactive oxygen species (ROS), which are important second messengers in many processes. Antioxidant defence mechanisms 
neutralise high levels of ROS to prevent cellular damage and activation of the apoptotic cascade. Excess ROS production or reduced antioxidant capacity result in an oxidative state or 
REDOX imbalance in the cell which compromises viability. IMS – intermembrane space, IMM – inner mitochondrial membrane, complex I – NADH dehydrogenase, complex II – 
succinate dehydrogenase, complex III – cytochrome bc1 complex, complex IV – cytochrome c oxidase, Q – ubiquinone, Cyt C – cytochrome c, ATP – adenosine triphosphate, H+ - 
proton, O2 – oxygen, e- - electron and O2- - superoxide.  Chapter 1: Introduction 
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1.7  EMBRYO HEALTH 
1.7.1  Embryo Metabolism 
The pre-implantation embryo has a dynamic metabolism, which differs significantly from that of somatic 
cells. The mammalian oocyte and zygote have a requirement for pyruvate as the predominant energy 
substrate (Biggers et al. 1967). From the 2-cell stage lactate can be used as a substrate, while glucose is 
not the preferred substrate until the blastocyst stage (see Figure 1.9, (Leese and Barton 1984, Gardner and 
Leese 1986, Hardy et al. 1989, Gott et al. 1990, Rieger et al. 1992, Thompson et al. 1992, Gardner et al. 
1993)). During this period of 4-6 days, the oocyte develops from a single cell that is quiescent and has a 
metabolic quotient similar to bone, to a multi-cellular blastocyst which has differentiated into 2 cell types, the 
inner cell mass (ICM) and the trophectoderm, and has a metabolic quotient similar to a tumour cell (Gardner 
and Lane 2003). Therefore, there are coordinated changes in the control of metabolism within the early 
embryo that must occur for normal metabolic capacity and developmental competence to be maintained. 
Metabolic  control  in  animal embryos  has  been  shown  to  be  essential for the  maintenance  of  viability 
(Gardner 1998, Gardner et al. 2000b, Lane and Gardner 2000a). Perturbations in metabolic parameters of 
embryos have been associated with a loss in viability (Lane 2001) and specific metabolic measures in 
animal models have been demonstrated to have a positive relationship with embryo viability (Renard et al. 
1980, Gardner and Leese 1987, Lane and Gardner 1996). Therefore, the energy metabolism of human 
embryos in in vitro culture has the potential to be used to predict viability. Non-invasive measurements of 
carbohydrates and amino acids have been extensively studied in the human with varying success and have 
potential to be employed as viability markers in the clinic (Leese et al. 1993, Turner et al. 1994, Gardner et 



































Figure 1.9 Consumption of pyruvate and glucose of the human pre-implantation embryo. 
Pyruvate is the dominant substrate until the blastocyst stage when glucose uptake significantly increases. 
(data from (Gott et al. 1990)). 
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1.7.2  Carbohydrate Metabolism  
Several studies have indicated that disrupted balance of carbohydrate metabolism is related to poor 
development in mouse and human embryos. A prospective study in the mouse with single embryo 
transfers  was  able  to  show  that  glycolytic  activity  (i.e.  glucose  uptake  and  lactate  production)  in 
blastocysts is a predictor of viability, where there was a 4-fold increase in viability in morphologically 
similar blastocysts selected using metabolic criterion over random selection. This demonstrates that 
metabolism can be used as a predictor of viability to differentiate morphologically similar blastocysts 
(Lane and Gardner 1996). In the human there have also been studies that have assessed embryo 
metabolism (Hardy et al. 1989, Gott et al. 1990, Conaghan et al. 1993b, Turner et al. 1994, Gardner et 
al. 2001, Seli et al. 2008). High levels of pyruvate uptake measured at intervals between day 2 of 
human embryo development and day 5 have shown improved development rates to the blastocyst 
stage (Hardy et al. 1989, Gott et al. 1990, Gardner et al. 2001). In further investigation of metabolic 
parameters with regard to pregnancy establishment, one study  of 44 patients found that glycolytic 
activity did not predict pregnancy outcome (Jones et al. 2001). However, the implantation rates in this 
study were very low (14%), likely due to the incubation medium lacking key regulators such as pyruvate, 
lactate,  amino acids  and vitamins,  which  may  have  resulted  in  significant  metabolic  stress on  the 
embryos  and  confounded  the  outcome.  In  contrast,  a  study  of  42  patients,  in  complete  medium, 
demonstrated that embryos with lower glycolytic activity had significantly higher pregnancy rates (Van 
den Bergh et al. 2001). This study did not alter the routine culture conditions for the analysis and the 
resultant  implantation  rates  were  in  an  acceptable  clinical  range  (43%).  In  addition,  glucose 
consumption on day 4 of human embryo development has been shown to be twice as high in embryos 
that subsequently form blastocysts, and within a patient‟s cohort, blastocysts with the same morphology 
score demonstrated a significant range of metabolic activity (Gardner et al. 2001), indicating as shown 
in  the  mouse,  that  metabolism  can  differentiate  morphologically  similar  blastocysts  with  regard  to 
viability. A limitation of this approach is that blastocyst culture is unlikely to be adopted as a routine 
treatment in the majority of clinics due to legal restrictions in some countries or technical and resource 
issues as highlighted previously. The majority of IVF transfers involve cleavage stage embryos so it is 
important to attempt to identify markers able to select the most viable embryo at the cleavage stage of 
development, or earlier in some cases, as legislation permits. 
 
In the human cleavage stage embryo, pyruvate uptake was found to be approximately 20% less in 
embryos which arrest at the cleavage stage compared to embryos that subsequently developed to the 
blastocyst  stage  (Hardy  et  al.  1989).  However,  the  small  range  of  differences  observed  between 
embryos with differing potential to form blastocysts most likely would not be sufficiently critical to  Chapter 1: Introduction 
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implement as a robust marker of viability in the clinic (Hardy et al. 1989). A subsequent study of 116 
patients with 243 embryos transferred, reported an inverse relationship between pyruvate uptake and 
pregnancy establishment (Conaghan et al. 1993b). Alternatively, Turner and colleagues (1994) found no 
difference in the mean pyruvate uptake of cleavage stage embryos, however the range in levels of 
pyruvate consumption was significantly larger in embryos which did not result in pregnancy. This study 
is particularly significant considering that single embryo transfers were performed on all 80 patients 
involved (Turner et al. 1994). Glucose uptake at the cleavage stage has been shown to be virtually 
identical between embryos that arrest and those that form blastocysts. If this study had been able to 
perform embryo transfers, subsequent blastocysts may have been able to be deemed viable or non-
viable to further evaluate glucose uptake at the cleavage stage as a potential marker of embryo health 
(Hardy et al. 1989).  
 
1.7.3  Amino Acid Metabolism  
Amino acids maintain cellular functions, promote development and differentiation (Bavister 1995), and 
are present in high levels in the female reproductive tract (Fahning et al. 1967, Miller and Schultz 1987). 
Glycine, taurine, alanine, aspartate, glutamine and glutamate are present at the highest concentrations, 
which excluding glutamine and taurine, are part of Eagle‟s non-essential amino acids (Eagle 1959). 
Supplementation of amino acids in embryo culture medium improves blastocyst development in mouse 
(Dumoulin et al. 1992a, Dumoulin et al. 1992b, Gardner and Lane 1993, Gardner and Lane 1996), 
hamster (McKiernan et al. 1995), sheep (Gardner et al. 1994), cow (Takahashi and First 1992, Steeves 
and Gardner 1999b) and human (Devreker et al. 1998, Devreker et al. 1999, Devreker et al. 2001). 
More specifically, there is a shift in amino acid requirements in the pre-implantation embryo. Up to the 8-
cell stage, non essential amino acids and glutamine enhance cleavage speed (Lane and Gardner 
1997a, Steeves and Gardner 1999b), which is reflective of the amino acids found in high levels in 
oviduct fluid. After the 8-cell stage, these same amino acids promote blastocyst formation, while the 
essential amino acids stimulate cell division and inner cell mass development (Lane and Gardner 1994). 
Overall, and most importantly, amino acids improve the viability of in vitro embryos following transfer 
(Gardner and Sakkas 1993, Gardner et al. 1994, Lane and Gardner 1997a). Alternatively, addition of 
Eagle‟s essential amino acids reduces mouse blastocyst cell number (Lane and Gardner 1997b) and 
viability (Lane and Gardner 1994). Furthermore, morulae grown in medium lacking amino acids result in 
blastocysts which produce very high levels of lactate indicating impaired oxidative metabolism (Gardner 
and Leese 1990), whilst amino acid supplementation of the medium prevents excess lactate production 
(Gardner and Sakkas 1993). Pre-implantation embryo development is inhibited by a range of amino 
acids  including  proline,  cysteine,  arginine  and  phenylalanine,  which  has  been  demonstrated  with 
hamster embryos (Bavister and Arlotto 1990). Subsequently, inclusion of non-essential amino acids and Chapter 1: Introduction 
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glutamine at the cleavage stage and all 20 amino acids following the 8 cell stage have been shown to 
improve mouse and human embryo development and viability (Gardner et al. 1998a, Gardner et al. 
1998b, Jones et al. 1998), and are now incorporated into complete sequential media formulations 
(Gardner and Lane 2004). 
 
The laboratory of H. J. Leese has pioneered the profiling of amino acids as predictors of embryo quality 
and pregnancy outcome. Partridge and Leese (1996) showed that individual amino acids are depleted 
by bovine embryos throughout pre-implantation development and that amino acid requirements change 
during development, suggesting that determination of amino acid profiles from spent media may be a 
suitable marker of embryo physiology, health and viability. Following this, Houghton et al. (2002) was 
the first to demonstrate a link between non-invasive amino acid metabolism and embryo developmental 
competence by showing that amino acid profiles on day 2 of human embryo development were able to 
predict the ability of an embryo to form a blastocyst. Embryos which formed blastocysts consumed lower 
levels of arginine and glutamine, while producing lower levels of alanine and threonine compared to 
embryos  which  subsequently  arrested  development.  Furthermore,  the  total  amino  acid  turnover  of 
embryos which developed to blastocysts was lower, and importantly, these metabolic measures were 
independent of morphological parameters of the embryos (Houghton et al. 2002). Consequently, Brison 
et al. (2004) performed a study investigating the relationship between day 2 human embryo amino acid 
profiles and the ability of the embryos to establish pregnancy and result in live birth. No amino acid 
metabolism was correlated with morphological embryo grade, however asparagine, glycine and leucine 
turnover were significantly associated with live birth (Brison et al. 2004a). Although some single embryo 
transfers were performed in this study, the mean number of embryos replaced in the study was 2.2, with 
up to three embryos being replaced at one time, which confounds accurate correlation of viability to 
individual embryos.  
 
Much of the work on human embryos to date has been performed on embryos donated to research 
either  fresh  or  following  cryopreservation.  This  provides  valuable  information  in  the  pursuit  to 
understand human embryo development, however does not allow viability to be evaluated to the point of 
pregnancy and live birth. 
 
1.7.4  Modern Metabolomics  
In contrast to individual carbohydrate or amino acid measures, metabolomics is a technology able to 
identify  and  quantify  low  molecular  weight  metabolites.  Metabolomics  analyses  entire  profiles  of 
metabolites giving an indication of the physiology of an embryo with large numbers of metabolites being 
analysed simultaneously and the relationship between those metabolites being characterised.  Most Chapter 1: Introduction 
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recently, the use of infrared spectroscopy and other methods of multiple substrate measurement have 
demonstrated that this approach can distinguish embryos of different competency by the analysis of the 
medium used to culture them (Singh and Sinclair 2007, Botros et al. 2008).  Spent media from oocyte 
culture prior to ICSI for 11 patients has shown that a resultant relative viability score following near infra-
red (NIR) spectroscopy analysis correlates with subsequent day 3 embryo morphology, day 5 blastocyst 
development  and  implantation  ability  with  multiple  embryos  transferred  (Nagy  et  al.  2009).  Other 
investigations have determined that the embryo metabolome is independent of embryo morphology 
(Seli et al. 2009b), and that embryos with the same appearance have different viability scores following 
metabolomics analysis (Sakkas et al. 2009). In addition, metabolome profiles of embryos from single 
embryo transfers on day 2, 3 and 5 have been retrospectively correlated with implantation (Go et al. 
2009, Henman et al. 2009, Makinen et al. 2009). Furthermore, two prospective multi-centre trials have 
demonstrated in day 5 single embryo transfers that viability scores resulting from metabolome profiles 
were correlated with implantation independent of embryo morphology as well as different commercially 
available culture media (Botros et al. 2009, Seli et al. 2009a).  Despite promising technology, such 
approaches to date have yet to openly reveal the most significant changes to medium components 
which determine developmental competence.   
 
With the exception of metabolomics, a major limitation to all studies that have been performed to 
determine  viability  markers  of  human  embryos  is  that  single  embryo  transfers  have  not  been 
undertaken, rendering information gained scientifically interesting, but limited in value for application in a 
clinical setting. In addition, the development of culture media systems over time has superseded many 
studies of metabolism as the analysis of nutrient consumption and production was largely investigated 
prior to the knowledge of a more physiological in vitro system. 
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1.8  SUMMARY 
Morphological measures of oocyte, zygote and embryo assessment are quick and relatively simple to 
perform and as such are extremely popular tools in the clinic. Morphological assessments are valuable 
and  are  therefore  unlikely  to  ever  be  superseded.  Additional  potential  measures  to  supplement 
morphology  include  follicular  fluid  analysis,  which  with  modern  metabolomics  may  be  a  more 
promising tool than has been previously demonstrated. However, single follicle aspiration is technically 
demanding and a higher risk procedure for the patient. It is currently unknown, but highly likely that 
there is significant contribution of maternal factors that may confound the ultimate viability determination 
of resultant embryos with follicular fluid analysis.  
 
Cumulus cell parameters are promising viability candidates due to their close proximity and influential 
dynamic with the oocyte. In addition, single culture and tracking of COCs can commence once in the 
laboratory following the aspiration procedure. The discovery of such a technique will be particularly 
important in clinics which are restricted by legislation to inseminate minimal numbers of oocytes, and 
thus selection of the oocyte is required. However. any assessment tool which is performed prior to 
embryonic  genome  activation  may  have  a  limited  viability  prediction  value.  Similarly,  oocyte 
metabolism as an evaluation tool has many of the benefits and disadvantages of cumulus cell analysis, 
with only the maternal contribution to the potential embryo being accounted for, but with tracking of 
individual oocytes able to begin in the laboratory. With any parameter that occurs prior to fertilization, 
some results obtained will be redundant, as those oocytes that do not fertilize have had a significant 
amount of investigation undertaken which will not provide benefit to the IVF cycle. Such parameters may 
only be useful in clinics which are restricted by legislation to inseminate minimal numbers of oocytes, in 
order to select the most viable oocytes to inseminate. 
 
The  earliest  stage  at  which  to  assess  the  embryo  is  currently  by  pronuclear  morphology. 
Morphological  assessments  are  quick  and  relatively  easy  to  perform,  and  again  are  valuable  in 
countries with limitations on embryo in vitro culture. Following this point, many morphological measures 
have been introduced to aid selection including early cleavage status, cleavage stage morphology 
and  blastocyst  morphology.  An  extension  of  embryo  morphology  is  an  analysis  of  embryo 
metabolism at the cleavage and blastocyst stages. Metabolomics may result in easier incorporation of 
such techniques into the clinic and as such are quite promising. As previously mentioned, embryonic 
genome activation occurs in the cleavage stages of the human embryo and therefore metabolism of the 
cleavage stage embryo may have limited predictability. Ultimately, blastocyst culture allows for extended Chapter 1: Introduction 
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morphological  assessments  and  embryonic  genome  activation.  Therefore,  metabolic  measures  in 
addition to the current techniques have potential to improve an already high implantation rate. However 
implementation of blastocyst culture and transfer in many clinics is not a viable option.  
 
1.9  CONCLUSION 
Given the known risks associated with multiple pregnancies, the ultimate goal of ART must be to 
achieve singleton pregnancies. The only effective way to achieve this is by the transfer of a single 
embryo. The long-established reluctance to transfer a single embryo due to fear of reduced pregnancy 
rates highlights the need to identify factors that are prognostic of outcome.  Transfer of only one embryo 
makes embryo selection of utmost importance. Current embryo selection techniques are valuable in 
selecting embryos with little developmental potential, but information is required which can supplement 
what is observed, to select the most viable embryo from a cohort. In recent years there has been a 
substantial body of evidence that has determined several factors that are associated with increased 
viability of animal embryos. However, due to the various limitations of animal models, few of these 
markers have also been used prospectively in the human.  
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1.10   HYPOTHESIS 
We  propose  that  the  potential  of  an  embryo  to  result  in  a  viable  pregnancy  is  multifactorial,  and 
influenced by dynamic interactions between the cells within the follicle, the bi-directional communication 
of the cumulus-oocyte-complex and the ability of the resulting embryo to maintain normal development 
in an environment which may be less than optimal. Therefore markers of health of the oocyte and pre-
implantation embryo, which take these factors into account, may result in the ability to select the most 
developmentally competent embryos from a cohort.  
 
1.10.1  Specific Hypotheses and Aims 
Hypothesis 1: Group embryo culture provides no additional benefit to embryo development and viability 
than single embryo culture. 
  Determine cleavage and blastocyst development rates in mouse embryos grown individually 
and in groups. 
  Analyse  viability  of  mouse  embryos  grown  individually  or  in  groups  following  transfer  to 
recipients,  through  implantation  rates,  fetal  development  rates  and  fetal  and  placental 
parameters. 
  Analyse implantation rates of human embryos grown individually or in groups prior to embryo 
transfer. 
 
Hypothesis 2: Extended culture of human embryos to day 4 of embryo development confers a selection 
advantage and improved pregnancy rates over cleavage stage embryo assessment and viability. 
  Describe a scoring system for day 4 of human embryo development. 
  Implement scoring system in a clinical setting and analyse resultant implantation rates with 
regard to morphology grade. 
  Analyse implantation rates of day 4 embryo transfers compared to cleavage and blastocyst 
stage embryo transfers. 
 
Hypothesis 3: Cumulus cell REDOX levels correlate with resultant embryo viability. 
  Establish the measurement of REDOX levels in human cumulus cells. 
  Assess REDOX levels in human cumulus cells with relation to resultant fertilization ability, 
embryo morphology and viability. Chapter 1: Introduction 
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Hypothesis 4: Metabolism of the COC and early embryo correlate with embryo viability. 
  Assess spent media from COC and embryo culture for metabolites that may indicate embryo 
viability. 
  Analyse  metabolites  with  respect to  embryo  quality and pregnancy establishment  following 
single embryo transfers.  
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2.1  HUMAN PROCEDURES  
Human  procedures  are  summarised  in  Figure  2.1.  All  research  was  approved  by  the  NHMRC 
sanctioned Human Ethics Committee, Women‟s and Children‟s Hospital, Adelaide, South Australia. 
 
2.1.1  Patient Consent 
All patients seeking IVF treatment at Repromed, Adelaide were screened for eligibility to the study prior 
to  attendance  at  the  clinic  for  their  first  follicular  scan.  Patients  were  approached  by  the  primary 
researcher on the project (D.Feil) to explain the details of the study, including the points at which 
samples would be collected and what type of information would be obtained from the samples collected 
(see Figure 2.1). The couples approached were given a Patient Information Sheet and Consent Form 
(see Appendix 1) and were then followed up at their next clinic appointment (blood test, scan or oocyte 
retrieval) where any questions were addressed and informed consent was obtained from both partners. 
In all cases consent was obtained prior to attendance in theatre for the oocyte retrieval. Separate 
cohorts of patients were recruited for each chapter detailed in this thesis, with some overlap occurring 
only between chapters 3 and 6 where single embryo culture and metabolites in spent media were 
assessed.  
 
2.1.2  Patient Stimulation 
Patients were stimulated using a long down-regulation protocol. For patients requiring menstrual cycle 
manipulation, the oral contraceptive pill (OCP, Marvelon, Organon, Sydney, Australia) was initiated on 
day 3 of the cycle and continued for 14-28 days. The administration of a Gonadotrophin Releasing 
Hormone analog (Nafarelin acetate (Synarel 2mg/ml), Pharmacia Australia, Leuprolide acetate (Lucrin), 
Abbott Australasia) was combined with the OCP for 6 days (termed crossover). Following at least 14 
days of analog, down regulation was confirmed when blood oestrogen and progesterone levels were 
below  0.2nM/L  and  4.0nM/L  respectively.  Patients  were  then  administered  recombinant  Follicle 
Stimulating  Hormone  (FSH,  Gonal-F,  Serono,  Sydney,  Australia  or  Puregon,  Organon,  Sydney, 
Australia), doses ranging from 150IU to 300IU (see Appendix 2) for 9-12 days.  
  
 








Pink boxes indicate routine clinic activities. Blue boxes indicate routine laboratory protocols. Green 
boxes indicate the incorporation of activities performed as part of this research study, which are not 
routine protocols. Processes are linked as indicated with arrows. The progression of time is displayed in 
the far left column. h=hours.  
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2.1.3  IVF Process 
2.1.3.1  Oocyte Retrieval Scheduling 
Follicle growth was monitored from day 9 by transvaginal ultrasound and serum oestrogen levels, until 
the lead ovarian follicle was a size of 18mm. Patients were then given human Chorionic Gonadotrophin 
(5,000IU hCG, Pregnyl, Organon, Sydney, Australia) and the oocyte collection scheduled for 36 hours 
later.  
 
2.1.3.2  Oocyte Pick Up (OPU) 
Patients were anaesthetized with neurolept sedation (fentanyl and midazolam) for the oocyte collection 
by an anaesthetist. Follicles were imaged by transvaginal ultrasound with an attached guide for the 
ovum collection needle (17-gauge, COOK, Australia) which punctured the vaginal wall to access the 
ovary.  Follicle  aspiration  was  performed  using  suction  generated  by  a  vacuum  pump  (-120mmHg, 
COOK, Australia). Fluid was aspirated from follicles greater than 14mm and collected in warmed 14mL 
tubes batch tested for embryo toxicity. An enclosed environment maintained at 37°C, 6% CO2 was used 
for microscopic evaluation (magnification x6.7-40) of the follicular fluids to reveal any cumulus-oocyte 
complexes (COCs) present. COCs were removed from the follicular fluid using a polished glass Pasteur 
pipette and washed twice through glucose supplemented (2.5mM) GFert Plus v3 (Vitrolife, Kungsbacka, 
Sweden) to remove any follicular fluid and blood cells, and pooled in a final volume of 1mL of glucose 
supplemented GFert Plus v3 medium. The oocyte collection was preceded by flushing of the collection 
needle and line with HEPES buffered handling medium (Quinn‟s Advantage Medium, Gytech, Australia). 
Following aspiration of all follicles present in each ovary the collection needle and line were again 
flushed with HEPES handling media to ensure they did not contain any COCs, before terminating the 
procedure.  All COCs collected were maintained in 1mL glucose supplemented GFert Plus v3 and 
incubated at 37°C, 6% CO2, 5%O2, 89%N2 until further manipulation was required.  
 
2.1.3.3  Semen Preparation 
Sperm for all patients was obtained from fresh ejaculate produced by masturbation. No donor gamete 
treatments were assessed as part of these studies. 
Semen samples with greater than 1 million sperm per mL and greater than 10% progressive motility 
were washed by gradient centrifugation. In a 15mL conical tube, 1 mL of 40% SpermGrad (Vitrolife) in 
HEPES (Gytech) was layered on top of 1mL of 80% SpermGrad to create 2 layers. Up to 1mL of neat 
semen was then layered on top of the gradient preparation. The sample was then centrifuged at 100g  
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for 20 minutes. The pellet was removed from the conical tube and transferred to a fresh 6mL tube and 
mixed with approximately 3mL of GSperm Plus v3 (Vitrolife) and centrifuged at 300g for 10 minutes. The 
supernatant was then removed and the pellet resuspended in approximately 0.5mL GSperm Plus v3. A 
final count and motility analysis were performed and the sample diluted to 1 million/mL in preparation for 
insemination. 
 
2.1.3.4  Insemination 
For both IVF and ICSI, COCs were trimmed of their outer layers of cumulus cells with an insulin syringe 
and 30G needle, post-OPU. For IVF insemination, trimmed COCs (see Figure 2.2) were placed either 
singly in 10µL drops of glucose supplemented GFert Plus v3 or in pairs in 50uL drops of the same 
medium under oil for 16 hours, and were co-incubated with 1,000 and 5,000 motile sperm respectively.  
Following removal of the outer layers of cumulus cells, for ICSI insemination, remaining cumulus cells 
were  denuded  in  75IU  Hyaluronidase  (Hyalase®,  Aventis  Pharma  Pty  Ltd,  Australia)  in  glucose 
supplemented GFert Plus v3. Between 4 and 6 hours post-OPU ICSI was performed. Individual oocytes 
were  placed  in  5µL  drops  of  G1.3  Plus  medium  under  oil,  in  the  same  dish  as  5µL  of 
polyvinylpyrrolidone  (PVP,  ICSI™,  Vitrolife)  with  approximately  0.2µL  of  final  sperm  preparation 
(concentration 1.0x106/mL). Sperm that appeared to have a normal morphology (as determined by 
head, neck, and tail appearance, as well as quality of motility, (World Health Organisation 1999)) were 
selected under magnification x200, and immobilized by a sharp downward action with the glass injection 
pipette (The Total Pipette Company, Australia) on the midpiece of the sperm. This action was repeated 
to ensure destabilisation of the sperm plasma membrane. The selected sperm was then aspirated into 
the injection pipette containing PVP. The oocyte was then positioned with the single polar body at 12 
o‟clock (see Figure 2.3) and held in place with light suction on the glass holding pipette (The Total 
Pipette Company, Australia). The injection pipette was then guided into the oocyte through the zona 
pellucida and oolemma, and the inner membrane was broken by aspirating a small volume of cytoplasm 
into the injection pipette. The aspirated cytoplasm was then returned to the oocyte with the sperm, and 
the injection pipette removed from the oocyte (see Figure 2.3). Injected oocytes were cultured either 
individually in 10µL drops of G1.3 Plus under oil, or in groups of 4 in 50µL drops of the same medium 














Figure  2.2  Cumulus-oocyte  complex  prior  to  and  following  trimming  of  cumulus  cells  in 
preparation for insemination. 
a) Cumulus-oocyte complex following retrieval from the ovary and washing. b) Cumulus-oocyte complex 
following trimming of outer layers of cumulus cells, prior to insemination. Magnification of images x100. 
 























Figure  2.3  Microinjection  of  an 
oocyte  with  a  single  spermatozoa 
(ICSI). 
 
a)  positioning of the oocyte with 
the polar body at 12 o‟clock, 




b)  sperm at end of injection 
pipette and forced through the 






c)  oolemma broken, cytoplasm 
aspirated and then expelled 





d)  completed injection of oocyte 
 
 










sperm head  
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2.1.3.5  Fertilization 
The  morning  following  insemination,  IVF  oocytes  were  mechanically  denuded  of  their  remaining 
cumulus cells and washed thoroughly through G1.3 Plus medium prior to fertilization assessment.  
For both IVF and ICSI, all normally fertilized embryos with two pronuclei and two polar bodies present 
were cultured individually in 10µL drops, or in groups of 4 in 50µL drops, of G1.3 Plus medium under oil 
for the next 48 hours. Other oocytes/zygotes present at fertilization check were discarded including; 
unfertilized oocytes, abnormally fertilized zygotes, lysed and non-viable oocytes and immature oocytes 
(see Figure 2.4).  
 
2.1.3.6  Embryo Culture 
Human  oocytes  and  embryos  were  cultured  in  the  sequential  GIII  Series  Plus  Medium  (Vitrolife, 
Kungsbacka, Sweden) and overlayed with Ovoil (Vitrolife). All oocyte and embryo culture was performed 
at 37°C, 6% CO2, 5%O2, 89% N2 in a humidified atmosphere. All manipulations of oocytes and embryos 
occurred  at  37°C,  6%  CO2  (excluding  cryopreservation,  thawing  of  embryos  and  embryo  transfer 
procedures). All consumables in contact with gametes or embryos at any point during treatment were 
tested for embryo toxicity using a 1-cell mouse assay. 
 
2.1.3.7  Embryo Morphology Assessments 
During culture, embryo development was assessed at various critical time points (see Figure 2.5). Early 
Cleavage checks were performed 23 hours post-insemination for ICSI patients and 24 hours post-
insemination for IVF patients. These checks assessed whether the zygotes had undergone the first cell 
division or syngamy by a set time point (see Figure 2.5).  
For patients having a cleavage stage embryo transfer (day 2 or 3), embryos were assessed on the 
morning of transfer according to a morphological scoring system. This scoring system is based on the 
number and quality of blastomeres, the degree of fragmentation and the presence of multinucleated 
cells. Good quality embryos were determined to have 4-cells on day 2 of culture (41±1 hours post-
insemination) or 7-8 cells on day 3 of culture (65±1 hours post-insemination), with <10% fragmentation 
and the absence of multinucleated blastomeres (see Figure 2.5 and Appendix 3). For patients having an 
extended culture embryo transfer (day 4 or 5), embryos were assessed on the morning of transfer 
according to the appropriate scoring system. A new scoring system was described for day 4 embryos 
(see Chapter 4) which assesses the degree of compaction and early cavitation of the embryo, as well as 
the  number  of  blastomeres  present.  Day  5  embryos  were  assessed  as  per  the  grading  system  
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described by Gardner and Schoolcraft (Gardner and Schoolcraft 1999). Briefly, the degree of expansion 
and morphology of the inner cell mass and trophectoderm were visually assessed (see Appendix 3). 
Independent of day of transfer, embryo morphology was assessed using a scale of 1-4, where grade 1 
indicated the best morphological quality and grade 4 indicated a poor morphological quality embryo. 
 
2.1.3.8  Embryo Transfer 
Embryo selection for transfer was based purely on assessment of morphology, and blinded to any 
quantitative measures. In all cases the single highest morphological quality embryo, as determined by 
the scoring system applicable to the stage of embryo development, dependent on the day of transfer 
(cleavage stage, day 4 or day 5 of embryo culture), was transferred. Embryos selected for transfer were 
incubated in EmbryoGlue® (Vitrolife) for 0.5-4 hours before transfer and transferred into the uterus in a 
volume of approximately 10µL, using an embryo transfer catheter (COOK, Sydney, Australia) under the 
guidance of abdominal ultrasound.  
The day in which individual patients had their transfer was determined prior to the commencement of 
treatment  in  a  clinic  appointment  with  their  clinician,  where  all  decisions  regarding  the  upcoming 
treatment were decided upon, and consent forms signed to reflect these decisions. 
Patients were consented to have either a cleavage (day 2, 3) or extended culture (day 4, 5) transfer. 
After the commencement of treatment and scheduling of the patient for oocyte collection in theatre, 
embryo transfer appointments were allocated based on the patient‟s own clinician being available for 
transfer,  and  avoiding  embryo  transfers  on  Sundays.  These  reasons  alone  determined  whether  a 
cleavage stage transfer was performed on day 2 or day 3 and whether an extended culture stage 
transfer was performed on day 4 or day 5 of embryo culture.  
 
Figure 2.5 Critical cleavage stage time points for checking human IVF embryos. 
Early Cleavage Check 
ICSI    23±0.5 hours post-injection 
IVF    24±0.5 hours post-insemination 
a)  2 cell embryo (early cleaver) 
b)  1 cell embryo, no pronuclei present (syngamy) 





Day 2 Cleavage Check 
40-42 hours post insemination 
a) 4 cell embryo, <10% fragmentation 
b) 3 cell embryo, <10% fragmentation, even cell division 
c) 2 cell embryo, <10% fragmentation 
 
 
   
 
Day 3 Cleavage Check 
64-66 hours post-insemination 
a) 8 cell embryo, <10% fragmentation 
b) 6 cell embryo, <10% fragmentation, uneven division of cells 






Magnification x200 for all images. 
a  b  c 
a  b  c 
c  a  b  
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2.1.3.9   Embryo Cryopreservation 
Assessment of surplus embryos for cryopreservation took place on days 3, 5 and 6 when a cleavage 
stage embryo transfer was performed, and on days 5 and 6 when either a day 4 or 5 embryo transfer 
was performed. Only embryos of good quality (Grade 1 or 2) were eligible for freezing.  
Cleavage stage embryos underwent preparation for cryopreservation by transferring embryos to be 
frozen to warmed (37°C) HEPES buffered handling medium with 10% human serum albumin (HSA, 
HEPES/HSA) and then placing the dish containing the embryos at room temperature for 10 minutes. 
Embryos were then transferred to HEPES/HSA containing 1.5M propandiol for 15 minutes  at room 
temperature before transferring into the final cryopreservation solution containing 1.5M propandiol and 
0.1M sucrose and loading individually into cryostraws and placed in a programmable freezer (Cryologic 
Freeze Controller) at a start temperature of 20°C. Embryos were cooled at a rate of 2°C per minute to -
7°C with seeding performed manually at this temperature. Embryos were then cooled at 0.3°C per 
minute to -35°C and then rapidly cooled at 4°C per minute to -196°C before storing in liquid nitrogen.  
Blastocyst stage freezing was assessed on days 5 and 6. Cryopreservation was performed as described 
for cleavage stage embryos with embryos selected for cryopreservation being transferred to warmed 
HEPES/HSA,  brought  to  room  temperature  then  transferred  to  the  first  cryopreservation  solution 
containing  0.69M  glycerol  and  0.1M  sucrose  for  10  minutes,  then  transferred  to  the  final 
cryopreservation  solution  containing  1.37M  glycerol  and  0.2M  sucrose  for  7  minutes  before  being 
loaded  individually  into  cryostraws  and  placed  into  a  programmable  freezer  (Cryologic  Freeze 
Controller) with a start temperature of -6°C, and seeded manually after 2 minutes at this temperature. 
Embryos were then cooled at rate of 0.5°C per minute to -35°C, and then rapidly cooled at 4°C per 
minute to -196°C before storing in liquid nitrogen.  
 
2.1.3.10   Embryo Thawing 
Individual  cryostraws  were  selected  and  removed  from  liquid  nitrogen  storage  and  exposed  to  air 
temperature for 40 seconds and 30°C for a further 40 seconds. All embryos were thawed in HEPES 
buffered  handling  medium  containing  10%  HSA  and  varying  concentrations  of  cryoprotectants  as 
indicated below, at room temperature. 
For cleavage stage embryos, the embryo was expelled from its cryopreservation straw into HEPES 
buffered handling medium at room temperature containing 10% HSA and  0.2M sucrose and 1.0M  
propandiol and incubated for 5 minutes. The embryo was then transferred to a variation of the same 
medium containing 0.2M sucrose and 0.5M propandiol for a further 5 minutes and then transferred to a  
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third thawing solution containing 0.2M sucrose in the absence of propandiol. Finally, the embryo was 
placed  into  a  solution  of  HEPES  handling  medium  and  10%  HSA  only,  for  10  minutes  at  room 
temperature. Warming of the embryo to 37°C was then initiated for a period of 10 minutes in the same 
medium. An embryo with 50% survival or greater, at this point, was deemed to have survived the 
thawing procedure, and washed through the appropriate culture medium dependent on the age of the 
embryo (Day 2 embryo G1, Day 3 embryo G2), and placed in drop culture overnight. The following 
morning the embryo was assessed for development prior to embryo transfer. 
For blastocyst stage embryos, the embryo was expelled from its cryopreservation straw into HEPES 
buffered handling medium at room temperature containing 10% HSA and  0.2M sucrose and 0.69M 
glycerol and incubated for 10 minutes. It was then transferred to a variation of the same medium 
containing 0.2M sucrose and no glycerol for a further 10 minutes, and then placed into a third thawing 
solution containing 0.1M sucrose. Finally, the embryo was placed into a solution of HEPES handling 
medium and 10% HSA only for 10 minutes at room temperature. Warming of the embryo to 37°C was 
then  initiated  for  a  period  of  10  minutes.  The  embryo  was  then  assessed  for  the  proportion  of 
blastomeres  that  had  survived  the  cryopreservation  and  thawing  procedure.  An  embryo  with  50% 
survival or greater was deemed to have survived and washed through G2 culture medium and prepared 
for embryo transfer. Blastocysts were re-assessed 2-4 hours post-thawing to assess re-expansion of the 
blastocoel cavity. 
 
2.1.3.11   Pregnancy Outcome 
Pregnancy  establishment  was  assessed  by  an  initial  β-hCG  result  >20  IU/L,  16  days  after  OPU. 
Subsequent blood tests were performed to determine ongoing pregnancy and diagnosis of ectopic 
pregnancy, as required.  
A viable pregnancy was defined as the presence of an intrauterine fetal heart beat by ultrasound 5-6 
weeks after embryo transfer. Ongoing pregnancies were tracked throughout gestation and outcomes 
analysed.  
For the purposes of this thesis, pregnancy rates refer to the pregnant status of a patient irrespective of 
the  number  of  embryos  transferred  or  the  presence  or  absence  of  a  multiple  gestation,  while 
implantation rates refer to the number of intrauterine fetal heartbeats divided by the number of embryos 
transferred.   
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3.1  INTRODUCTION 
Despite  the  microlitre  volumes  of  fluid  that  the  embryo  is  exposed  to  in  vivo  (Leese  1988),  embryos 
traditionally have been cultured in large volumes of media (≤1mL) (Lane and Gardner 1992). The beneficial 
effect of culturing mouse, sheep and cow embryos in groups or small volumes in simple style media for the 
entire culture period is well established (Wiley et al. 1986, Paria and Dey 1990, Canseco et al. 1992, Lane 
and Gardner 1992, Gardner et al. 1994, Kato and Tsunoda 1994, Keefer et al. 1994). In the human, group 
culture has been shown to enhance cleavage rates and embryo scores (Moessner and Dodson 1995). To 
date,  there  are  conflicting  results  on  the  effect  of  grouping  during  culture  with  reports  indicating  an 
improvement in implantation rates following cleavage stage embryo transfer (Almagor et al. 1996), and 
others  reporting  no  benefit  in  cleavage  or  blastocyst  stage  transfers  (Rijnders  and  Jansen  1999, 
Spyropoulou et al. 1999). Similar to the animal studies, these human studies were performed in older style 
media systems (single tissue culture media with added serum at high oxygen concentrations) rather than 
the sequential culture systems which are now routinely used in human IVF protocols.  
 
With research investigating the metabolic requirements for embryo development leading to advancements 
in embryo culture systems, the emphasis is now on how to select the most viable embryo from a cohort to 
maximize the chance of implantation and pregnancy. This is particularly so in human ART where multiple 
gestations have increased complications during and after pregnancy for both the mother and babies (Baird 
et al. 1998, Senat et al. 1998, Russell et al. 2003, Wang et al. 2009). 
 
In clinical IVF, the assessment and selection of the most viable embryo from a cohort is paramount to 
maximizing the likelihood of successful implantation and pregnancy. Multiple morphological assessment 
criteria  are  now being employed  at  specific cleavage  stages of  pre-implantation  embryo  development, 
including oocyte and pronuclear morphology (Scott and Smith 1998, Wittemer et al. 2000), early cleavage 
(Shoukir et al. 1997, Shapiro et al. 2000, Lundin et al. 2001), on-time cleavage on days 2 and 3 of culture 
(Ziebe et al. 1997, Racowsky et al. 2000, Shapiro et al. 2000), assessment of fragmentation (Alikani et al. 
1999) and cell quality parameters (Van Royen et al. 2003). Implementation of such assessment criteria, 
employed  at  numerous  distinct  time  points,  requires  the  tracking  of  individual  embryos  throughout 
development in culture thus the utilisation of single embryo culture is increasingly important.  
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Blastocyst stage embryo transfers were introduced as a selection tool, enabled by improvements in the 
quality of culture media and systems (Gardner and Schoolcraft 1999). The extended culture period required 
for development to the blastocyst stage presents further questions regarding the ideal environment for an 
embryo, in particular for the duration of the post-compaction period for which it has been suggested that 
embryo-derived growth or survival factor(s) exert an effect between the 8-cell and blastocyst stage in mouse 
(Paria and Dey 1990). In addition, it has also been demonstrated in mouse embryos that embryo-derived 
survival factors are required pre-compaction, although do not show an effect on development until the post-
compaction stage (O'Neill 1998). Furthermore in human embryos, proteins for growth factors and their 
receptors are present in unfertilized oocytes and throughout  pre-implantation development (Chia et al. 
1995). Therefore a beneficial effect of group culture might be expected prior to, but particularly after the 8-
cell stage in mouse and human embryos.  
 
Despite  the  widespread  implementation  of  both  single  and  group  culture  in  clinical  IVF  programs  in 
physiological media, there is a current lack of understanding about the consequences of these protocols on 
embryo, fetal and placental development. Therefore the aim of this study was to explore the effects of in 
vitro  single  embryo  culture  with  a  consistent  embryo:  incubation  volume  by  assessing  cleavage  and 
blastocyst stage pre-implantation development and subsequent viability in the mouse and human.  
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3.2  MATERIALS AND METHODS 
3.2.1  Animal Procedures 
3.2.1.1  Animals 
All animals used in this study were bred at The University of Adelaide‟s Waite Campus, and housed at the 
Laboratory Animal Services Facility at The University of Adelaide Medical School. Animals were caged with 
access to food and water ad libitum, under a 14:10 light cycle, (700 hours to 2100 hours). C57BL6xCBA F1 
hybrid male and females were used to generate embryo cohorts. Swiss Albino female mice were used as 
recipients for embryo transfer experiments. All procedures were approved by the Animal Ethics Committee, 
The University of Adelaide. 
 
3.2.1.2  Superovulation/Mating 
Virgin female 3-4 week old C57BL6xCBA F1 hybrid females underwent a superovulation regime involving 
an injection of 5IU equine chorionic gonadotrophin (Folligon, Intervet, Boxmeer, Holland), followed 48 hours 
later by 5IU of human chorionic gonadotrophin (hCG, Pregnyl, Organon, Sydney, Australia). Immediately 
following hCG administration, females were caged individually overnight with a male of the same strain. 
Mating was confirmed the following morning by the presence of a vaginal plug. 
 
3.2.1.3  Collection of Zygotes 
Twenty-two  hours  post-hCG  females  were  humanely  killed  by  cervical  dislocation.  The  abdomen  was 
sterilized with 70% ethanol and a small incision was made in the ventral midline. Either side of the incision 
the skin was held firmly and pulled apart towards the head and tail to expose the abdomen. The peritoneum 
was cut, and the visceral organs moved aside to expose the reproductive tract. The uterine horn and 
oviduct were located and a cut was made between the oviduct and ovary with a second cut being made 
through the utero-tubal junction.  This process was repeated for collection of the second oviduct. Oviducts 
were placed into warmed HEPES (Quinn‟s Advantage Medium, Gytech, Australia) containing 5% HSA 
(Vitrolife). A dissecting microscope was used to visualize zygotes and surrounding cumulus cells in the 
distended ampulla of the oviduct which were released into HEPES/HSA medium by tearing open the oviduct 
wall close to the zygotes. Individual zygotes were denuded from surrounding cumulus by incubation in 
50IU/mL hyaluronidase (Sigma-Aldrich Pty Ltd, Castle Hill, New South Wales, Australia) in HEPES/HSA. Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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Following  dispersion  of the  cumulus  cells,  the  remaining  coronal cells  were mechanically removed  by 
pipetting. Zygotes were then washed 2-3 times in HEPES/HSA medium, and once in the final culture 
medium (G1v3, Vitrolife), before being placed into the final culture environment. 
 
3.2.1.4  Collection of Blastocysts 
Both uterine horns were removed by cuts below the utero-tubal junction and a second cut through the 
cervix.  Uterine  horns  were  collected  88  hours  post-hCG  and  blastocysts  were  flushed  by  injecting 
HEPES/HSA handling medium through the cervical opening using a 32G needle.  
 
3.2.1.5  Embryo Culture 
Mouse embryos were cultured in the sequential GIII Series Plus Medium (Vitrolife) and overlayed with Ovoil 
(Vitrolife). All embryo culture was performed at 37°C, 6% CO2, 5%O2, 89% N2 in a humidified atmosphere. 
All manipulations of embryos occurred at 37°C. Embryos were cultured under various grouping conditions, 
either (1) singly in 2µL drops, (2) grouped, 10 embryos per 20µL drop (3) singly to the 8 cell stage (in 2μL 
drops, up until 48 hours post-collection) and then grouped (10 embryos/20μL) for the final period of culture 
to the blastocyst stage. All consumables used for embryo collection and culture had been previously tested 
for embryo toxicity. 
 
3.2.2  Assessment of Mouse Embryo Development In Vitro 
3.2.2.1  Morphological Embryo Assessment  
Embryo morphology was assessed at a magnification of 200x. All embryos were assessed for development 
to the 2-cell stage (41 hours post-hCG). Embryos failing to develop to a 2-cell were removed from culture. 
All embryos were assessed for developmental stage (2- to 8-cell stage, 65 hours post-hCG) and washed 
through G2v3 (Vitrolife), and placed in culture drops of the same medium, for the final 48 hours of culture to 
the blastocyst stage. The final morphological assessment took place 113 hours post-hCG. Embryos at the 
final assessment were considered blastocysts when they contained a blastocoel cavity greater than ¾ of the 
blastocyst in volume. Hatching blastocysts were identified by herniation of the trophectoderm through the 
zona pellucida. 
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3.2.2.2  Differential Cell Staining 
Blastocyst  cell  allocation  to  the  inner  cell  mass  (ICM)  or  trophectoderm  (TE)  in  mouse  embryos  was 
assessed using a previously described differential staining protocol (Mitchell et al. 2009). Briefly, 113 hours 
post-hCG embryos at the blastocyst stage were placed in 0.5% pronase (Sigma-Aldrich) until the zona 
pellucida was visually observed to dissolve, followed by a 10 minute incubation at 4◦C in 10mM 2,4,6-
trinitrobenzenesulfonic  acid  (Sigma-Aldrich).  Blastocysts  were  then  transferred  to  0.1  mg/mL  anti-
dinitrophenyl-bovine  serum  albumin  (Sigma-Aldrich)  for  10  minutes  at  37◦C  followed  by  a  5  minute 
incubation in 10μg/mL propidium iodide (PI, Sigma-Aldrich) in guinea pig serum (Sigma-Aldrich) at 37◦C. 
Blastocysts were then placed in 6μg/mL bisbenzimide (Sigma-Aldrich) in ethanol overnight at 4°C, followed 
by washing in 100% ethanol. Blastocysts were then mounted in glycerol on microscope slides and viewed 
under an ultra-violet (UV) filter on a fluorescent microscope (see Figure 3.1). 
 
3.2.2.3  Assessment of Blastomere Apoptosis 
Apoptotic  DNA  in  blastomeres  of  blastocysts  was  detected  using  a  TUNEL  (terminal  deoxynucleotidyl 
transferase (TdT) biotin-dUTP nick end labeling) technique, as previously described (Brison et al. 2004b), 
incorporating  an  In  Situ  Cell  Death  Detection  Kit  (Roche  Molecular  Biochemicals,  Indianapolis,  USA). 
Apoptotic cell nuclei were labeled with fluorescein and all cell nuclei were counterstained with propidium 
iodide (PI, see Figure 3.2). Positive controls were exposed to Dnase prior to TUNEL labeling and negative 
controls were incubated in the labeling mix minus TdT instead of TUNEL. The number of apoptotic cells was 











Figure 3.1 Differentially stained blastocyst. 







Figure 3.2 Imaging of apoptotic cells in mouse blastocysts with TUNEL and PI labeling. 
a) positive control   b) negative control   c) treated blastocyst 
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3.2.3  Animal Surgical Procedures 
3.2.3.1  Vasectomy 
Male CBABL6xCBA F1 hybrid mice 6-8 weeks of age were anaesthetized by intraperitoneal injection of 
Avertin (0.02ml/g body weight, see Appendix 4). Each male had a horizontal incision made in the lower 
abdomen. Vasa deferentia were ligated at two places using silk suture and cut between the two ligations 
(Nagy et al. 2003). Incisions were closed with silk suture and mice were allowed to recover for 3 weeks. 
Test mating to superovulated females was performed to clear the vasa deferentia of any residual sperm. A 
second mating, 3-5 days later, was performed with superovulated females, and sterility confirmed by the 
presence of a vaginal plug the morning following mating and the absence of fertilized embryos collected 48 
hours post-hCG.  
 
3.2.3.2  Embryo Transfer 
Female Swiss mice 10-12 weeks of age were used as recipients for embryo transfers. Natural matings were 
carried out with vasectomised males to induce pseudopregnancy. Mating was confirmed by the presence of 
a vaginal plug the morning following mating (day 0.5 of pseudopregnancy). Cleavage stage transfers were 
performed  on  day  3  of  pseudopregnancy.  Blastocyst  transfers  were  performed  on  day  3.5  of 
pseudopregnancy.  
Recipients were anaesthetized by intraperitoneal injection of Avertin (0.02ml/g body weight, see Appendix 
4). A 10mm vertical incision was made in the dorsal midline below the ribs. The skin was moved to visualize 
the location of the ovary through the body wall. An incision was made in the peritoneum above the ovary 
and adjoining fat pad. The fat pad was secured with a clasp and removed from the body cavity with the 
ovary, oviduct and uterus. The embryos to be replaced (six per uterine horn) were picked up in a minimum 
volume of medium in a flame-pulled glass pipette, with a diameter slightly larger than the embryos. The 
upper end of the exposed uterus was pulled taut and a hole was made into the lumen of the uterus with a 
26G needle. The pipette containing the embryos was then inserted into the hole in the uterine wall and the 
embryos expelled into the uterus. The pipette was then checked to ensure all the embryos had been 
transferred to the uterus. The uterus, oviduct and ovary were then eased back into the body cavity. This 
procedure was then repeated on the other uterine horn. The skin incision was sealed with clips and the 
female recipient placed on a heating stage at 37°C while recovering from the anaesthetic. Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
 
Feil    Page 81  
 
3.2.3.3  Post-Mortem 
Embryo  transfer recipients  were  humanely killed  on  day  18  of  pregnancy by  cervical dislocation.  The 
numbers of viable or resorbing implantation sites was recorded. Fetuses and placentas were individually 
weighed and fetal crown-rump was measured.   
 
3.2.4  Human Procedures 
3.2.4.1  Patient Selection 
Seventy-three  patients  undergoing  routine  IVF/ICSI  with  elective  Single  Embryo  Transfer  (SET)  at 
Repromed‟s  Adelaide  clinic  between  May  and  December  2005  consented  to  be  involved  in  research 
(Appendix 1). Ethical approval was obtained from the NHMRC sanctioned Human Ethics Committee of the 
Women‟s and  Children‟s Hospital,  Adelaide,  South Australia.  Consenting  patients  all  underwent  single 
culture of their embryos.  
 
3.2.4.2  Embryo Culture 
All protocols of the laboratory were followed as per standard practice, with embryos cultured individually in 
10μL drops of the appropriate medium dependent on the stage of development. Single culture commenced 
following the collection of cumulus-oocyte complexes in theatre and was maintained throughout the culture 
period.  All  oocyte/embryo  culture  was  performed  at  37°C,  6%  CO2,  5%O2,  89%  N2  in  a  humidified 
atmosphere. All manipulations of oocytes/embryos occurred at 37°C, 6% CO2.  
 
3.2.5  Statistics 
All data are presented as mean ± standard error of the mean (SEM), with statistical analyses carried out 
using Statistical Package for the Social Sciences 13.0 for Windows (SPSS Inc., Chicago, IL). Replicate 
embryo development data was expressed as proportions and determined by Kolmogorov-Smirnov testing to 
be normally distributed therefore analysed using a univariate generalized linear model. Each replicate was 
treated as a covariate. Differential cell staining data was transformed for ICM and ICM: TE ratio for all data 
sets to be normally distributed and assessed using a univariate general linear model. Post-hoc tests as 
required were least significant difference (LSD) if data had equal variances as determined by Levene‟s test Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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of  equality,  or  Dunnett‟s  T3  for data  sets  with  unequal  variance.  Cellular  apoptosis  was  not  normally 
distributed and was analysed by a Kruskal-Wallis non-parametric test. 
Implantation rates were analysed by chi square testing. Fetal development rates were analysed using a 
univariate  general  linear  model  with  embryo  culture  replicate  and  surrogate  mother  incorporated  as 
covariates. A univariate generalized linear model was used to analyse fetal and placental outcomes with 
litter size incorporated as a covariate for fetal and placental outcome measures. Fetal and placental data 
that was not normally distributed was analysed by Kruskal-Wallis testing.  
Human demographic data was not normally distributed and analysed by a Kruskal-Wallis test. Proportional 
data was analysed by a chi-square test. Significance was accepted at p<0.05. 
  
 
3.3  EXPERIMENTAL DESIGN 
 
Figure  3.3  Animal  experimental  design  detailing  culture  grouping  under  investigation  while 
maintaining embryo density. 
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Figure  3.4  Human  experimental  design  (experiment  5)  detailing  culture  grouping  under 
investigation. 
* Patients not recruited for research underwent group culture as per the standard protocol of the laboratory 
at the time. 
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3.4  RESULTS 
3.4.1  EXPERIMENT 1. Mouse embryo development rate. 
Embryo  development  was  assessed  after  48  hours  of  culture  (8-cell  stage)  and  90  hours  of  culture 
(blastocyst stage). There were no differences in embryo development rates between the two treatment 
groups (single and group culture) at 48 hours of culture (p=0.433) or between the three treatment groups 
(single culture, group culture or single  group culture) in the ability to form a blastocyst at 90 hours of 
culture (p=0.271, see Table 3.1). However, the proportion of blastocysts undergoing hatching at 90 hours 
was  significantly  lower  when  embryos  were  cultured  singly,  compared  to  grouped  throughout  culture 
(p=0.002), or cultured singly pre-compaction and grouped for the final period of culture (p=0.033, Table 3.1).  
 
3.4.2  EXPERIMENT 2. Effect of embryo culture grouping on resultant blastocyst cell number and 
allocation. 
Embryos cultured singly throughout the entire in vitro culture period had fewer inner cell mass (ICM) cells at 
the blastocyst stage (11.8 cells) when compared to embryos cultured either in groups for the whole period 
(18.0  cells,  p<0.001)  or  singly  pre-compaction  followed  by  group  culture  post-compaction  (16.0  cells, 
p=0.002, see Table 3.2). Furthermore, single culture had a reduced ICM: trophectoderm (TE) cell number 
compared to embryos cultured in groups throughout in vitro culture (p=0.047). The number of TE cells and 
total cell number were not altered by differing embryo culture groupings (p=0.32 and p=0.101 respectively). 
 
3.4.3  EXPERIMENT 3. Effect of embryo culture grouping on apoptosis levels in blastocysts. 
The proportion of apoptotic cells present in blastocysts resulting from embryos cultured in differing groups 
was not altered (p=0.372, Table 3.2).  
 
 
                   Table 3.1 Effect of embryo grouping during in vitro culture on pre-implantation embryo development. 
  % development 
Culture Conditions 
8-cell stage 
(48 hours culture) 
Blastocyst 
(90 hours culture) 
Hatching Blastocyst 
(90 hours culture) 
Group Culture  99.4 ± 0.01  95.5 ± 0.005  75.6 ± 3.2a 
Single Culture  97.0 ± 0.01  95.7 ± 0.005  58.7 ± 4.4b 
Single  Group Culture*  97.0 ± 0.01  98.9 ± 0.006  70.9 ± 3.6a 
Data expressed as the number of embryos that were compacted or blastocysts respectively, as a proportion of the total 
number of embryos cultured ± SEM. Hatching blastocysts are expressed as a proportion of the embryos that were 
blastocysts ± SEM. Different superscripts within a column represent statistically significant differences. * Single  Group 
Culture represents embryos cultured singly for the pre-compaction period (48 hours) followed by grouping for the final 






       Table 3.2 Effect of in vitro embryo culture grouping on blastocyst cell numbers. 
Culture Conditions  n  ICM  TE  ICM:TE  TOTAL  % APOPTOSIS 
Group Culture  31  18.0 ± 1.0a  47.1 ± 3.3  0.44 ± 0.04a  65.1 ± 3.4  1.8 ± 0.5 (37) 
Single Culture  22  11.8 ± 1.3b  44.7 ± 3.7  0.30 ± 0.05b  56.5 ± 3.7  1.8 ± 0.3 (38) 
Single  Group Culture  54  16.0 ± 0.9a  41.9 ± 1.6  0.39 ± 0.02ab  57.9 ± 2.2  2.3 ± 0.5 (35) 
Different superscripts within a column represent statistically significant differences p<0.05. Data expressed as mean ± SEM. n values for  
% apoptotic cells indicated in parentheses. n=3 replicates. 
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3.4.4  EXPERIMENT 4. Effect of embryo culture grouping on embryo viability following transfer. 
Embryo culture grouping was assessed following cleavage stage and blastocyst stage transfers. Cleavage 
stage embryo transfers assessed the viability of embryos grown either singly or in groups for the early 
cleavage stages of development. Blastocyst stage transfers assessed the viability of embryos grown; 
  singly for the entire culture period, 
  in groups for the entire culture period, 
  singly for the pre-compaction stage (48 hours) and grouped for the final period of culture (single  
group). 
 
a)  Cleavage stage embryo transfers (single v group culture) 
Cleavage  stage  embryos  were  transferred  to  19  recipients.  In  total,  28  uterine  horns  (14  from  each 
treatment group) were studied.  The remaining 4 non-pregnant females, and 2 non-pregnant uterine horns, 
which contained embryos from both treatment groups, were excluded from further analysis. It was assumed 
that lack of uterine receptivity played a role in females that were completely non-pregnant, and in the case 
of lack of pregnancy in individual uterine horns, technical error or uterine irritation during the transfer of 
embryos may have resulted in total absence of implantations. Implantation rates and the ability of a fetus to 
develop  following  implantation  (viable  fetuses/implantation)  were  not  different  between  the  two  culture 
groups (p=0.890, Table 3.3). Placental weights were significantly reduced when embryos were cultured 
singly prior to transfer (p=0.021). Fetal weight, crown rump length and fetal: placental weight did not change 
as a result of culture treatment (p=0.394, p=0.455, p=0.142 respectively, Table 3.3). 
 
b)  Blastocyst stage embryo transfers (single v group v single  group) 
Blastocysts were transferred to a total of 33 recipients, of which 27 were pregnant in at least one uterine 
horn on day 18 of pregnancy. Females who were not pregnant in both uterine horns contained embryos 
from all treatment groups (group = 5 horns, single = 2 horns, single  group = 5 horns), and were excluded 
from subsequent analysis. In addition, mothers who were completely non-pregnant in one uterine horn were 
also excluded from further analysis (single = 2 horns, single  group = 4 horns). In total, 48 uterine horns 
were studied (group n = 18, single n = 20, single  group n = 10).  
Implantation rates were not altered as a consequence of embryo culture grouping when embryo transfers 
were performed at the blastocyst stage following group or single culture throughout development (p=0.865), Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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or if embryos were cultured singly initially followed by grouping (single  group, p=0.683 and p=0.843 
respectively, Table 3.4). Fetal weight, crown rump length and placental weight were not altered between 
culture groups (p=0.475, p=0.701, p=0.792 respectively), and there was no effect of culture grouping on the 
fetal to placental weight ratio (p=0.843, Table 3.4). 
  
 
       Table 3.3 Effect of in vitro culture grouping on pregnancy outcomes with cleavage stage embryo transfers. 
 
Data expressed as mean  SEM. Values represent 46 (group) and 49 (single) fetuses or placentas.  
A Implantation rate - number of fetal/placental units or resorptions present as a percentage of the number of embryos 
transferred.  B  Viable  fetuses/implantation  -  percentage  of  implanted  embryos  that  developed  into  a  viable  fetus. 
Number of uterine horns per treatment indicated in parentheses beneath treatment group.  Different superscripts within 
a row represent statistically significant differences p<0.05. 
    Group Culture 
(14 uterine horns) 
Single Culture 
(14 uterine horns) 
Implantation rate A (%)  67.8  5.0  73.3  4.7 
Viable fetuses/implantation B (%)  78.0  5.4  80.3  4.9 
Fetal weight (mg)  792  20  767  20  
Fetal crown-rump length (mm)  17.9  0.2    17.6  0.2  
Placental weight (mg)  112  3a  102 3b 
Fetal: placental weight ratio  7.3  0.2  7.7  0.2  
 
 
           Table 3.4 Effect of in vitro culture grouping on pregnancy outcomes with blastocyst stage embryo transfers. 
  Group  
(18 uterine horns) 
Single  
(20 uterine horns) 
Single  Group  
(10 uterine horns) 
Implantation rate A (%)  81.3  5.7  80.3  5.3  77.7  6.6 
Viable fetuses/implantation B (%)  37.9  6.5  46.5  7.5  36.7  9.5 
Fetal weight (mg)  837  26   864  21  883  30  
Fetal crown-rump length (mm)  19.2  0.3   18.7  0.3  18.9  0.3  
Placental weight (mg)  117  6   107  5   117  5  
Fetal: placental weight ratio  7.6  0.4  8.5  0.3  7.8  0.5 
Data expressed as mean  SEM. Values represent 29 (group), 39 (single) and 14 (single→group) fetuses or placentas 
A Implantation rate - number of fetal/placental units or resorptions present as a percentage of the number of embryos 
transferred. B Viable fetuses/implantation - percentage of implanted embryos that developed into a viable fetus. Number 
of uterine horns per treatment indicated in parentheses beneath treatment group.   
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3.4.5  EXPERIMENT 5. Effect of embryo culture grouping on human embryo viability.  
a)  Cleavage stage embryo transfer 
There was no significant difference in implantation rates when embryos were cultured in vitro in either 
groups or singly and transferred to patients at the cleavage stage (p=0.681, Figure 3.5).  
 
b)  Blastocyst stage embryo transfer 
Transfer of embryos at the blastocyst stage following either single or group culture throughout the 




Table 3.5 Patient demographic characteristics. 
  Embryo Grouping   
  Single  Group  Significance 
Number of patients  73  162  p=1.0 
Maternal Age  34.2±0.4  34.1±0.4  p=0.511 
% ICSI patients  72.6  77.2  p=1.0 
Number of oocytes collected  9.7±0.6  8.5±0.4  p=1.0 
Number of oocytes fertilized  5.4±0.4  4.9±0.3  p=0.746 
% blastocyst transfer  23.0  25.9  p=1.0 
Grade of transferred embryo  2.0±0.1  1.9±0.1  p=0.893 
Infertility Diagnosis (%)* 
-  Male Factor 
-  Endometriosis 
-  Tubal 
-  Ovulation/ovarian defect 
-  Unexplained 

















There were no statistically significant differences between groups with any variables analysed. *Infertility 
diagnoses include both male and female factors, and are listed as the number of cases of each diagnosis. 
In some cases more than one category is applicable to a patient pair. Percentage infertility diagnoses are 













Figure 3.5 Human implantation rates following single and group culture with cleavage and blastocyst stage transfers. 
Number of patients in each group indicated in bars. All patients had elective single embryo transfers. 
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3.5  DISCUSSION 
The widespread introduction of single embryo transfers in clinical IVF in order to reduce the incidence of 
multiple gestations is dependent on the ability to select the most viable embryo from a cohort for 
transfer.  The  ability  to  track  single  human  embryos  individually  throughout  development  in  the 
laboratory, significantly aids in the sequential assessment of development and therefore the choice of 
the highest quality embryo for transfer. This study aimed to assess the consequences of culturing 
embryos  individually  or  in  groups,  and  of  cleavage  and  blastocyst  stage  embryo  transfers  under 
different grouping conditions, in mouse and human embryos, as well as investigating fetal and placental 
development  following  these  in  vitro  culture  conditions  in  the  mouse.  This  data  demonstrates  that 
culture of mouse embryos singly in conditions that maintain the embryo: incubation volume to that of 
group culture did not affect the subsequent ability of the embryo to develop to the blastocyst stage or 
implant  and  produce  a  viable  fetus  compared  to  embryos  cultured  in  groups.  Additionally,  human 
embryo implantation rates were not altered by in vitro culture groupings. 
 
It has previously been demonstrated in animal models that in vitro culture in smaller volumes or in 
groups facilitates blastocyst formation, increases blastocyst development rate, blastocyst cell number 
and  blastocyst  viability  (Schini  and  Bavister  1988,  Paria  and  Dey  1990,  Lane  and  Gardner  1992, 
Gardner  et  al.  1994,  Keefer  et  al.  1994,  Stoddart  et  al.  1996,  O'Neill  1997).  The  current  study 
contradicts  many  previous  observations  that  single  culture  of  mouse  embryos  during  the  pre-
implantation  period  decreases  blastocyst  formation  rates  (Wiley  et  al.  1986,  Paria  and  Dey  1990, 
Canseco et al. 1992, Lane and Gardner 1992, Keefer et al. 1994, Stoddart et al. 1996). No differences 
were observed in this study between cleavage rates and blastocyst development rates, which differs 
from the majority of the published literature performed in animals (Schini and Bavister 1988, Canseco et 
al. 1992, Lane and Gardner 1992, Gardner et al. 1994, Kato and Tsunoda 1994, Keefer et al. 1994, 
Fujita et al. 2006), although it should be noted that in many of these studies the methodologies differed 
in that embryos which were cultured in groups had smaller embryo: incubation volumes. Human studies 
(Almagor et al.  1996,  Rijnders and  Jansen  1999,  Spyropoulou et  al.  1999)  and  one bovine  study 
(Carolan  et  al.  1995)  that  have  been  performed  evaluating  culture  grouping  are  supportive  of  the 
observations in the present study with no difference being observed in cleavage rates and morphology. 
However these human studies observed embryos only until day 2 of development prior to embryo 
transfer, with the exception of Rijnders et al. (1999), who observed embryos to the blastocyst stage in a 
single tissue culture media system, and observed no difference in blastocyst development rates. This 
can potentially be explained by a number of factors incorporated in the culture system employed. Most 
significantly, embryos were cultured in medium containing pasteurized plasma as a protein source, 
which contains an undefined array of factors potentially capable of stimulating embryo growth. For Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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regulatory  issues  coupled  with  variations  between  batches,  serum  is  not  used  in  embryo  culture 
systems today. This factor alone likely confounded the interpretation of the ability of embryos to develop 
to the blastocyst stage in group or single culture conditions as the milieu of factors in the medium is 
unknown.  
The work presented in this chapter is the first density study to use a highly optimized sequential culture 
media, with recombinant albumin as a protein source, and to culture mouse embryos at low oxygen 
concentrations.  This  system  could  be  expected  to  provide  the  embryo  with  greater developmental 
support than previously established simpler in vitro culture systems and may account for the success of 
the single culture embryos in this study. However, mouse blastocyst hatching rates were observed to be 
significantly reduced in singly cultured embryos in the present study. The apparent delay in blastocyst 
hatching of the singly culture embryos may be an indication of an overall delay in development, that has 
been  previously  reported  for  singly  cultured  embryos  (Gardner  et  al.  1994,  Keefer  et  al.  1994, 
Salahuddin et al. 1995). A reduction in blastocyst hatching rates has been observed in grouping studies 
in cases with and without maintenance of embryo density between singly and group cultured embryos. 
In single culture, when albumin or growth factors, epidermal growth factor (EGF) and transforming 
growth factor-β1 (TGFβ1) supplement the media, the proportion of blastocyst hatching is equivalent to 
group cultured embryos, while addition of these same factors to group culture does not further impact 
hatching  rates  (Keefer  et  al.  1994).  This  provides  evidence  for  a  role  of  autocrine  factors  in  the 
stimulation of embryo development. 
 
A prevalent argument in the literature suggests that the positive outcomes of culturing embryos in 
groups  involves  growth-promoting  factors  that  one  embryo  can  provide  to  another  to  assist  in 
development (Schini and Bavister 1988, Paria and Dey 1990, Lane and Gardner 1992, Gardner et al. 
1994, O'Neill 1998). Thus, if embryos are cultured singly, they would not benefit from any factors that 
may be secreted due to the lack of surrounding embryos in culture. Of the large volume of literature that 
has investigated culture groupings, very few of these studies deliberately maintained the embryo density 
of in vitro culture (Keefer et al. 1994, Fujita et al. 2006). As such, these are the only studies in which a 
direct comparison can be made regarding the production of any growth-promoting factor secreted by the 
embryo. In both studies, a decrease in blastocyst development rates was seen with single embryo 
culture compared to group culture. It can therefore be hypothesised that the benefit of stimulatory 
factors would likely only be evident in embryos which require additional support for development, in 
particular in meeting developmental checkpoints that are associated with development to the blastocyst 
stage. Thus the benefit of group culture may be that embryos with a higher intrinsic developmental 
capability  are  able  to  support  the  development  of  less  capable  sibling  embryos  through  autocrine 
factors, to enhance their implantation potential. It is therefore expected that good quality singly cultured Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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embryos are producing these growth-promoting factors themselves, however in the case of  poorer 
quality sibling embryos which might require additional stimulation, single culture is of no benefit and 
these embryos would have reduced developmental potential under such conditions. 
 
Total cell numbers were not significantly altered by culture groupings in this study, however fewer ICM 
cells developed in embryos that had been cultured singly throughout the culture period, compared to 
embryos  grouped  either  for  the  entire  culture  period,  or  only  during  the  post-compaction  period. 
Interestingly, the single  group culture blastocysts had an ICM cell number and total cell number 
lower than the group cultured embryos and higher than the single cultured embryos. This implies that 
either the post-compaction period is more critical for embryo density than the pre-compaction period or 
that  crucial  effects  in  the  pre-compaction  phase  can  partially  be  recovered  post-compaction.  This 
phenomenon of recovery has also been observed in bovine embryos where conditioned media was 
transferred from embryos grown in groups to embryos of the same developmental stage which were 
incubated singly. An improvement in blastocyst development rate was seen when the media of the 
singly cultured  embryos  was  supplemented  with  media  from  group  cultured  embryos  compared  to 
embryos which were maintained in static single culture without media supplementation (Fujita et al. 
2006). Multiple growth factor candidates have been shown to stimulate ICM development in embryos, 
which  has  been  investigated  through  knockout  mouse  models  (Feldman  et  al.  1995)  and 
supplementation of growth factors to the embryo culture media (Harvey and Kaye 1990, Gardner and 
Kaye 1991, Rappolee et al. 1992, Feldman et al. 1995). Therefore with a reduction in ICM cell number 
observed,  it  is  still  possible  that  autocrine  factors  play  a  considerable  role  in  optimal  embryo 
development, however this role may not be a critical one. An alternative explanation for the reduction in 
ICM in singly cultured embryos may be that cells were undergoing apoptosis at an increased rate. This 
was determined not to be the case in the current study, with similar low levels of apoptosis observed 
throughout the blastocysts cultured individually and in groups. There is evidence that apoptosis in the 
pre-implantation embryo  is  regulated  by  growth/survival factors acting  in  an autocrine  or paracrine 
manner such as transforming growth factor-α and members of the insulin-like growth factor family 
(Brison 2000). A reduction in ICM cell number has been associated with embryos cultured individually 
previously, compared to a larger number of embryos cultured in the same volume (Brison and Schultz 
1997). However, in the same study a ~50% increase in cell death in the ICM and trophectoderm in 
embryos cultured singly was seen, which was not observed in the current study.  
 
The most stringent test of embryo viability is to perform embryo transfers and investigate subsequent 
developmental outcomes. This study found no difference in the ability of embryos to implant when Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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cultured individually or in groups with the same embryo: incubation volume prior to transfer at the 
cleavage or blastocyst stage. It could have been expected from my results that embryos cultured singly 
would be less viable than their group cultured counterparts, as reduced ICM cell number and total cell 
counts are correlated with a reduction in embryo viability following transfer (Lane and Gardner 1997b). 
Therefore, it would not have been surprising given the reduced ICM, for singly cultured embryos to have 
reduced implantation or fetal development rates, however it has also been demonstrated that blastocyst 
viability is not always correlated with a greater ICM cell number (Banwell et al. 2007). It is feasible that 
there is a threshold proportion of ICM development and total cell counts required to adequately support 
development and although singly cultured embryos in the present study had significantly reduced ICM 
development compared to group cultured embryos, this was not adequate to impact on implantation and 
subsequent development. Further, it may be that the number of epiblast cells within the ICM were not 
altered between the treatments thus not affecting fetal development. 
 
To establish the effect of single versus group culture on the pre-compaction stage of development, 
embryos were returned to the reproductive tract at the cleavage stage, to be exposed to a complex 
milieu of factors, unable to be replicated in vitro. Transfer of embryos that had been grouped or singly 
cultured at the cleavage stage of development, did not influence implantation or fetal development rates 
in human (with single embryo transfers) or in mouse. This supports a previous study of human embryos 
where  despite  the  transfer  of  multiple  embryos,  no  difference  in  implantation  rate  was  observed 
following group or single culture (Spyropoulou et al. 1999). Alternatively, it has also been observed in 
human that group culture benefits embryos transferred at the cleavage stage with higher implantation 
rates  (Moessner  and  Dodson  1995,  Almagor  et  al.  1996).  However,  again  multiple  embryos  were 
transferred  in  these  studies,  highlighting  the  requirement  for a  single  embryo  transfer study  to  be 
performed in this area. A further significant consideration in these studies is the volume of media that 
embryos were cultured in. Moessner et al. (1995) and Almagor et al. (1996) cultured embryos in 1000μL 
and 700μL of media respectively, either singly or grouped, which based on animal studies investigating 
the ideal embryo density for in vitro culture, is a large volume (Canseco et al. 1992, Lane and Gardner 
1992, Gardner et al. 1994, Keefer et al. 1994). In addition, any autocrine stimulatory factors would most 
certainly have been significantly diluted in the single culture of an embryo in a volume as large as 700-
1000μL,  while  in  smaller  volumes  i.e.  20μL,  stimulatory  factors  would  have  a  higher  likelihood  of 
influencing quality. Furthermore, previous studies have incorporated up to 15% serum in their embryo 
culture systems (Moessner and Dodson 1995, Almagor et al. 1996, Rijnders and Jansen 1999), which 
contains a complex undefined array of growth factors, which may potentially make the embryo density 
less critical when investigating cellular development. This factor was considered by Spyropoulou et al. Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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(1999) who used a synthetic serum replacement as a protein source, and despite multiple embryo 
transfers, saw no difference in implantation rates between group and single culture. 
 
Following  transfer  of  blastocysts  to  both  mouse  and  human  after  single  and  group  culture,  no 
differences in implantation rates were observed. Previously, one study in the human has explored the 
effect of embryo grouping and embryo culture volume on viability. This study grouped all embryos until 
day 3 of development and then investigated group and single culture in both large and smaller volumes 
of media for development to the blastocyst stage prior to embryo transfer (Rijnders and Jansen 1999). 
No difference in blastocyst formation or implantation rates for either grouping or volume of culture media 
was found which supports the current study, despite the employment of different protocols. Additionally, 
no  effect  was  found  on  mouse  fetal viability  following  embryo  transfer of  group  or singly cultured 
embryos at the cleavage or blastocyst stage. However, placental weights were significantly reduced 
when embryos were cultured singly prior to cleavage stage embryo transfer. Interestingly, the blastocyst 
stage transfers did not have statistically significant differences in placental weights. Fetal weights were 
unaltered  despite  a  difference  in  placental  weight  for  embryos  transferred  at  the  cleavage  stage, 
suggesting that compensatory changes occur in the placenta to maintain function (Constancia et al. 
2002, Wyrwoll et al. 2009). However, the longer-term effect on the development of the offspring in this 
case is unknown and warrants further study.  
 
This study requires further investigation into fetal outcomes to conclude the full impact of group and 
single culture of embryos. Live birth outcomes were not assessed in human or the mouse, which may 
provide valuable developmental data, specifically any effect of reduced placental weight on offspring. It 
would be valuable to assess human live birth data, as human and mouse placentation differ and the 
differences observed in mouse placental weights may not be applicable to humans. Alternatively, further 
investigations into the altered mouse placental weights could be undertaken including morphometry 
analysis to determine any impact on placental junctional zone size (exchange region) or anomalies. 
Furthermore, gene expression of placental growth related genes may be warranted. 
 
Poor prognosis patients, particularly those with advanced maternal age and low quality oocytes, may 
potentially be further disadvantaged with the employment of single culture. Mitochondria play a vital role 
in the oocyte through provision of ATP for fertilization and preimplantation embryo development. Poor 
quality  oocytes  have  been  shown  to  have  perturbed  mitochondrial  function  which  reduces 
developmental competence (Muller-Hocker 1996 Mol HR). Therefore the existence of any stimulatory Chapter 3: Single Embryo Culture as a Tool for Embryo Selection 
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factors that one embryo may provide to another when cultured in groups may provide benefit to poorer 
quality embryos, while removal of these stimulants by performing single culture may impart a more 
stressful environment for low quality oocytes. 
 
A small statistically insignificant difference was observed between single and group culture for the good 
prognosis patient population assessed in this study. Recent studies have illustrated that very large 
sample sizes are required to determine an effect of a subtle treatment such as embryo density, and 
often these are only found when assessing live birth rates (Meintjes et al. 2009). A power analysis 
based on the preliminary human data in this study, for patients with a maternal age less than 38 years, 
indicates for a prospective randomised controlled study 143 patients with cleavage stage transfers and 
74 patients with blastocyst transfers would be required in each arm of the study to detect a significant 
difference between single and group culture. 
 
Single culture provides the ability to track embryos throughout development in the clinical laboratory, 
significantly  aiding  in  the  sequential  assessment  of  development  from  oocyte  and  pronuclear 
morphology through the early cleavage stages and therefore choice of the highest quality embryo for 
transfer. This study has demonstrated no difference between single and group embryo culture in human 
embryo implantation ability at the cleavage or blastocyst stage. In a mouse model, differences were 
seen in ICM cell number of singly cultured embryos, which did not appear to impact on subsequent 
ability to implant. Furthermore, a decrease in placental weights was observed with single culture of 
mouse  embryos,  which  did  not  affect  fetal  weight  however  other  consequences  remain  unknown. 
Neither of these parameters was able to be assessed in the human. Further studies would be required 
to determine the impact of these factors on offspring. Single culture of embryos with other than high 
intrinsic developmental potential may be more likely perturbed than if the same embryos were group 
cultured  and  able  to  take  advantage  of  interactions  between  embryos.  Therefore  single  culture  of 
human embryos should only be employed with caution, particularly in women with advanced maternal 
age, for which it is known that embryo developmental potential is reduced.  
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CHAPTER 4   
DAY 4 EMBRYO TRANSFER AS A 
MORPHOLOGICAL EMBRYO 
SELECTION TOOL  
 
 
Portions of the data presented in this chapter have been published as follows; 
Feil D, Henshaw R, Lane M (2008) Day 4 Embryo Selection is Equal to Day 5 using a new Embryo Scoring 
System Validated in Single Embryo Transfers. Human Reproduction 23 (7) p1505-1510. (see Appendix 5). Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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4.1  INTRODUCTION 
In clinical IVF the majority of embryos are transferred on day 2 or 3 following insemination (Wang et al. 
2009).  Replacement  of embryos  at  this stage  involves  transferring  embryos  that are  governed  by  the 
maternal genome (Braude et al. 1988). Implantation is more likely to occur when an embryo that has 
developed beyond embryonic genome activation is transferred (Gardner and Lane 1997). Critical stages of 
development and indications that this has successfully occurred are compaction and blastulation of the 
embryo (Veeck and Zaninovic 2003). Furthermore, there is significant selection advantage, as embryos that 
are unable to activate the embryonic genome or complete compaction and/or cavitation can be easily 
identified and excluded for transfer (Balaban et al. 2000, Behr et al. 2000). It is reported that only 48% of 
embryos selected for transfer on day 3 are subsequently re-selected for transfer at the blastocyst stage 
(Graham et al. 2000), indicating the importance of the increased selection value of extended culture.  
 
In animal models the majority of embryos arrest development following transfer of early developmental 
stages to the uterus (Noyes and Dickmann 1960, Moore and Shelton 1964, Newcomb and Rowson 1975). 
As a result, animal embryos, particularly from domestic species, are routinely transferred at the blastocyst 
stage (Hasler 2003). One of the clear advantages of blastocyst transfer is that the embryo is returned to the 
uterus at a stage of development where it would normally reside (Gardner et al. 2002). In vivo, the human 
blastocyst moves from the oviduct into the uterus on day 4 of development (Gardner et al. 2002), and at this 
stage the embryo has compacted and is developing a transporting epithelium (Biggers et al. 1988). This is a 
critical window in the development of the mammalian embryo, as acquisition of the ability to regulate its own 
physiology enables precise homeostatic control (Lane 2001). At this stage, as discussed earlier, the embryo 
has also activated its own genome. Therefore, it was postulated that the transfer of embryos on day 4 of 
development may result in the selection benefits of blastocyst transfer, while limiting the period of time in 
culture and burden on the IVF laboratory. Therefore, this study retrospectively assessed the effect of day 4 
embryo transfer on implantation rates following single embryo transfer (SET) compared to cleavage stage 
SET (day 2 or 3) and day 5 SET. Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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4.2  MATERIALS AND METHODS  
4.2.1  Patient Cohorts 
Two cohorts of patients/embryos were assessed for this study. The first cohort of patients, treated between 
March-May 2006 (n=168 patients) had embryos observed only on day 4 of development, with no other 
change to clinic protocols. From the observations in cohort 1, a day 4 scoring procedure was described and 
the second cohort of patients included outcome assessment of day 4 embryo transfers. All patients in the 
second cohort underwent a SET between June 2006 and January 2007 at Repromed, Adelaide, Australia 
(n=705),  excluding  only  treatment  cycles  that  incorporated  donor  gametes  or  pre-implantation  genetic 
diagnosis (PGD).  The decision for a cleavage stage (day 2-3) or extended stage (day 4-5) embryo transfer 
was made prior to the commencement of treatment between the patient and their clinician. This decision 
was only altered if there was only a single embryo fertilized. Patients who had consented to an extended 
stage embryo transfer underwent a day 4 embryo transfer if their oocyte collection was on a Monday or 
Tuesday, while oocyte collections on Wednesday-Friday had a day 5 embryo transfer. All patients were 
stimulated using a long down-regulation protocol, as described in Chapter 2, Materials and Methods. 
 
4.2.2  Culture Conditions 
All  laboratory procedures occurred  as described  in Chapter 2,  Materials and Methods.  Embryos  were 
cultured in groups of 4 in 50µL drops of medium under oil. Cryopreservation for patients undergoing a day 4 
embryo transfer was performed only on days 5 and 6 of development, as for day 5 embryo transfers. 
 
4.2.3  Statistics 
Data are presented as percentages or mean ± SEM, where appropriate. Proportion of patients undergoing 
ICSI,  fertilization  rates,  infertility  diagnoses  and  implantation  rates  underwent  chi-square  analysis. 
Remaining demographic data were analysed by One-Way ANOVA. Bonferroni post-hoc tests were applied, 
while Dunnett‟s T3 post hoc tests were applied for data that had unequal variances. Linear regression of 
implantation  rates  resulting  from  the  transfer  of  embryos  of  different  grades  on  day  4  of  culture  was 
assessed using Pearson‟s correlation coefficient test. P values <0.05 were considered to be statistically 
significant.  
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4.2.4  EXPERIMENT 1. Establishment of a day 4 morphological scoring system for human embryo 
development.  
Morphology was assessed on day 4 of embryo development for all patients undergoing IVF treatment with 
extended culture (n=168 patients, 996 embryos) between March-May 2006. All embryos were observed and 
described by appearance to be classified into categories.  These categories were subsequently used to 
develop a scoring system for day 4 human embryos. 
 
4.2.5  EXPERIMENT 2. Assessment of the newly developed morphological grading system for day 
4 human embryos. 
The morphological grading system for embryos in Experiment 1 was implemented in a human IVF clinic to 
assess its effectiveness for embryo viability selection prior to embryo replacement. The developed grading 
system was distributed amongst embryologists in the clinic. Patients undergoing extended culture had an 
embryo replacement on either day 4 or day 5, dependent on the day of oocyte retrieval. On the morning of 
transfer for patients having a day 4 embryo transfer, embryos were graded according to the developed 
criteria and the highest morphological scoring embryo available was selected from the patient‟s cohort of 
embryos to be replaced. Similarly for day 5 embryo transfers, on the morning of transfer embryos were 
graded according to the scoring system developed by Schoolcraft and Gardner (see Appendix 3, (Gardner 
and  Schoolcraft  1999)).  Pregnancy  was  determined  by  a  positive  serum  β-hCG  result  with  viable 
implantation confirmed by ultrasound 5-6 weeks after embryo transfer.  
 
4.2.6  EXPERIMENT 3. Comparison of implantation rates for day 4 embryo transfer to day 2-3 and 
day 5 embryo transfers. 
Implantation rates for patients having a cleavage stage (day 2/3, n=388), day 4 (n=124) or day 5 (n=193) 
embryo replacement were compared for SETs in unselected patients. Pregnancy was determined by a 
positive serum β-hCG result with viable implantation being confirmed at ultrasound 5-6 weeks after embryo 
transfer. 
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4.3  RESULTS 
4.3.1  EXPERIMENT 1. Establishment of day 4 morphological scoring system for human embryo 
development.  
The range of embryo morphologies observed for embryos assessed on day 4 is detailed in Figure 4.1. 
There was a large range of developmental stages observed; a small number of embryos were undergoing 
cavitation and were able to be scored on a blastocyst scoring system (n=10, 1%), some embryos were yet 
to compact and still exhibited all the characteristics of a cleavage stage embryo (n=340, 34.1%) and other 
embryos appeared to have arrested (n=177, 17.8%). However, the majority of the embryos on day 4 were 
exhibiting  some  degree  of  compaction,  either  complete  or  partial  (n=226,  22.7%,  n=243,  24.4% 
respectively, Figure 4.1). A scoring system based on the range of morphologies observed on day 4 was 
developed to enable selection of high morphological quality embryos for replacement. The scoring system 
developed to grade embryos on day 4 of culture is shown in Figure 4.2. 
 
4.3.2  EXPERIMENT 2. Assessment of the newly developed morphological grading system for day 
4 human embryos. 
The resultant implantation rates for the day 4 scoring system with regard to embryo stage are shown in 
Figure 4.3.  A linear decrease in implantation rate with grade was observed on day 4 of culture (Pearson‟s 
coefficient  r=-0.249, p=0.036). Interestingly, embryos with partial compaction on day 4 were shown to be as 
viable as completely compacted embryos when transferred, and as such have been included in the scoring 
system as eligible for assignment as a Grade 2 embryo, providing no additional morphological anomalies 
were present. 
 
4.3.3  EXPERIMENT 2 and 3. Patient demographics.  
Patient demographic characteristics are shown in Table 4.1. There was no difference in maternal age 
between treatment groups of day 2-3, day 4 or day 5 embryo transfers. The number of previous cycles 
undergone by patients and the rates of ICSI and IVF in the different embryo transfer day groups were also 
not significantly different. However, patients that had a transfer of a day 2/3 embryo had fewer oocytes 
collected and lower fertilization rates, compared to patients having a day 4 or 5 embryo transfer (p=0.0001, 
p=0.001 respectively).  The grade of embryos transferred on day 5 (2.2±0.08) was significantly poorer than 
the grade of transferred embryos on days 2/3 or day 4 (1.6±0.05 and 1.5±0.05, respectively, p=0.0001). In 
addition, fewer embryos were frozen when embryos were transferred on day 4 or day 5 (3.0±0.2 and Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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2.7±0.2 respectively) compared to embryos being transferred at the cleavage stage (3.7±0.2, p=0.029 and 














Figure 4.1 Range of morphologies observed on day 4 of human embryo development. 























Figure 4.2 Scoring system developed for day 4 embryos. 
Grade 1: Early blastocyst, visible signs of cavitation occurring (A) OR Completely compacted embryo, 
lacking morphological anomalies (B) e.g. Vacuolation, excessive fragmentation, large number of excluded 
cells, self cavitation of cells 
Grade 2: Grade 1 compacted morula, with some morphological anomalies e.g. one of the following present, 
vacuolation, excessive fragmentation, excluded cells, self cavitation of cells OR At least an 8 cell embryo, 
with partial compaction present or the majority of cells at least showing signs of compaction (C, D) 
Grade 3: Partially compacted embryo with vacuoles or excessive fragmentation present 
OR 8 cell embryo or greater, with no signs of compaction evident (E) 
Grade 4: Embryos with 8 cells or greater, with no sign of compaction and vacuoles or excess fragments OR 
















Figure 4.3 Implantation rates resulting from developed day 4 embryo scoring system with single 
embryo transfers. 
* Pearson‟s coefficient r=-0.249, p=0.036. Numbers in columns indicate the number of embryos of each 






Table 4.1 Patient demographic characteristics for Experiment 2 and 3. 
  Day 2/3 Transfer  Day 4 Transfer  Day 5 Transfer 
Number of patients  388  124  193 
Maternal Age  34.5±0.2  34.8±0.4  33.9±0.3 
% ICSI  79.6%  82.3%  81.3% 
Number previous IVF/ICSI cycles  0.88±0.08  1.25±0.14  0.94±0.10 
Number of oocytes collected  8.8±0.3a  11.6±0.6b  11.8±0.4b 
Percent fertilized  52.3%a  63.3%b  62.0%b 
Grade of transferred embryo†  1.6±0.05a  1.5±0.05a  2.2±0.08b 
Number of surplus embryos frozen  3.7±0.2a  3.0±0.2b  2.7±0.2b 
Infertility Diagnosis % (n)* 
-  Male Factor 
-  Endometriosis 
-  Tubal 
-  Ovarian 
-  Unexplained 
























Implantation rate‡  29.1% (113)  38.7% (48)  32.1% (62) 
 
Variables with statistically significant differences are indicated by different superscripts within a row. 
*Infertility diagnoses include both male and female diagnoses; in some cases more than one category is 
applicable to a patient pair. † It should be noted that different assessment systems were used to score 
embryos at each of the different days of transfer. ‡ Numbers in parentheses indicate the number of patients 
with an ongoing pregnancy. Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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4.3.4  EXPERIMENT 3. Comparison of implantation rates for day 4 embryo transfer to day 2-3 and 
day 5 embryo transfers. 
Implantation rates for SETs at the cleavage stage (day 2/3), day 4 and day 5 are shown in Figure 4.4. 
Ongoing implantations were significantly increased following extended culture and embryo transfer on day 4 
(38.7%) compared to cleavage stage transfer (29.1%, p=0.05). The higher implantation rate for extended 
culture with day 4 embryo transfer was further increased, compared to cleavage stage transfer, when 
implantation rates for only patients <38 years were examined (p=0.025, Figure 4.5). Implantation rates 
following extended culture of embryos and transfer on day 5 (32.1%) were not significantly increased 
compared to cleavage stage transfer (29.1%, p=1.0) in this study of SETs and unselected patients.  Day 4 
and day 5 embryo transfers combined also did not result in significant differences in resultant implantation 

















Figure 4.4 Implantation rates following single embryo transfer of cleavage and extended culture 
embryos. 

























Figure 4.5 Effect of maternal age and day of transfer on implantation rates. 
Dark bars indicate patients <38 years of age, light bars indicate patients ≥38 years of age. 
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4.4  DISCUSSION 
The ability to select the most viable embryo for transfer is an increasingly important aspect to an IVF 
cycle. Key considerations for selection of the most viable embryos include the assessment be non-
invasive and that it occurs in a timely fashion that can easily occur within the operations of the clinical 
laboratory. As such, methods to increase selection based on embryo morphology are an attractive 
option.  My  data,  though  observational  and  retrospective,  suggests  that  transfer  of  day  4  human 
embryos is a viable alternative to the transfer of embryos on day 5. 
 
Human embryo development on day 4 has largely been neglected as a morphological marker of viability 
and was initially implemented following embryo biopsy for PGD, when embryo transfer required a delay 
in order for genetic testing to be performed and reported (Grifo et al. 1998, Gianaroli et al. 1999). Two 
previous morphological scoring systems have been described for human embryos on day 4. Huisman 
and colleagues (2000) described day 4 embryos as advanced (cavitating), average (compacted) or 
retarded (4-12 cells). Alternatively, a particularly detailed scoring system was described by Tao et al. 
(2002), which classified embryos initially as compacted or non-compacted embryos. This system further 
catalogued embryos with specific emphasis on the proportion of cells undergoing compaction, with 
consideration for the morphology of the compacted embryo, fragmentation and embryo quality on day 
2/3 (Tao et al. 2002). Both previously described day 4 morphology scoring systems have assessed 
resultant pregnancy rates, however Tao et al. (2002) generally transferred 4 embryos, with occasions 
where 6 embryos were replaced, and Huisman et al. (2000) transferred 2 embryos to the majority of 
patients, and occasionally transferred a single embryo. The transfer of multiple embryos and mixed 
quality of embryos in previous studies make the validation of any scoring system difficult to analyse.  
Nevertheless,  it  was  shown  that  the  good  quality  graded  embryos  in  both  systems  had  a  higher 
implantation rate than the poorly graded embryos (Huisman et al. 2000, Tao et al. 2002). In addition, a 
significantly higher implantation rate resulted from embryo transfer on day 4 compared to day 3, with 
fewer embryos being replaced for day 4 embryo transfers (Tao et al. 2002). The lack of implementation 
of a day 4 scoring system and embryo transfers in routine embryology thus far is likely based on the 
deficiencies of the morphological scoring systems that have been described to date. Any scoring system 
needs to be able to be easily incorporated into a laboratory while providing sufficient morphological 
description to differentiate embryos with higher viability from embryos with reduced potential. Previous 
attempts at describing morphological scoring systems have demonstrated that a compromise must be 
reached between ease of assessment and extremely detailed descriptions of embryo appearance. For 
example, blastocyst grading was first described by Dokras et al. (1993), which mainly incorporated the 
degree  of  blastocyst  expansion  (Dokras  et  al.  1993).  Blastocyst  morphology  grading  was  further 
developed  by  Gardner  and  Schoolcraft  (1999)  before  it  became  widely  accepted,  and  included Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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assessment of expansion as well as visual estimation of ICM and TE cell number and quality (Gardner 
and Schoolcraft 1999). The day 4 scoring system described in the current study is simple to learn as it 
incorporates descriptive factors similar to a cleavage stage scoring system, however the diversity of 
morphological changes observed on day 4, in particular the degree of compaction, which is very easily 
observed,  has  a  significant  impact  on  the  post-transfer  outcome  and  is  simple  to  teach.  All 
embryologists in the clinic performed embryo assessments and selection of an embryo for transfer, 
which demonstrates the ease and consistency with which the grading system was introduced to the 
clinic. Furthermore, this grading system had a linear correlation between embryo grade and pregnancy 
rate, as well as improving embryo selection over cleavage stage embryo transfers. 
 
The patients involved in this study were unselected and were comparable between groups. Patients 
having a cleavage stage transfer had fewer oocytes collected and a lower fertilization rate than patients 
having either a day 4 or day 5 embryo transfers, which was not caused by a difference in maternal age 
of patients or the proportion of patients undergoing ICSI or IVF. It could be postulated that the reduction 
observed in oocytes retrieved and fertilization rate in the cleavage stage embryo transfer group is likely 
a patient bias, where those who were expected to have a poor response to stimulation, as determined 
by ovarian reserve markers prior to treatment, were advised by their clinician to have a cleavage stage 
transfer. This would explain both the lower number of oocytes retrieved in this cohort of patients  and 
the reduced fertilization rate (Lekamge et al. 2007), despite the similar maternal age to the other groups. 
Other  differences  that  were  observed  between  groups  in  the  study  were  the  grade  of  transferred 
embryo, which was significantly reduced in patients having an embryo transfer on day 5. This is not an 
unexpected result as different morphology grading systems were used for each stage of transfer, and a 
top quality blastocyst grading has extremely restrictive criteria. In addition, fewer embryos were frozen in 
both extended culture embryo transfer groups, which is result of both of these groups only having 
cryopreservation on days 5 and 6 of development, as day 4 cryopreservation was not implemented in 
this study. Furthermore, fewer embryos eligible for cryopreservation are expected as extended culture is 
a selection tool, with which fewer embryos are able to achieve good blastocyst formation (Blake et al. 
2007). 
 
This study is unique to the current literature as it is the first to analyse implantation rates following the 
transfer of single embryos on day 4 of development. Previous studies (Huisman et al. 2000, Tao et al. 
2002, Margreiter et al. 2003, Skorupski et al. 2007) transferred up to four embryos to the uterus at one 
time, making the determination of which embryos resulted in viable implantations difficult. All SETs 
performed in the clinic were included in this study, excluding cycles that involved donor gametes or Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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PGD. Although patients included in the analysis for this study were non-selected, it must be noted that 
the clinic has a Single Embryo Transfer Policy, which recommends patients under the age of 38 have a 
single embryo transferred. However, unlike previous studies, the decision of whether a patient would 
have a transfer following extended culture, was not based on the patient‟s response to gonadotrophins, 
the number of pronuclear embryos available or embryo quality at the cleavage stage (Gardner et al. 
1998a, Coskun et al. 2000, Karaki et al. 2002, Levron et al. 2002, Rienzi et al. 2002, Bungum et al. 
2003, Emiliani et al. 2003, Frattarelli et al. 2003). Rather, this decision was made clinically, prior to the 
commencement  of  the patient‟s  treatment. Patients were  only converted  from  an  extended  culture 
transfer to a cleavage stage transfer in the event that there was no selection advantage to be gained by 
growing embryos for an extended period (i.e. there would be only one embryo in the patient‟s cohort).  
 
The increased implantation rate previously described for blastocyst transfer on day 5 over cleavage 
stage embryo transfers was not observed for transfer of day 5 embryos in this study. The lack of 
difference between cleavage stage and day 5 embryo transfer pregnancy rates has previously been 
suggested to be due to patients having an embryo transfer regardless of whether there was a formed 
blastocyst on day 5 and therefore there were no transfer cancellations (provided the embryo had at 
least undergone compaction by day 5).  However, if only the patients that had a good quality embryo 
replaced at day 5 or day 2/3 are compared (a blastocyst on day 5 or an „on-time‟ unfragmented embryo 
at the cleavage stage), there was again, no difference in resultant implantation rates (37.0% compared 
to 35.1% respectively, data not shown). Therefore, in our clinic with unselected patients there is no 
added selection with blastocyst transfers compared to cleavage stage transfers, which further supports 
the proposal that blastocyst transfer is beneficial only in selected patient populations (Gardner et al. 
1998a, Coskun et al. 2000, Karaki et al. 2002, Levron et al. 2002, Rienzi et al. 2002, Bungum et al. 
2003, Emiliani et al. 2003, Frattarelli et al. 2003). 
 
An increase in implantation rate was seen for embryos transferred on day 4 compared to cleavage 
stage transfers in the current study. However, day 4 embryo selection provided no additional selection 
advantage over day 5 embryo transfer. A previous study comparing cleavage stage (day 2/3) and 
extended stage (day 4/5) transfers in a prospective randomised multi-centre study showed an increase 
in implantation rate in extended stage compared to day 2/3 transfers (Margreiter et al. 2003). However, 
day 4 and day 5 pregnancy rates were reported as one result in this study, so a true comparison of day 
4 and day 5 pregnancy rates cannot be made. Others have observed no improvement in pregnancy 
rates resulting from day 4 embryo transfers compared to cleavage stage transfers (Huisman et al. 2000, 
Tao et al. 2002). However, when Huisman and colleagues (2000) excluded transfers of embryos with Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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delayed developed from their analysis, a significant improvement in pregnancy rates for day 4 transfers 
was noted. Furthermore, with significantly fewer embryos being transferred, a similar pregnancy rate 
was achieved for extended culture compared to cleavage stage embryo transfers (Tao et al. 2002).  
 
One  of  the  clear physiological  differences  between cleavage  and  blastocyst  stage  transfers is the 
synchronisation of the embryo with the stage of the reproductive tract that the embryo would normally 
develop in vivo. The cleavage stage embryo would normally reside in the oviduct, and traverse to the 
uterus  on  day  4  of  development  (Gardner  et  al.  2002).  The  surroundings  of  the  oviduct  differ 
significantly from the uterus in nutrient levels, gas environment and pH (Fischer and Bavister 1993, 
Gardner et al. 1996a), and this change in nutrient levels is reflected in modern embryo culture systems 
with sequential media. In addition, the levels of growth factors such as cytokines that are produced in 
the oviduct and uterus differ (Kane et al. 1997), which provide a complex milieu of factors that are 
completely excluded from an in vitro system. The embryo undergoes physiological changes in its early 
development that reflect the differing environments of the oviduct and uterus. As such, it has been 
suggested that the premature transfer of the cleavage stage embryo to the uterus may induce stress on 
the embryo, in particular metabolic stress (Gardner and Schoolcraft 1998, Lane 2001). However, the 
human embryo has a high degree of plasticity (Gardner and Lane 2004) and as evidenced by the high 
implantation  rates  noted  in  the  current  study,  any adaptation  to  the  uterine environment  made  by 
cleavage stage embryos did not impact on viability. Synchronisation of the tract and embryo with a day 
4 transfer may facilitate continued development and implantation. Although this is supported by the day 
4 implantation rates compared to the cleavage stage, it would be expected that a similar advantage 
would be obtained with a day 5 embryo transfer, which was not the case in this investigation. Perhaps a 
potential advantage to replacement of a day 4 embryo to the uterus includes an additional ~24 hours of 
exposure to uterine components compared to a day 5 embryo transfer.  
One of the key advantages of a day 4 embryo assessment appears to be in the wide range of observed 
embryo development on day 4, from cleavage stages through to early blastocysts. Therefore, it appears 
that this is a dynamic time-period of development and that assessment at this time may assist in 
selection of an “on-time” developing embryo. It is well documented in both animal models (McKiernan 
and Bavister 1994, Gonzales et al. 1995) and in the human (Cummins et al. 1986, Van Royen et al. 
1999, Racowsky et al. 2000) that the speed of development is an indicator of viability, with embryos that 
reach defined periods of development at a rate more similar to in vivo development having greater 
viability. A further advantage of day 4 morphology is that the scoring system is founded based on a 
cleavage stage scoring system. Therefore, an embryo can be selected for transfer quickly with the 
added benefit that there is no requirement for extra training that is necessary with blastocyst embryo 
selection for transfer.  Chapter 4: Day 4 Embryo Transfer as a Morphological Embryo Selection Tool 
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A demonstrated benefit of blastocyst culture and transfer is the ability to determine which embryos have 
not yet activated the embryonic genome, which occurs at the 4-8 cell stage in the human (Braude et al. 
1988).  Thus  those  embryos  with  limited developmental potential  in a  cohort  can  be  identified  and 
excluded. My data, along with others (Huisman et al. 2000, Tao et al. 2002, Skorupski et al. 2007) has 
demonstrated this increased selection is evident with a day 4 embryo transfer.  
 
The implementation of embryo transfers on day 4 of development has enabled flexibility for embryo 
replacements to be scheduled to suit the patient, clinician and laboratory. The overall laboratory impact 
has been minimal, as only the transfer occurs on day 4 with cryopreservation still being performed on 
days 5 and 6. Thus the introduction of day 4 embryo transfers was purely a mechanism to improve the 
management  of  treatment  by  providing  flexibility  for  the  patient,  their  clinician  and  the  laboratory. 
Cryopreservation of morulae has been investigated and shown to be a viable cryopreservation option 
(Tao et al. 2004). Mutliple IVF clinics in Australia have now implemented the culture and transfer of 
embryos on day 4 (Repromed Adelaide, Repromed Darwin, Flinders Reproductive Medicine and Fertility 
SA , personal experience Feil, D 2006-2009). 
 
The transfer of day 4 embryos is beneficial in numerous ways; the embryo is returned to the uterus, to 
an environment where it would normally reside. This occurs post-genome activation to allow the embryo 
with the highest developmental potential to be selected from a cohort. An added advantage is being 
exposed to the uterine environment for the maximum time period, and an in vitro environment for a 
minimal time period before implantation. In addition, uterine contractility is reduced at this time (Fanchin 
et al. 1998, Lesny et al. 1998), all of which maximises the potential for implantation. The ability to 
transfer the embryo to the uterus on day 4 enables the benefits of embryo selection for transfer post-
genome activation to be obtained with significantly less burden on the laboratory, and offers a viable 
alternative to day 5 transfers. It also has the advantage in a busy unit to enable flexibility as to the day 
of embryo transfer on day 4 or 5 without affecting ongoing pregnancy rates. Day 4 embryo selection 
appears  to  be  an  effective  tool  to  maintain  implantation  rates  in  our  laboratory,  and  as  such  the 
laboratory continues to perform day 4 embryo transfers to enable flexible treatment for patients. In order 
to further validate this observational data, a prospective randomised study should be undertaken to 
determine if day 4 embryo transfers result in improved pregnancy outcomes. A power analysis based on 
the preliminary data in this study, for patients with a maternal age less than 38 years, indicates for a 
prospective study 226 patients would be required in each arm of the study to detect a significant 
difference between day 4 and day 5 embryo transfers.   
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CHAPTER 5   
HUMAN CUMULUS CELL REDOX 
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5.1  INTRODUCTION 
Embryo quality and viability is ultimately determined by the health of the gametes from which the embryo is 
derived  and  therefore  markers  of  oocyte  quality  are  potential  candidates  to  reflect  the  developmental 
potential of the resultant embryo (Hardy et al. 2002). Previous studies using oocyte donors or mathematical 
modeling have confirmed that the quality of the oocyte is a rate-limiting factor for the success of IVF 
procedures (Schoolcraft and Gardner 2000, Hardy et al. 2002). Therefore markers for embryo viability 
should include information on the quality of the oocyte. It is clear that although a large number of meiotically 
mature  sibling  oocytes  (i.e.  with  an  extruded  first  polar  body)  can  be  generated,  these  cohorts  are 
heterogeneous  with  differing  levels  of  developmental  competence  (Pellicer  et  al.  1987,  Stouffer  and 
Zelinski-Wooten 2004, May-Panloup et al. 2005, Scott et al. 2008). Therefore, it is likely that the molecular 
or metabolic profile of these oocytes differ. 
 
A key component for the establishment of developmental competence during oocyte growth and maturation 
is the bi-directional communication between the oocyte and its surrounding cumulus cells (Sugiura et al. 
2007, Gilchrist et al. 2008). The oocyte secretes factors (such as GDF-9 and BMP-15) that act on the 
surrounding follicular cumulus cells to stimulate growth and development and modulate their function. In 
turn, the cumulus cells signal to the oocyte to maintain development (Dong et al. 1996, Elvin et al. 1999a, 
Elvin et al. 1999b, Gilchrist et al. 2008). These oocyte derived growth factors regulate expression of several 
cumulus cell genes that control the metabolism of the cumulus cells (Elvin et al. 1999a, Elvin et al. 1999b). 
Therefore, the metabolic state of the cumulus cells surrounding the oocyte likely reflects the functioning of 
this communication loop, as well as the developmental environment of the follicle (Russell and Robker 
2007). Evidence that the gene expression of the cumulus cells has the potential to indicate oocyte and 
embryo  quality  has  recently  been  shown  in  patient  cohorts  (McKenzie  et  al.  2004,  Cillo  et  al.  2007, 
Feuerstein et al. 2007, Assou et al. 2008, Hamel et al. 2008, Anderson et al. 2009). Further to this, cumulus 
cell  gene  expression  has  been  correlated  with  pregnancy  (Assou  et  al.  2008,  Anderson  et  al.  2009), 
indicating  cumulus  cell  parameters are  reflective  of  oocyte  quality  and  have  potential as  non-invasive 
biomarkers of implantation potential.  
 
Normal  cellular  metabolism  is  dependent  on  enzymatically  catalyzed  reduction-oxidation  (REDOX) 
reactions. The REDOX state refers to the ratio of oxidized and reduced forms of coupled reactions such as 
NADH/NAD+, NADPH/NADP+ and glutathione/oxidised glutathione and can be used to describe the cellular Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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environment (Dumollard et al. 2009). The cellular REDOX state is significantly influenced by factors that 
stimulate and neutralise reactive oxygen species (ROS). Oxidative regulation is important to protect cells 
from the harmful production of ROS, but also to ensure physiological levels of ROS are present as required, 
for involvement in some signaling pathways (Forman and Torres 2001). An imbalance in the production of 
ROS and the neutralizing antioxidant defence mechanisms of the cell results in oxidative stress (Agarwal et 
al. 2003, De Haan et al. 2003). The consequences of excessive ROS production and the resultant REDOX 
imbalance  includes;  mitochondrial  damage,  ATP  depletion,  embryo  cell  block  and  retardation,  and 
apoptosis (reviewed by (Guerin et al. 2001)). Oxidative stress may be one of the factors that regulates 
ovarian follicle recruitment and growth, selection of the dominant follicle as well as follicular atresia  (El 
Mouatassim et al. 1999, Goto et al. 2002, Lonergan et al. 2003). Furthermore, ROS have historically been 
of great interest in regards to pre-implantation development (reviewed by (Johnson and Nasr-Esfahani 
1994,  Guerin  et  al.  2001).  In  embryos,  excessive  ROS  production  is  related  to  perturbed  embryo 
development and viability (Nasr-Esfahani et al. 1990, Nasr-Esfahani and Johnson 1991). It is likely that 
disrupted REDOX levels in the cumulus cells would reflect a reductive or oxidative environment within the 
follicle that may subsequently reduce oocyte competence. It is proposed that a direct but non-invasive 
method to determine the functional vitality of oocytes is to measure cumulus cell physiology. Therefore the 
aim of this study was to retrospectively determine the REDOX state in cumulus cell masses from individual 
cumulus-oocyte complexes of patients undergoing IVF/ICSI. The REDOX state from each cumulus mass 
was correlated with embryo quality, by tracking the fate of each oocyte/embryo individually through single 
embryo transfer and birth outcome. Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
 
Feil    Page 122  
 
5.2  MATERIALS AND METHODS 
5.2.1  Patient Selection 
Twenty-six  patients  undergoing  routine  IVF/ICSI  with  Single  Embryo  Transfer  (SET)  at  Repromed‟s 
Adelaide  clinic  between  April  and  September  2006  consented  for  cumulus  cells  to  be  collected  and 
analysed. All patients had treatment with their own gametes and were not candidates for pre-implantation 
genetic diagnosis. Ethical approval was obtained by the NHMRC sanctioned Human Ethics Committee of 
the Women‟s and Children‟s Hospital, Adelaide, South Australia. 
 
5.2.2  Cumulus Cell REDOX Analysis 
5.2.2.1  Cumulus cell collection and subsequent culture 
COCs were isolated from follicular fluid as described in Chapter 2, Materials and Methods. For patients 
whose oocytes were destined to undergo either IVF or ICSI inseminations, COCs were trimmed of their 
outer layers of cumulus cells (n=250) with a 30G needle on a syringe, and cumulus masses for analysis 
were collected in GMOPS (Vitrolife) containing 5% HSA (Vitrolife) and maintained at 37°C (see Figure 5.1). 
Each cumulus mass and its respective oocyte were numbered to track which cumulus mass came from a 
particular oocyte. Oocytes undergoing ICSI (n=141) were then exposed to 75IU Hyaluronidase (Hyalase®, 
Aventis Pharma Pty Ltd, Lane Cove, Australia) in glucose supplemented GFert Plus  medium and ICSI 
performed in G1.3 Plus prior to culture individually in 10µL drops of the same medium under oil for 16 
hours, at 37°C 6%CO2, 5%O2, 89% N2. Oocytes undergoing IVF (n=109) had the inner layers of cumulus 
left intact and were co-incubated with 1,000 motile sperm in 10µL drops of glucose supplemented GFert 
Plus under oil for 16 hours, at 37°C 6%CO2, 5%O2, 89% N2. All oocytes underwent individual culture in 
order to track oocytes and resultant embryos with respect to fertilization, embryo quality, cryopreservation 
and embryos resulting in pregnancy following SET. 
 
5.2.2.2  REDOX staining 
Redox Sensor Red (2,3,4,5,6-pentafluorodihydrotetramethylrosamine, Redox Sensor Red CC-1, Molecular 
Probes, Invitrogen, Australia) was used as a fluorogenic indicator of cellular REDOX state (see Appendix 6). 
Redox Sensor Red enters cells passively and is oxidised to produce a fluorescent signal (Chintapalli et al. 
2007). Human cumulus cell masses were incubated with 1μM Redox Sensor Red in GMOPS with 5% HSA 
(MOPS-HSA, Vitrolife), for 15 minutes at 37◦C (see Figure 5.1). Cumulus masses were then washed twice Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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through MOPS-HSA and once through imaging medium (MOPS lacking protein) and placed onto glass 
coverslips in a minimal volume of imaging medium so the cumulus mass was able to be flattened for 
imaging with an Olympus BX51 microscope (Olympus, Melbourne, Australia) and MacProbe v 4.3 software. 
 
5.2.2.3  Microscopy for REDOX analysis 
Cumulus cell masses stained for REDOX analysis were imaged using an Olympus BX51 microscope at 
100x magnification. Cumulus cell masses were located under bright field, and focus adjusted to have as 
many cells in focus as possible. Bright field light was then extinguished and a fluorescent filter (excitation 
540nm, emission 600nm) applied. An image was then captured using an Olympus Optical BX51 camera 
(Olympus, Japan) and MacProbe v 4.3 software. 
 
5.2.2.4  Analysis of REDOX state 
Single images incorporated the majority of a cumulus cell mass for which average staining intensity was 
analysed using Adobe® Photoshop® v11.0 (see Figure 5.2). Images were saved in tagged image file format 
(TIFF) and the intensity of REDOX staining was quantified as the mean fluorescent pixel intensity of four 
random regions of the same size in each image. A fifth area of each image which did not contain cumulus 
cells  was  quantified  for  background  staining  and  subtracted  from  the  mean  of  the  fluorescing  areas.  
Thresholds were determined based on quartile analysis to segregate the cumulus cell complexes into three 
groups of low, intermediate or high REDOX state. Data was not normally distributed, with a positive skew. 
Intermediate REDOX range was assessed to be the central range between the 25th and 75th percentile. A 
Low REDOX state was classified as the lower quartile (up to the 25th percentile), and High REDOX the 
upper quartile (above the 75th percentile, see Figure 5.3). 
The resultant REDOX value was retrospectively correlated with fertilization outcome, embryo quality on day 
2 of development and embryo viability through single embryo transfer, as determined by fetal heart beat at 
an 8 week scan. 
REDOX  values  were  also  retrospectively  investigated  on  subsequent  frozen  embryo  cycles  (n=9)  for 
patients who did not become pregnant on their initial cycle, or for those returning to attempt subsequent 
pregnancies using cryopreserved embryos. This enabled the calculation of cumulative implantation rates. 
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5.2.3  Statistics 
Data  are  presented  as  percentages  or  mean  ±  SEM,  as  appropriate.  Patient  demographic  data  was 
analysed by one-way ANOVA if normally distributed, and Kruskal-Wallis test for data that was not normally 
distributed,  followed  by  Mann-Whitney  U  analysis  for  between  treatment  comparisons.  Proportion  of 
patients  undergoing  ICSI,  infertility  diagnosis,  implantation  and  live  birth  rates  underwent  chi-square 
analysis. Spearman‟s correlation coefficient was used to assess the relationship between REDOX level and 








Figure 5.1 Procedure for determination of REDOX status of cumulus cells. 
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IVF  ICSI 
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5.3  RESULTS 
Patient  demographic  characteristics  are  detailed  in  Table  5.1.  The  mean  maternal  age  of  patients 
participating in this study was 33.6±0.7 years, who had undergone an average of 0.9±0.2 previous IVF 
cycles.  The overall implantation rate following single embryo transfer for this group of patients was 30.8%. 
Patients  had  an  average  of  9.3±0.9  oocytes  collected  and  68%  of  patients  underwent  ICSI  as  the 
insemination  method.  All  patients  had  a  single  embryo  transferred  (n=26).  When  patients  were 
retrospectively  segregated  into  the  cumulus  cell  REDOX  category  that  their  transferred  embryo  had 
originated from, there was no difference in maternal age, number of previous cycles, number of oocytes 
collected or fertilized in each group (see Table 5.1).  
 
5.3.1  EXPERIMENT 1. Establishment of REDOX levels in human cumulus cells. 
A total of 250 cumulus masses were trimmed from oocytes and 208 (83%) of these were able to be 
assessed for REDOX level. Representative images for Low, Intermediate and High REDOX state cumulus 
masses are shown in Figure 5.2. The range of REDOX levels observed in the cumulus masses removed 
from oocytes for each patient is shown in Figure 5.3.  This figure shows the REDOX level for every oocyte 
collected for each patient, regardless of ultimate fate. A range of cumulus cell REDOX levels was observed 
both between and within patients (see Figure 5.3). The majority of patients (n=25, 92.6%) had cumulus cell 
masses from their retrieved cohort that spanned more than one REDOX category.  
 
5.3.2  EXPERIMENT 2. Effect of cumulus cell REDOX on fertilization potential of oocytes. 
The REDOX state of a cumulus cell mass influenced the fertilization outcome of its corresponding oocyte. 
High REDOX levels in the cumulus cells resulted in a lower fertilization rate, compared to cumulus cell 
masses with Low REDOX levels (p=0.005, Figure 5.4a). The same pattern of fertilization rates with regard 
to REDOX level was maintained for both ICSI and IVF insemination techniques (see Figure 5.4b, 5.4c). As 
REDOX level in the cumulus cells increased, the overall resultant fertilization potential of the corresponding 
oocyte decreased (ρ correlation coefficient=-0.189, p=0.003, see Figure 5.4a). This result was also evident 
for oocytes inseminated by ICSI (ρ correlation coefficient=-0.201, p=0.033, see Figure 5.4c), while for IVF 
insemination the same pattern of fertilization rates with regard to   
 
 Table 5.1 Patient demographic characteristics. 
  REDOX level of cumulus cells for the transferred embryo   
  LOW  INTERMEDIATE  HIGH  Significance 
Number of patients  10  12  4   
Maternal age  33.9±1.2  33.4±1.2  35.1±1.7  p=0.759 
% ICSI patients  70  58  75  p=0.778 
Number previous IVF/ICSI cycles  0.7±0.3  1.1±0.3  1.3±0.8  p=0.687 
Number of oocytes collected  7.9±1.7  9.3±1.2  10.3±1.8  p=0.642 
Number of oocytes fertilized  3.9±0.7  5.9±1.2  6.0±1.4  p=0.361 
Grade of transferred embryo  2.4±0.3  1.7±0.3  1.3±0.3  p=0.086 
Number of embryos frozen  0.1±0.1  0.4±0.3  0.3±0.3  p=0.775 
Infertility diagnosis* 
-  Male factor 
-  Endometriosis 
-  Tubal 
-  Ovulation/ovarian defect 
-  Unexplained 























There were no statistically significant differences between groups with any variables analysed. *Infertility diagnoses include both male and female 











Figure 5.2 Representative examples of the REDOX levels observed in human cumulus cells. 



















Figure 5.3 Range of REDOX levels observed in human cumulus cells. 
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Figure 5.4 Effect of REDOX state on fertilization rate with IVF/ICSI. 
Data are expressed as the number of normally fertilized (2PN) zygotes per number of oocytes 
inseminated.  Number  of  oocytes  inseminated  for  each  group  is  shown  in  bars.  *significant 
correlation between REDOX level and fertilization potential of oocytes. † correlation between 
REDOX level and fertilization potential of oocytes undergoing IVF insemination p=0.084. 
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REDOX status was evident, but did not reach significance (ρ correlation coefficient=-0.178, p=0.084, see 
Figure 5.4b). 
 
5.3.3  EXPERIMENT 3. Effect of cumulus cell REDOX on resultant embryo quality of oocytes. 
Cumulus REDOX state did not significantly affect resultant embryo quality, as indicated by cleavage stage 
embryo grade (p=0.082) when all cleavage stage embryos were included in the analysis (n=116, Figure 
5.5a).  Those embryos that were selected for transfer (n=26), also showed no significant difference between 
the REDOX groups with regard to embryo quality when assessed at the cleavage stage, however, though 
not statistically significant, it is interesting to note that there was higher levels of REDOX in cumulus cell 
masses with higher quality (grade 1) embryos at the cleavage stage (Figure 5.5b, p=0.091). Furthermore, 
the relationship between REDOX levels in cumulus cells and grade of the embryo which was selected for 
transfer was significantly negatively correlated with embryo morphological grade (ρ correlation coefficient=-
0.442, p=0.016, see Figure 5.5b).  
All patients had surplus embryos following embryo transfer, of which 15 patients had at least one good 
quality embryo available for cryopreservation. Patients having a cleavage stage embryo transfer (n=11) had 
high quality surplus embryos cryopreserved following transfer, as well as the remaining poorer quality 
embryos being re-assessed for cryopreservation at the blastocyst stage on days 5 and 6 of development. 
Patients having a blastocyst stage transfer (n=15) had embryos assessed for cryopreservation only on days 
5 and 6 following their embryo transfer on day 5. 
Overall, 38 of 116 surplus embryos were cryopreserved (33%). Of this, 35.6% (16/37) embryos in the Low 
REDOX group were suitable for cryopreservation, 28.8% (17/59) embryos in the Intermediate REDOX 





















Figure 5.5 Morphological grade of embryos and associated REDOX state of cumulus cells. 
* significant correlation between REDOX level and embryo grade of transferred embryo. Numbers in 
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Figure 5.6 Distribution of embryos suitable for cryopreservation.* 
*  cryopreservation  may  have  been  performed  at  either  the  cleavage  or  blastocyst  stage  of 
development, depending on the stage of embryo transfer. Values in bars indicate the number of 
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5.3.4  EXPERIMENT  4.  Effect  of  cumulus  cell  REDOX  on  embryo  viability  following  fresh  and 
frozen embryo transfers. 
Overall the fresh implantation rate as assessed by a viable fetal heartbeat for this group of patients, having 
a single embryo transfer was 30.8%. (8/26).  There was no correlation with the morphological grade of the 
embryos on day 2 that were transferred and with subsequent pregnancy outcome (p=0.208, grade 1 41.7% 
implantation  (n=12),  grade  2  28.6%  implantation  (n=7),  grade  3  20%  implantation  (n=5),  grade  4  0% 
implantation (n=2)). 
 
Implantation rates were clustered in an Intermediate range of cumulus cell REDOX levels (see Figure 5.7) 
when  raw  REDOX  pixel  fluorescence  was  analysed.  Furthermore,  implantation  rates  were  statistically 
significantly higher, when an embryo resulting from an oocyte with an Intermediate level of REDOX staining 
in its corresponding cumulus cells was transferred, compared to cumulus masses that had Low REDOX 
staining (p=0.031, Figure 5.8). Due to the low number of patients with an embryo transferred originating 
from the High REDOX group, and the lack of pregnancies in this group no statistics have been performed 
comparing this group to the Low and Intermediate REDOX groups. 
 
It should be noted that 11 pregnancies were actually obtained in this study of 26 patients, 3 of which were 
not viable, and have not been included in any analyses. One ectopic pregnancy in the High REDOX group, 
one pregnancy with no fetal heart in the Low REDOX group and a biochemical pregnancy in the Low 
REDOX group were obtained. 
 
Following the initial treatment cycle of a fresh embryo transfer, 9 patients that either did not become 
pregnant from their fresh embryo transfer or those who had had a successful pregnancy, returned for frozen 
embryo transfer cycles, enabling the calculation of the cumulative implantation rate (see Figure 5.9). One 
frozen embryo pregnancy was a biochemical pregnancy, which originated from an embryo transferred from 
the Intermediate cumulus cell REDOX group, and was not included in any analysis for this study. Cumulus 
cells with Intermediate REDOX levels trended towards higher viability embryos than oocytes with cumulus 
cells that had Low REDOX levels (p=0.07). No viable implantations were achieved in the High REDOX 


























































Figure  5.7  Range  of  REDOX  levels  observed  in  human  cumulus  cells  and  resultant 



















Figure 5.8 Cumulus cell REDOX levels and resultant implantation rates following fresh 
embryo transfer. 
























































Figure 5.9 Cumulative implantation rates for embryos originating from oocytes with various 
cumulus cell REDOX levels. 
Values in bars indicate the number of embryos transferred in each group. Different superscripts 
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5.3.5  EXPERIMENT 5. Effect of cumulus cell REDOX on cumulative birth outcomes. 
Pregnancies were followed from positive scan result through to birth outcome. There was no significant 
difference in live birth rate between Low, Intermediate and High REDOX groups (p=0.09). One pregnancy 
following a fresh embryo transfer was lost in the Intermediate REDOX group by spontaneous abortion at 13 
weeks gestation.  The remaining pregnancies (n=7) that detected a fetal heart beat at their first scan 
resulted in successful live births. The sample size for number of births in this study is small, and the majority 
of births have resulted from the Intermediate REDOX group, therefore statistics have not been performed 
on birth outcomes (see Table 5.2).  






Table 5.2 Cumulative implantation rate and live birth rate for embryos from cumulus-oocyte 
complexes with low, intermediate and high REDOX levels. 
 
  REDOX level of cumulus cells transferred embryos 
  LOW  INTERMEDIATE  HIGH 
Fresh implantation rate (%)  10a (10)  58.3b (12)  0 (4) 
Cumulative implantation rate (%)  13.3c (15)  44.4d (18)  0 (5) 
Cumulative live birth rate (%)  13.3 (15)  38.9 (18)  0 (5) 
Average gestation (weeks)  38.3 ± 0.2 (2)  39.4 ± 0.3 (7)  - 
Birth weight (g)  3660 ± 270 (2)  3389 ± 166 (7)  - 
 
a, b superscripts within a row indicate significant difference. c, d superscripts within a row indicate a 
trend towards significance (p=0.07). Numbers in parentheses indicate the number of patients in 
each group. Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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5.4  DISCUSSION 
The data collected during this study suggests that the level of REDOX measured in cumulus cells during 
IVF treatment may have predictive value with regard to embryo viability.  Importantly, a range of REDOX 
levels were observed in cumulus cells within individual patients, suggesting that REDOX levels have the 
potential to be highly discriminating between cumulus-oocyte complexes. The majority of patients in this 
study had cumulus cell masses that spanned more than one REDOX category, which supports the 
concept  that  a  heterogeneous  population  of  sibling  oocytes  is  obtained  following  gonadotrophin 
treatment which have varying developmental competence (Pellicer et al. 1987, Scott et al. 2008), and 
also have differing metabolic parameters.  
 
Cumulus cells have been shown in animal models to provide protection to the oocyte and prevent 
oxidative-induced  damage.  ROS  induce  apoptosis  in  in  vitro  matured  denuded  porcine  oocytes, 
whereas intact cumulus-oocyte complexes are able to more readily withstand exogenous ROS and 
successfully complete maturation (Tatemoto et al. 2000). In addition, bovine and porcine cumulus cells 
assist with the synthesis of glutathione and enhance the glutathione content of the oocyte, providing 
elevated antioxidant capacity, which is not observed in denuded oocytes (Yoshida et al. 1993, de Matos 
et al. 1996, Tatemoto et al. 2000). 
 
The REDOX state of a cumulus cell mass influenced the fertilization outcome of its corresponding 
oocyte independent  of insemination technique in this study. Complexes with a  High REDOX state 
produced oocytes that had reduced fertilization potential compared to those with a Low or Intermediate 
REDOX state. Initially I predicted that IVF COCs would be more severely affected by a High REDOX 
state  than  ICSI  oocytes.  It  was  assumed  that  high  intracellular  REDOX  levels  would  affect  the 
extracellular  environment,  as  oxidative  species  have  been  detected  in  follicular  fluid  and  medium 
surrounding in vitro embryos (Bedaiwy et al. 2004, Das et al. 2006). Therefore spermatozoa, in the case 
of IVF, would need to penetrate a hostile cumulus matrix environment likely to cause significant damage 
to spermatozoa during their journey to the oocyte. Sperm are highly susceptible to oxidative-induced 
stress with in vitro exposure leading to impairment of  fertilization through a decreased capacity to 
undergo the acrosome reaction (Griveau et al. 1995, Mammoto et al. 1996, Aitken et al. 1998, Twigg et 
al. 1998), although it is widely accepted that ROS formation is required for capacitation to occur ((de 
Lamirande et al. 1997b). However, in this study, ICSI and IVF fertilization outcomes appeared similarly 
affected by High REDOX levels in the cumulus cells. One of many potential explanations is that oocytes 
undergoing ICSI had compromised sperm decondensation following injection. In human and non-human 
primate oocytes that fail to fertilize there is often impairment in sperm decondensation (Simerly et al. Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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1995,  Rawe  et  al.  2000).  Glutathione  is  important  for  this  process  in  many  species  (Mahi  and 
Yanagimachi 1975, Perreault et al. 1988, Reyes et al. 1989, Yoshida et al. 1992) and a key antioxidant 
in the oocyte (de Matos and Furnus 2000). Glutathione content of the oocyte may be required as an 
antioxidant defence in the case of a High COC REDOX environment, rendering it unavailable, or only 
available  in  reduced  concentrations,  for  sperm  decondensation.  In  addition,  cumulus  cells  play  an 
important role in the synthesis of glutathione for accumulation in the oocyte prior to fertilization, as 
mentioned  previously.  Thus  the  altered  REDOX  state  in  cumulus  cells  may  result  in  perturbed 
physiology  and  therefore  an  alteration  of  glutathione  level  in  the  oocyte.  However,  despite  the 
insemination technique the fertilization rate and viability of resultant embryos was altered, which may 
reflect the exposure to oxidative stress in the follicle prior to cumulus cell removal in the IVF laboratory, 
or alternatively indicate the susceptibility of the COC to combat the three hour incubation in an in vitro 
environment in this study.  
 
It is already clear that morphological assessment is able to distinguish embryos with no or very little 
developmental potential, as they can be easily differentiated by slow or arrested cleavage development. 
However, what is less clear is how to discriminate good morphological quality embryos into those which 
are viable and those which have limited developmental competence. In this study, using morphology as 
the  assessment  method,  it  is  clear  that  although  morphologically  similar,  only  around  one-third  of 
embryos were capable of establishing a viable pregnancy whilst the remaining two-thirds resulted in 
failed pregnancy attempts. This study found that the morphological quality of the embryos observed was 
similar  between  the  different  REDOX  groups.  However,  for  those  embryos  that  were  selected  for 
transfer, the higher morphological quality embryos had a High REDOX state in their cumulus cells. In 
contrast, when transferred these embryos proved to have reduced viability, although the numbers of 
embryos transferred from this group was low. The most viable embryos originated from the Intermediate 
REDOX group. Thus, as is desired for a viability marker, the REDOX measurement of the cumulus cells 
was  better  associated  with  implantation  rate  than  morphology.  The  developmental  competence  of 
oocytes  retrieved  during  IVF  is  contributed  to  by  multiple  factors,  therefore  in  combination  with 
established techniques, REDOX measurement of cumulus cells may improve embryo selection and 
resultant  implantation  success.  The  current  study  aimed  to  maximise  the  information  available  by 
performing single embryo culture and single embryo transfers to allow a true assessment of how the 
marker  of  interest  (REDOX  state  of  individual  cumulus  cell  masses)  influences  the  quality  of  the 
enclosed oocyte and the subsequent embryo, through to pregnancy establishment and live birth. 
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In the current study, an Intermediate level of REDOX in the cumulus cells was associated with the 
highest  implantation  potential.  A  recent  study  of  human  granulosa  cells  determined  that  a  high 
percentage of cells producing ROS were associated with a diminished implantation rate (Jancar et al. 
2007). The high levels of REDOX within the cumulus cells observed in this study suggest that there is 
either an increased level of ROS production in the cells or a reduction in the cell‟s antioxidant defenses, 
resulting in oxidative stress (De Haan et al. 2003). In animal models, experimental exposure of the pre-
implantation  embryo  to  culture  environments  that  increase  the  levels  of  ROS  in  blastomeres  are 
associated with reduced development rates and high rates of developmental arrest (Nasr-Esfahani et al. 
1990,  Nasr-Esfahani  and  Johnson  1991).  Further  it  is  known  that  oocytes  with  lower  levels  of 
glutathione,  an  oxidative  defence  mechanism,  are  also  associated  with  lower rates  of  oocyte  and 
embryo development (Gardiner and Reed 1994, Zuelke et al. 1997, Abeydeera et al. 1998, de Matos 
and Furnus 2000, de Matos et al. 2002). 
 
A consequence of oxidative stress in many tissues is DNA damage. Detection of DNA damage by eight-
hydroxy-2-deoxyguanosine  (8-OHdG)  in  granulosa  cells  was  shown  to  be  associated  with  lower 
fertilization  and  reduced  rates  of  growth  in  embryos  (Seino  et  al.  2002).  Further,  this  marker  is 
associated with lower numbers of good morphological embryos after any insemination method (Seino et 
al. 2002). The current study has also concluded an increase in REDOX in the cumulus cells surrounding 
the oocyte is similarly associated with a reduction in developmental competence. These observations 
may suggest that the increase in REDOX and oxidative stress in the cumulus cells may also have 
resulted in an increase in DNA damage. 
 
The oocyte and embryo are a source of ROS produced by the metabolism of oxygen to produce energy 
through mitochondrial oxidative phosphorylation (Biggers et al. 1967, Quinn and Wales 1973). The main 
sources  of  ROS  in  oocytes  and  embryos  are  produced  by  several  pathways,  namely,  oxidative 
phosphorylation (Thompson et al. 2000), nicotinamide adenine dinucleotide phosphate oxidase (Manes 
and Lai 1995), and xanthine oxidase (Nasr-Esfahani and Johnson 1991) systems. ROS are produced 
as a normal by-product of metabolism and are important second messengers capable of modulating the 
expression  of  genes  that  govern  physiological  processes  of  gametes  and  embryos,  essential  for 
spermatozoa capacitation, acrosomal reaction, fertilization and cleavage development (de Lamirande et 
al.  1997a,  Hensley  et  al.  2000,  Droge  2002).  A  balancing  act  exists  for  aerobic  metabolism  with 
mitochondrial  oxidative-phosphorylation  reducing  oxygen  to  water  by  ROS,  while  maximizing  ATP 
synthesis and maintaining ROS production to only the amounts required for cell signaling. The vital roles 
of ROS production in a cell suggest that a critical threshold of ROS is important. The data from the Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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current study suggests that this may also be the case for cumulus cells and oocyte/embryo viability, as 
COCs  with  very  low  or  high  levels  of  ROS  resulted  in  oocytes  displaying  lower  developmental 
competence. 
 
The concept that there is an optimal level of REDOX, with levels too low and too high resulting in 
perturbed outcomes has previously been reported for the oxidative state of follicular fluid. In a study that 
examined oxidative stress indices in follicular fluid, it was similarly shown that there was a reduction in 
associated embryo morphology for follicular fluid that had low or high oxidative levels, with optimal 
development occurring with moderate oxidative levels (Wiener-Megnazi et al. 2004). Wiener-Megnazi et 
al. (2004) examined oxidative state by thermochemiluminescence, which differs from the methodology 
of the current study, but suggests that various methods of detection may be feasible as biomarkers of 
oocyte/embryo health. A key advantage to examining cumulus cells rather than follicular fluid is that 
cumulus masses are removed from the follicle with the oocyte, making identification of individual COCs 
simple, and able to be performed following the completion of all oocytes being aspirated from the ovary. 
 
By design, this study was retrospective in nature. It is clear that although this preliminary study is 
indicative of a correlation between optimal REDOX levels in cumulus cells and pregnancy, the potential 
of this as a diagnostic tool requires validation in a prospective study with much larger patient numbers. 
This will determine the true effectiveness of cumulus cell REDOX levels as a marker of viability and 
health. 
 
The current study was focused in methodology and subsequent investigations should therefore explore 
alternative methods of determination of REDOX in cumulus cells. Redox Sensor Red CC-1 allows 
fluorogenic determination of the REDOX or ROS level by passively entering cells and being oxidised by 
superoxide anions and hydrogen peroxide (Chintapalli et al. 2007), which are two of the three major 
ROS  produced  by  early  mammalian  embryos  (reviewed  by  (Guerin  et  al.  2001).  There  are  other 
commercially available candidate dyes which may be used for this purpose including others which 
detect hydrogen peroxide and superoxide similar to the dye in the current study, or dyes which detect 
the  hydroxyl  radical,  hypochlorous  acid,  nitric  oxide,  peroxyl  radical,  peroxynitrite  anion  or  singlet 
oxygen.  Other  reagents  utilising  conjugated  dienes,  lipid  hydroperoxides,  glutathione  reductase 
markers, catalase markers and thiobarbituric acid-reactive substances may also be used to assess the 
metabolic state of cumulus cells. Indicators of DNA damage caused by oxidative stress such as 8-
OHdG may also be used to determine the metabolic state of cumulus cells. Furthermore, there are Chapter 5: Human Cumulus Cell REDOX Levels as a Marker of Embryo Viability 
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alternate detection methods which may be more accurate than the method employed in this study. The 
current method was limited as it is possible that cell density may be responsible for differences in 
intensity, as it is difficult to determine that the same amount of cells were being measured between 
samples, although all attempts to make this uniform were performed. Further analyses could be utilised 
in addition or preference to fluorescence microscopy including; flow cytometry, enzyme measurements, 
fluorescence  assays,  phosphorescence  measurement  and  enzyme  spin  resonance  spectrometric 
measurements. 
 
Any potential viability marker needs to be assessed for its degree of contribution from maternal factors 
of infertility. The close relationship between the cumulus cells and  the oocyte potentially provide a 
balance between maternal aetiology and oocyte developmental competence, compared to follicular fluid 
as a marker, which most likely has a mainly maternal contribution. The numbers in this study were too 
low  to  discern  any  correlations  of  REDOX  state  with  any  particular  patient  aetiology,  however 
previously, enhanced oxidative stress has been shown in women with endometriosis (Portz et al. 1991, 
Shanti et al. 1999, Agarwal et al. 2003, Szczepanska et al. 2003). In addition, these women have a high 
incidence of apoptosis in their granulosa cells compared to patients with other infertility causes (Seino et 
al. 2002) and deregulation of the apoptotic cascade appears to be partly mediated by the effect of 
oxidative stress on cell membranes, DNA, and mitochondria (Yang et al. 1998).  
 
Oxidative damage in cumulus cells appears to be a promising candidate biomarker that may affect the 
developmental potential of the enclosed oocyte. The availability of a diagnostic marker for oocytes has 
many benefits. As well as the potential to improve resultant embryo selection for transfer, such a tool 
could be employed at early points of development and determine which oocytes should be selected for 
insemination or cryopreservation, which is particularly important in countries which are limited in the 
number of oocytes  they  can  legally  inseminate.    This study  retrospectively determined  a  range  of 
REDOX measurements for cumulus cells that was associated with an increased likelihood of pregnancy. 
Further investigation into this concept is required. The future goals of this work are to establish whether 
this  concept  can  consistently  differentiate  oocyte  competence  in  combination  with  the  current 
capabilities of morphology to improve implantation rates beyond current capacities. 
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6.1  INTRODUCTION 
Metabolic control in the embryo is essential to maintain viability (Gardner 1998, Gardner et al. 2000b, Lane 
and Gardner 2000a). Perturbations in metabolic parameters of embryos, in all species studied to date, have 
been associated with a loss in viability (Renard et al. 1980, Zhang and Armstrong 1990, Conaghan et al. 
1993b, Gardner et al. 1994, Lane and Gardner 1996, Lane et al. 2001). The pre-implantation embryo has a 
dynamic metabolism which is significantly different to that of somatic cells, with the oocyte, zygote and 
cleavage stage embryo preferentially utilising pyruvate as a dominant substrate (Biggers et al. 1967, Hardy 
et al. 1989, Gott et al. 1990). From the 2-cell stage lactate can be used as a substrate, while glucose is not 
the preferred substrate until the blastocyst stage (Leese and Barton 1984, Gardner and Leese 1986, Hardy 
et al. 1989, Gott et al. 1990, Rieger et al. 1992, Thompson et al. 1992, Gardner et al. 1993). Further to a 
change in preference of carbohydrate substrates in pre-implantation development, there is also an alteration 
in preference of amino acids (Partridge and Leese 1996). Eagle‟s non-essential amino acids and glutamine 
are utilised at the cleavage stages while all 20 Eagle‟s amino acids are preferred following the 8 cell stage. 
Provision of amino acids in the culture media in this sequential fashion has been shown to improve mouse 
and human embryo development and viability (Gardner et al. 1998a, Gardner et al. 1998b, Jones et al. 
1998). 
 
Metabolites are the end product of cellular processes and indicate the response of the system to genetic 
and environmental influences, including nutrient exposure. Changes in gene expression do not necessarily 
correlate with a change in protein expression (Gygi et al. 1999), and in addition, are subject to post-
translational modifications which can affect function, indicating that changes in gene and protein expression 
do  not  always  correspond  to  cellular  phenotype.    However,  metabolites  can  demonstrate  functional 
alterations in gene/protein function. The early embryo modifies it‟s in vitro culture environment and as such, 
non-invasive  measurements  of  metabolites,  specifically  carbohydrates  and  amino  acids,  have  been 
extensively studied across species (Renard et al. 1980, Gardner and Leese 1987, Gardner et al. 1994, 
Turner et al. 1994, Lane and Gardner 1996, Houghton et al. 2002, Brison et al. 2004a). Several studies 
have  indicated  that  disrupted  balance  of  carbohydrate  metabolism  is  related  to  poor  development  in 
embryos. Studies in a variety of species, including human, have shown improved blastocyst development 
and viability when embryos have a higher glucose or pyruvate utilisation (Renard et al. 1980, Rieger 1984, 
Gardner and Leese 1987, Hardy et al. 1989, Gott et al. 1990, Gardner et al. 2001). Lactate production has 
been used in conjunction with glucose consumption as a measure of glycolytic activity to prospectively 
select mouse blastocysts for transfer, resulting in a significantly improved implantation rates (Lane and 
Gardner 1996). However, rate of glycolytic activity in human embryos under varying culture conditions has Chapter 6: Metabolite Analysis of COCs and Embryos 
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shown  differing  results.  One  study  showed  no  relationship  to  pregnancy  establishment,  although  the 
embryos were cultured in stressful culture conditions without amino acids and antioxidants (Jones et al. 
2001). In contrast, a second study which assessed embryos in a complete media indicated that blastocysts 
with a lower glycolytic activity had improved  viability after transfer  (Van den Bergh et al. 2001). Most 
significantly,  for  glycolytic  activity,  bovine  blastocysts  after  cryopreservation  and  thawing  have  shown 
distinct profiles of glucose consumption and lactate production between blastocysts able to survive thawing 
and undergo expansion and those blastocysts which were not viable (Gardner et al. 1996a). These results 
are desirable for any viability marker in order to conclusively separate oocytes/embryos from their cohort for 
selection. 
 
Amino acids are important regulators of embryo development (Gardner 1998, Gardner et al. 2000b). Amino 
acid profiles differ with the stage of bovine embryo development, with alanine being the only amino acid that 
is  consistently  produced  throughout  development  (Partridge  and  Leese  1996).  Human  embryos  that 
produce high levels of alanine are less capable of forming blastocysts (Houghton et al. 2002). Furthermore, 
Leese and colleagues have related amino acid turnover by human cleavage stage embryos to blastocyst 
development (Houghton et al. 2002, Stokes et al. 2007), and following transfer, these profiles were able to 
predict embryos that were capable of establishing pregnancy (Brison et al. 2004a).  While promising, this 
method currently requires a specific medium, specialised equipment and technical expertise that is not 
readily available in IVF clinics. 
 
A great deal of research has been performed on the metabolism of the embryo and its potential to predict 
viability. In contrast, relatively little work has been performed on the metabolism of the oocyte or the 
cumulus-oocyte complex in terms of biomarkers of viability. Cumulus cell oxidative metabolism is a major 
contributor to energy production (Rieger and Loskutoff 1994), and influences the metabolic state of the 
oocyte (Downs and Utecht 1999). Oocytes from immature animals or those which are in vitro matured have 
altered metabolic activity and reduced developmental competence relative to oocytes from adult animals or 
those which are in vivo matured (O'Brien et al. 1996, Steeves and Gardner 1999a, Steeves et al. 1999, 
Khurana and Niemann 2000, Spindler et al. 2000), indicating the role of the cumulus cells in establishing an 
appropriate metabolic environment for the oocyte to maintain developmental potential. 
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Cumulus cells provide essential nutrients for oocyte growth (Donahue and Stern 1968, Leese and Barton 
1985). Stimulated by paracrine factors from the oocyte, cumulus cell metabolic pathways are upregulated 
(Eppig et al. 2005, Sugiura et al. 2005). Further to this, glucose and lactate metabolism by the cumulus both 
play prominent roles in the physiology of the oocyte, including regulation of meiosis (Fagbohun and Downs 
1992, Downs et al. 1998). Therefore the metabolic activity of the cumulus cells are likely reflective of the 
health and viability of the oocyte, making COC metabolism an interesting avenue to explore in the pursuit of 
a biomarker.  
 
It is useful to attempt to identify markers able to select the most viable embryos at the cleavage stage of 
development or earlier, as early identification of viability would be most relevant for worldwide application. 
Furthermore, in order to identify the possibilities of metabolism as a marker of viability, a complete medium 
as used for in vitro oocyte/embryo culture in IVF clinics must be used for analysis, so as not to compromise 
the health of the oocytes/embryos being assessed (Conaghan et al. 1993a, Jones et al. 2001).  Therefore, 
the present study was undertaken to determine if non-invasive analysis of cumulus-oocyte complex or 
cleavage stage embryo metabolism have potential to be indicators of resultant implantation potential, when 
analysing complete commercial embryo culture media. Chapter 6: Metabolite Analysis of COCs and Embryos 
 
Feil    Page 149  
 
6.2  MATERIALS AND METHODS  
6.2.1  Patient Selection 
Forty-two patients undergoing routine IVF/ICSI at Repromed‟s Adelaide clinic between May and November 
2005 consented for spent media samples following cumulus-oocyte/embryo culture to be collected and 
analysed. Patients having PGD or using donor gametes/embryos were excluded from recruitment. Ethical 
approval was obtained by the NHMRC sanctioned Human Ethics Committee of the Women‟s and Children‟s 
Hospital, Adelaide, Australia. 
 
6.2.2  Sample collection and processing 
Spent media samples were collected at specific periods during the culture period:  
1)  Immediately following collection of COC‟s in theatre, COC‟s were transferred in 10µL of GFert Plus 
medium (Vitrolife), into individual 10µL drops of GFert Plus to have a final incubation volume of 
20µL, under paraffin oil at 37°C, 6% CO2, 5% O2. COC‟s were incubated in these drops for 3 
hours, prior to trimming for IVF or complete denudation for ICSI insemination. The spent media was 
then collected for analysis. 
2)  Normally fertilized zygotes were placed in individual 10µL drops of fresh media (G1v3, Vitrolife) 16 
hours post insemination for continuing culture. After 24 hours incubation, media was replenished 
once again (G1) and the spent media for the previous 24 hour period, during which the embryos 
should undergo the first and second cell cycles, was collected for analysis. 
Media samples were labeled to correspond with the appropriate oocyte/embryo from which they were 
sourced in order to relate metabolic analyses to individual oocytes/embryos. Media samples were frozen 
and stored at -80°C until required for analysis.  
 
6.2.3  Microfluorometric Analysis  
Quantitative  microfluorimetry  was  employed  to  analyse  the  spent  media  for  nutrient  consumption  and 
metabolite production by conventional biochemical assays on a smaller scale (Mroz and Lechene 1980, 
Leese and Barton 1984). The measurement of metabolites utilised and excreted by singly cultured embryos 
was able to be determined by performing a variety of metabolic assays using spent media and comparing to 
control media from the same patient which did not contain an embryo. Control media from each individual Chapter 6: Metabolite Analysis of COCs and Embryos 
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patient‟s culture dish was collected to compare to the media containing an embryo allowing for spontaneous 
breakdown of metabolites as well as the metabolic activity of the embryo.  
This technique was based on coupled reactions which generate or consume NADPH or NADH. Upon 
exposure to ultra-violet (UV) light (340nm), the reduced forms of these nucleotides fluoresce, the degree to 
which can be quantitated using a fluorescent microscope and photometer (Leica DMIRB and Leitz MPV-
Combi, Leica, Wetzlar, Germany). Standard curves of fluorescence and substrate level were constructed for 
each set of assay analysis. 
 
Assay conditions are optimized to favour the conversion of the substrate of interest to its product. The 
reaction volumes ranged from 5-60µL, depending on the assay being performed, on siliconised slides under 
mineral oil (Sigma Chemical Co.). The initial fluorescence of the „cocktail‟ drop, containing all the co-factors 
and enzymes was determined under UV light. The sample 0.5-1µL was then added to the cocktail drop and 
after  the  reaction  had  reached  completion  the  final  fluorescence  reading  was  taken.  The  change  in 
fluorescence was then determined and the concentration of the substrate of interest was then quantified 
from a standard curve generated at the beginning of each assay. 
 
6.2.4  Assay principles  
6.2.4.1  Glucose 
Assessment of glucose concentration, is based on the phosphorylation of glucose to glucose-6-phosphate 
by hexokinase and the oxidation of glucose-6-phosphate to 6-phosphogluconate by glucose-6-phosphate 
dehydrogenase  (G6PDH)  which  is  coupled  to  NADPH.  NADPH  is  fluorescent,  and  can  therefore  be 
quantified  by  fluorometric  analysis.  An  increase  in  glucose  concentration  results  in  an  increase  in 





A 0.5µL sample (GFert Plus diluted 1/10 (COC), G1.3 Plus undiluted (early embryo)) was added to a 5.0µL 
cocktail drop and 5 minutes allowed for the reaction to reach completion at room temperature.  
Glucose  +  ATP                              Glucose-6-Phosphate  +  ADP 
 
 
Glucose-6-Phosphate                                    6-Phosphogluconate 
+  NADP+                                                    +  NADPH  +  H+ 
Hexokinase 
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Assay reagents and concentrations can be seen in Appendix 7. Mean R2 for COC and early embryo 
glucose in spent media samples analysed was R2=0.997 and R2=0.995 respectively. An example standard 
curve generated from this technique for glucose can be seen in Figure 6.1a. 
 
6.2.4.2  Pyruvate 
Pyruvate  concentration  was  determined  by  measuring  the  reduction  of  pyruvate  to  lactate  by  lactate 
dehydrogenase (LDH), via the disappearance of NADH as it is converted to NAD+. Therefore this reaction 




A 0.5µL sample was added to a 5.0µL cocktail drop and 10 minutes allowed for the reaction to reach 
completion at room temperature.  
Assay reagents and concentrations can be seen in Appendix  7. Mean R2 for COC and early embryo 
pyruvate in spent media samples analysed was R2=0.999 and R2=0.993 respectively. An example standard 
curve generated from this technique for Pyruvate can be seen in Figure 6.1b. 
 
6.2.4.3  Lactate 
Lactate concentration was assessed by the conversion of lactate to pyruvate, by lactate dehydrogenase 




A 0.5µL sample (GFert Plus diluted 1/22.5, G1.3 Plus diluted 1/10) was added to a 5.0µL cocktail drop and 
5 minutes allowed for the reaction to reach completion at room temperature.  
Pyruvate  +  NADH  +  H+                              Lactate  +  NAD+ 
LDH 
Lactate  +  NAD+                         Pyruvate  +  NADH  +  H+ 
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Assay reagents and concentrations can be seen in Appendix 7. Mean R2 for COC and early embryo lactate 
in spent media samples analysed was R2=0.998 and R2=0.990 respectively. An example standard curve 
generated from this technique for lactate can be seen in Figure 6.1c. 
 
6.2.4.4  Alanine 
The  assessment  of  alanine  concentration  was  via  a  two-step  process.  The  initial  step  involves  the 
conversion of alanine to pyruvate by glutamate-pyruvate transaminase (GPT). The final step of the reaction 
then follows the determination of pyruvate concentration (see above). The conversion of NADH in the final 
reaction allows a fluorescent measurement to be taken. An increase in alanine concentration produces a 





A 1µL sample was added to a 60µL alanine cocktail drop and 60 minutes allowed for the reaction to reach 
completion at room temperature. A 1µL sample from the initial reaction drop was then added to a 10µL 
pyruvate cocktail drop for 10 minutes at room temperature for the final reaction to take place to produce 
NAD+.  
Assay reagents and concentrations can be seen in Appendix 7. Mean R2 for COC and early embryo alanine 
in spent media samples analysed was R2=0.997 and R2=0.997 respectively. An example standard curve 
generated from this technique for alanine can be seen in Figure 6.1d. 
Alanine  +  α-ketoglutarate                                  Pyruvate  +  glutamate 
 




Figure 6.1 Standard curves generated for microfluorometric assays. 
 
a) Glucose standard curve 
 
 
b) Pyruvate standard curve 
  
 
c) Lactate standard curve 
 
 
d) Alanine standard curve 
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6.2.5  Metabolic Analyses 
Nutrient levels of interest were calculated in the spent media by analysis of the change in fluorescence 
during the assay, the standard curve generated for each assay and the dilution (if any) of the unknown 
media sample prior to assessment. This value indicated the concentration of the nutrient of interest in the 
spent media, which was then deducted from the concentration of the same metabolite in the control media 
to reflect the consumption or production of the nutrient of interest by a single embryo for the incubation 
period. Consumption or production of the metabolite was also able to be calculated per hour of incubation 
and  compared  retrospectively  to  the  fate  of  oocytes  following  insemination,  the  cell  number  and 
morphological grade of an embryo 40 hours post insemination and the ability to establish a pregnancy. All 
analysis was conducted blinded to the quality of the resultant embryo. 
Ratios of metabolites were also analysed to account for cell number in COC investigations. Individual 
cumulus masses were not quantitated therefore cell number was only incorporated by investigating the ratio 
of metabolites. In addition, for individual embryos, ratio of metabolites was investigated to assess whether 
the fate of a metabolite was correlated with viability.  
 
6.2.6  Statistics 
Metabolite data is presented in box-whisker plots. Boxes detail the median, 25th and 75th percentile, with 
whiskers indicating the 10th and 90th percentile. Outliers are also indicated. Metabolite data in tables is 
expressed as mean ± SEM. Patient demographic data is presented as either mean ± SEM or percentages 
as  appropriate.  Normally  distributed  data  was  analysed  using  a  One-Way  ANOVA  and  treatment 
comparisons  performed  using  a  bonferroni  post-hoc  test.  Data  that  was  not  normally  distributed  was 
analysed  using  a  Kruskal-Wallis  test.  Proportional  data  was  analysed  using  chi-square  analysis. 
Spearman‟s  correlation  coefficient  was  used  to  assess  the  relationship  between  alanine  turnover  and 
embryo grade. P values <0.05 were considered to be statistically significant. 
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6.3  RESULTS 
6.3.1  Patient demographics 
Patient  demographic  characteristics  are  detailed  in  Table  6.1.  The  mean  maternal  age  of  patients 
participating in this study was 33.4±0.6 years.  The overall implantation rate following embryo transfer for 
this group of patients was 26.2%. Patients had an average of 10.6±0.7 oocytes collected and 71% of 
patients  underwent  ICSI  as  the  insemination  method.  There  was  no  correlation  of embryo  grade  with 
implantation  (grade  1  30.0%  implantation  (n=10),  grade  2  25.0%  implantation  (n=24),  grade  3  25.0% 
implantation (n=8)).There was no difference in any demographic parameters between patients who had 







Table 6.1 Patient demographics. 
  Pregnant  Non-pregnant  Significance 
Number of patients  12  30   
Maternal Age (years)  32.8±1.2  33.7±0.6  p=0.471 
% ICSI patients  75%  71%  p=0.794 
Number of oocytes collected  9.5±0.6  11.0±0.9  p=0.321 
Number of oocytes fertilized  5.4±0.5  5.8±0.6  p=0.741 
Grade of transferred embryo  2.0±0.2  1.9±0.1  p=0.683 
Number of embryos frozen  2.3±0.7  2.1±0.3  p=0.880 
Infertility Diagnosis (%) * 
-  Male Factor 
-  Endometriosis 
-  Tubal 
-  Ovulation/ovarian defect 
-  Unexplained 
















There were no statistically significant differences between groups with any variables analysed. 
*Infertility diagnoses include both male and female factors. In some cases more than one category is 
applicable to a patient pair. Numbers in parentheses indicate the proportion of infertility diagnoses. Chapter 6: Metabolite Analysis of COCs and Embryos 
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6.3.2  EXPERIMENT 1. Relationship between metabolite concentrations in spent media and embryo 
grade. 
a)  following COC incubation 
Forty-two patients had media collected following COC incubation. There was no significant relationship 
between  COC  metabolism  of  glucose  or  pyruvate  and  resultant  embryo  grade  (p=0.500,  p=0.528 
respectively,  see  Figure  6.2  and  Table  6.2).  Lactate  turnover  of  COCs  trended  towards  significant 
differences between resultant morphological grade of embryos (p=0.053). While alanine production was 
significantly higher in COCs that produced an embryo of poorer grade (p=0.049), with grade 3 embryos 
producing more alanine than grade 1 embryos (p=0.06, see Figure 6.2b and Table 6.2). Furthermore, there 
was  a  significant  correlation  between  COC alanine  turnover and  resultant  embryo  grade,  with  alanine 
turnover increasing with poorer embryo grades (correlation coefficient ρ=0.377, p=0.014, see Figure 6.2d).   
 
b)   following cleavage stage embryo incubation  
Thirty-three patients had spent media collected following cleavage stage embryo incubation. Samples for 
nine patients were unable to be collected due to laboratory constraints. 
There  was  no  significant  relationship  between  cleavage  stage  embryo  metabolism  and  any  of  the 
metabolites analysed; glucose, lactate, pyruvate or alanine and resultant embryo grade (p=0.159, p=0.572, 
p=0.525 and p=0.945 respectively, see Figure 6.3 and Table 6.3). However, it was observed that the 
metabolism of pyruvate by cleavage stage embryos occurred over a large range for embryos of grade 3, 
while the majority of grade 2 embryos and all the grade 1 embryos had pyruvate metabolism that was more 


















Figure 6.2 Metabolite turnover in individual cumulus-oocyte complexes prior to insemination 
relative to resultant embryo grade. 
a) glucose turnover, b) lactate turnover, c) pyruvate turnover, d) alanine turnover. Different superscripts 
indicate statistical significance.*significant correlation between alanine turnover of COC and resultant 
















































































































































































Figure 6.3 Metabolite turnover in individual cleavage stage embryos prior to embryo transfer 
relative to embryo grade. 








































































































































































Table  6.2  Mean  values  of  metabolite  turnover  by  cumulus-oocyte  complexes  in  relation  to 
morphology of resultant embryos. 
  COC Metabolite Turnover 
Metabolite  Grade 1 embryos (10)  Grade 2 embryos (24)  Grade 3 embryos (8) 
Glucose (nmol/hour)  19.5 ± 3.8  11.9 ± 4.3  10.9 ± 5.8 
Lactate† (nmol/hour)  -42.4 ± 12.0  -47.6 ± 11.9  4.3 ± 10.2 
Pyruvate (pmol/hour)  101.9 ± 71.3  -25.22 ± 69.6  -20.33 ± 102.7 
Alanine* (pmol/hour)  -361.0 ± 133.0a  114.3 ± 127.5ab  356.5 ± 285.6b 
Numbers in parentheses indicate the number of embryos in each group. Different superscripts within a 
row indicate statistical significance. * positive correlation between alanine turnover and embryo grade, 
correlation coefficient ρ=0.377, p=0.014. † trend towards significance p=0.053. 
 
Table  6.3  Mean  values  of  metabolite  turnover  by  cleavage  stage  embryos  in  relation  to 
morphological grade. 
  Embryo Metabolite Turnover  
Metabolite  Grade 1 embryos (8)  Grade 2 embryos (18)  Grade 3 embryos (7) 
Glucose (nmol/hour)  5.2 ± 25.3  -43.7 ± 14.6  -6.1 ± 22.9 
Lactate (nmol/hour)  -0.2 ± 0.4  0.3 ± 0.2  0.1 ± 0.6 
Pyruvate (pmol/hour)  20.2 ± 15.5  28.3 ± 24.2  -21.9 ± 49.3 
Alanine (pmol/hour)  -3.5 ± 9.9  3.5 ± 11.4  1.9 ± 21.9 
Numbers in parentheses indicate the number of embryos in each group. 
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6.3.3  EXPERIMENT 2.  Relationship  between  metabolite  concentrations  in  spent  media and 
implantation. 
a)  following COC incubation 
There was no significant relationship between COC metabolism of glucose, lactate, pyruvate or alanine 
and resultant implantation potential (p=0.872, p=0.694, p=0.313, p=0.869 respectively, see Figure 6.4 
and Table 6.4).  
 
b)  following cleavage stage embryo incubation 
Pyruvate  turnover  of  cleavage  stage  embryos  trended  towards  a  significant  difference  in  resultant 
implantation (p=0.067), with higher turnover in embryos which resulted in implantations (see Figure 
6.4c). There was no significant differences in cleavage stage embryo metabolism and implantation for 




















Figure 6.4 Metabolite turnover in individual cumulus-oocyte complexes prior to insemination 
relative to implantation. 














































































































































































Figure 6.5 Metabolite turnover in individual cleavage stage embryos prior to embryo transfer 
relative to implantation. 
a) glucose turnover, b) lactate turnover, c) pyruvate turnover, d) alanine turnover.  * trend towards 






























































































































































Table  6.4  Mean  values  of  metabolite  turnover  by  cumulus-oocyte  complexes  in  relation  to 
implantation of resultant embryos. 
  COC Metabolite Turnover 
Metabolite  Implantation (12)  No Implantation (30) 
Glucose (nmol/hour)  14.3 ± 3.7  13.3 ± 3.7 
Lactate (nmol/hour)  -32.0 ± 13.5  -39.0 ± 10.4 
Pyruvate (pmol/hour)  -72.5 ± 126.0  35.8 ± 45.2 
Alanine (pmol/hour)  20.3 ± 250.3  58.1 ± 103.9 
Numbers in parentheses indicate the number of embryos/patients in each group. 
 
 
Table  6.5  Mean  values  of  metabolite  turnover  by  cleavage  stage  embryos  in  relation  to 
subsequent implantation potential. 
  Embryo Metabolite Turnover 
Metabolite  Implantation (9)  No Implantation (24) 
Glucose (nmol/hour)  -35.9 ± 19  -19.4 ± 14.2 
Lactate (nmol/hour)  0.19 ± 0.27  0.11 ± 0.23 
Pyruvate (pmol/hour)  66.6 ± 23.9a  -3.4 ± 20.6b 
Alanine (pmol/hour)  -6.5 ± 16.1  4.8 ± 9.5 
Different  superscripts  within  a  row  indicate  a  trend  towards  significance  p=0.067.  Numbers  in 
parentheses indicate the number of embryos/patients in each group. 
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6.3.4  EXPERIMENT 3. Ratio of metabolite concentrations in spent media and effect on embryo 
grade and implantation. 
a) following COC incubation 
Glucose and lactate metabolic profiles of COCs did not show any relationship with resultant embryo 
grade  (p=0.218,  see  Figure  6.6a)  or  implantation  success  or  failure  (p=0.315,  see  Figure  6.7a). 
However, in contrast, the relationship between pyruvate and alanine metabolism of COCs showed a 
significant increase when subsequent embryos resulted in implantation compared to those which failed 
to implant (p=0.026, see Figure 6.7b). There was no association of morphological embryo grade with 
pyruvate: alanine turnover (p=0.722, see Figure 6.6b). 
 
b) following cleavage stage embryo incubation 
Cleavage stage embryos showed a significant negative correlation between embryo grade and glucose: 
lactate  turnover  (correlation  coefficient  ρ=-0.461,  p=0.008,  see  Figure  6.8a).  Higher  morphological 
quality embryos (grades 1 and 2) had significantly higher glucose: lactate turnover compared to poorer 
quality  embryos  (grade  3,  p=0.037  and  p=0.0033  respectively,  see  Figure  6.8a).  However,  this 
correlation was not observed with regard to implantation ability. There was no difference in glucose: 
lactate profiles for embryos which implanted and those which did not implant (p=0.438, see Figure 
6.9a). 
Pyruvate  and  alanine  metabolic  profiles  did  not  show any  significant  differences  for morphological 























Figure 6.6 Cumulus-oocyte complex metabolite interactions and resultant embryo grade. 
a) Glucose: Lactate turnover   b) Pyruvate: Alanine turnover.  
Embryo Grade












































































































Figure 6.7 Cumulus-oocyte complex metabolite interactions and implantation ability. 
a) Glucose: Lactate turnover   b) Pyruvate: Alanine turnover.  













































































































Figure 6.8 Cleavage stage embryo metabolite interactions and resultant embryo grade. 
a) Glucose: Lactate turnover   b) Pyruvate: Alanine turnover.  
Different  superscripts  indicate  statistical  significance.  *Significant  correlation  coefficient  ρ=-0.416, 
p=0.008) 
Embryo Grade
















































































































Figure 6.9 Cleavage stage embryo metabolite interactions and implantation ability. 
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6.4  DISCUSSION 
Early  determination  of  ideal embryo  culture  conditions  involved  investigation  of  the  composition  of 
reproductive  tract  fluids.  These  same  methods  have  been  extrapolated  to  examine  spent  media 
following embryo culture to attempt to differentiate embryos based on metabolic capacity and correlate 
this to implantation potential. A number of studies have considered the metabolism of embryos in in vitro 
culture as a potential measure to assess viability. The current study investigated metabolism of glucose, 
pyruvate, lactate and alanine of cumulus-oocyte complexes and cleavage stage embryos in a clinical 
setting to determine the potential of these metabolic measures in predicting viability of embryos.  The 
main findings suggest that there is considerable variability in substrate uptake/production by both COCs 
and embryos under the conditions employed here.  Nevertheless, there are some relationships between 
cleavage stage embryo metabolism and viability with pyruvate turnover trending to be different between 
embryos that ultimately produced a pregnancy compared to those that failed to implant. Similarly, the 
ratio  of  pyruvate  to  alanine  turnover  was  significantly  higher  in  COCs  that  produced  a  pregnancy 
compared to those that did not. However, the data collected during this study did not provide compelling 
evidence  to  support  the  use  of  metabolism  of  individual  metabolites  of  COCs  or  cleavage  stage 
embryos as absolute predictors with regard to embryo viability.  Although there were some differences 
between the populations of embryos that implanted and produced a pregnancy compared to those that 
did not, such as pyruvate and alanine metabolism of the COC and pyruvate metabolism of the embryo, 
in all cases there was significant overlap within these populations. None of the metabolites investigated 
showed a pattern of turnover that was exclusive to embryos that had the ability to implant, which is 
required for an absolute viability marker. Therefore, such criteria should only be used in conjunction with 
other measurable parameters. 
 
Lactate and alanine metabolism of the COC independently showed differences in the morphological 
grade of the resultant embryo. While this is interesting, it does not necessarily add further information to 
the viability assessment of IVF embryos. The morphological appearance of embryos is easily visually 
assessed therefore a marker which correlates with morphological appearance is redundant. A true 
viability marker is able to differentiate between embryos of similar morphological appearance and could 
therefore be used in conjunction with current morphological scoring systems.  
 
Glucose  metabolism  was  not  indicative  of  embryo  viability  or  morphology  in  the  current  study.  
Previously, Hardy et al. (1989) demonstrated that glucose uptake at the cleavage stage is almost 
identical  for  embryos  that  arrest  and  those  which  form  blastocysts  (Hardy  et  al.  1989).  The  data 
presented in this thesis chapter similarly showed no difference  in glucose metabolism of COCs or Chapter 6: Metabolite Analysis of COCs and Embryos 
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embryos,  which,  while  not  arrested  in  development,  had  similar  metabolic  profiles  of  glucose 
independent of implantation success or failure. It may not be completely surprising that cleavage stage 
embryo glucose metabolism is not a good candidate as a viability marker, as glucose utilisation of the 
embryo at this stage of development is relatively low. The higher rates of glucose uptake by the more 
advanced embryos (≥4-cells) that have entered the cleavage division to initiate the embryonic genome 
may reflect uptake to support advanced development while increased rates of uptake of the delayed 
embryos may reflect precocious uptake of glucose and disruption of metabolic balance.  
 
Conversely, as pyruvate is the preferred substrate at these early stages it could be expected to give a 
better indication of embryo physiology and thus viability. Indeed, the current study showed a  trend 
towards an increase in pyruvate turnover for embryos that implanted as opposed to those that did not. 
In the human cleavage stage embryo, pyruvate uptake has previously been shown to be approximately 
20% less in embryos which arrest at the cleavage stage compared to embryos that subsequently 
develop to the blastocyst stage  (Hardy et al. 1989), which is supported by the current study with 
embryos that were able to implant consuming a lower level of pyruvate compared to those which failed 
to implant. Hardy et al. (1989) demonstrated only a small range of pyruvate uptake between embryos 
with differing potential to form blastocysts/implant, which was supported by the current study which 
demonstrated  small  ranges  of  pyruvate  metabolism  in  good  morphology  cleavage  stage  embryos. 
Alternatively, a previous study has demonstrated a large range of pyruvate consumption in embryos 
which failed to implant (Turner et al. 1994).  In addition, Turner et al. (1994) also demonstrated that 
good  morphology  embryos  with  an  intermediate  uptake  of  pyruvate  were  more  likely  to  implant 
compared to poor morphology embryos with intermediate pyruvate uptake. This is particularly significant 
considering  that  the  potential of good  morphology embryos  was  able to  be differentiated  and  that 
morphology  and  metabolism  were  able  to  be  used  in  combination  to  improve  viability  prediction. 
Furthermore, single embryo transfers were performed on all 80 patients involved (Turner et al. 1994), 
however  these findings have not been able to be substantiated in other investigations, including the 
current study (Hardy et al. 1989, Devreker et al. 2000).  In contrast, an inverse relationship between 
pyruvate uptake at the cleavage stage and pregnancy establishment has been reported (Conaghan et 
al. 1993a), although this was determined with up to three embryos being transferred. Alternatively, 
another  study  found  no  difference  in  the  mean  pyruvate  uptake  of  early  embryos  in  relation  to 
implantation potential (Devreker et al. 2000). Despite interesting evaluations of metabolism of embryos 
under varied conditions, to date there does not appear to be a promising method of carbohydrate 
utilisation  in  predicting  viability  in  human  cleavage  stage  embryos.  Further  investigations  into 
techniques, culture systems and stage of development are required in this field. 
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Considering the significant levels of alanine present in the reproductive tract (Fahning et al. 1967, Miller 
and Schultz 1987) and the consistent appearance of alanine in culture media of embryos throughout 
pre-implantation development (Partridge and Leese 1996, Donnay and Leese 1999, Houghton et al. 
2002), an important role for this amino acid is suggested. The current study found an association 
between alanine turnover of cumulus-oocyte complexes and embryo grade, which has previously been 
reported in human cleavage stage embryos, where embryos which produced higher levels of alanine 
were more likely to arrest at the cleavage stage rather than form blastocysts (Houghton et al. 2002). 
However, the current observations did not extend to a difference in implantation potential of COCs or 
embryos  exhibiting  specific  alanine  turnover  profiles.  However,  the  ratio  of  pyruvate  to  alanine 
metabolism was investigated in the current study which revealed a significant association between 
COCs and implantation potential, suggesting that low pyruvate uptake to alanine production is a sign of 
cellular  stress and  reduced  oocyte  competence. Pyruvate  is transaminated  in embryos  to  produce 
alanine (Donnay et al. 1999), and this pathway is considered important in the clearance of ammonium 
generated  through  amino acid  metabolism  and  protein  degradation  (Orsi and Leese  2004).  Again, 
pyruvate: alanine metabolic profiles of COCs were not completely distinct for viable and non-viable 
resultant embryos. Further, COC metabolic profile determination has significant limitations for clinical 
implementation.  It  is a  substantial undertaking  to  implement  the  retrieval of  spent  media  following 
incubation of individual COCs as a reasonable number of the oocytes involved will not fertilize normally, 
or result in morphologically normal embryos likely to be selected for transfer. Ideally a metabolic marker 
would be useful after the determination of embryo morphology whether at the pronuclear, cleavage 
stage  or  blastocyst  stage,  when  only  embryos  suitable  for  transfer  need  to  be  differentiated. 
Furthermore, cell counts of cumulus masses surrounding oocytes were not performed and the almost 
certain difference in cell numbers between cumulus masses would have influenced the determination of 
single metabolites in the spent media. In an attempt to control for this, the relationship between some 
metabolites was assessed. Although in ICSI oocytes cell counts could be performed, it is not feasible for 
IVF embryos. Therefore, metabolic assessment of the spent medium around the COC may be limited as 
a marker unless ratios of metabolites or pathway interactions are determined. 
 
Several  studies  have  indicated  that  disrupted  balance  of  metabolism  is  related  to  poor  embryo 
development. The relationship between glucose consumption and lactate production, or glycolysis, has 
been related to blastocyst viability markers previously (Gardner et al. 1996b, Jones et al. 2001, Van den 
Bergh  et  al.  2001).  The  glucose:  lactate  metabolic  profiles  of  bovine  blastocysts  following 
cryopreservation have been shown to definitively identify blastocysts capable of re-expansion post-
thawing as opposed to those blastocysts which subsequently died (Gardner et al.1996b). Significantly, 
the metabolic profiles of these viable blastocysts did not overlap with non-viable blastocysts, indicating 
that such parameters would be appropriate for prospective selection of embryos for transfer. Glucose Chapter 6: Metabolite Analysis of COCs and Embryos 
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and lactate ratios were also assessed in the current study, with no association found between glucose 
and lactate metabolic profiles of COCs or embryos with regard to viability. A significant correlation was 
observed in the glucose: lactate metabolism of embryos and resultant morphological grade. However, 
as discussed previously, such an association does not confer benefit clinically in embryo selection. A 
prospective study with single embryo transfers in the mouse has shown that the balance of glucose 
uptake and lactate production in blastocysts is a predictor of viability (Lane and Gardner 1996). When 
mouse blastocysts from this study were prospectively selected for transfer based on glycolytic activity, 
fetal development  increased  four-fold  (80%)  over  random  blastocyst  selection  (20%).  Furthermore, 
blastocysts with abnormal metabolic activity had a fetal development rate of only 6% (Lane and Gardner 
1996). At the blastocyst stage the embryo exhibits a more somatic cell–like physiology and has the 
ability to utilise a wider array of nutrients. The embryo has also increased its metabolic quotient and 
there is a significant increase in biosynthetic activity, all of which increase energy demands required for 
essential activation of the embryonic genome, compaction and blastocyst formation. As a result it may 
be that metabolic prediction of viability may be more predictive at these later stages of development. 
Human  morulae  and  blastocysts,  with  a  more  dynamic  metabolic  rate  between  days  4  and  5  of 
development have shown lower glycolytic activity in embryos which implant (Van den Bergh et al. 2001), 
and may be a more appropriate stage of embryo development to investigate this. Further, it may be 
logical to assume that the quantification of metabolic pathway flux, as opposed to nutrient utilisation or 
consumption alone, is more likely to reflect cellular function and thus viability however this remains to be 
determined.   
 
The great variability and lack of consistency in results between different culture systems for metabolic 
measures to be used as biomarkers of embryo viability requires significant advancement before such 
technology could be considered as a clinical tool. In addition, it is widely known that the presence and 
concentration of one nutrient in the environment around the embryo can have a significant effect on the 
utilisation of other nutrients (Gardner and Leese 1988, Lane and Gardner 2000b). The embryo is readily 
able to adapt to its environment, and change its pattern of nutrient turnover, reflecting its plasticity. Any 
adaptation by the oocyte/embryo to less than optimal culture conditions would be expected to result in a 
level of physiological stress to the oocyte/embryo which would ultimately result in a reduction in viability 
(Menke and McLaren 1970, Gardner and Leese 1990) due to the allocation of resources to repair and 
maintenance  processes.  This  may  prove  to  be  a  negative  influence  in  the  pursuit  to  establish  a 
biomarker  such  as  metabolism  unless  such  patterns  are  clearly  described  and  accounted  for.  A 
significant barrier to metabolic viability measures may involve the varied compositions of commercial 
media altering measured parameters between media systems. 
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Since the beginning of my studies, a new area of metabolomics has emerged that may provide a 
promising future for the determination of a metabolic marker. Investigation into entire profiles of 
metabolites where data is relatively easily obtained is likely to determine a relationship, between one or 
more metabolites/metabolic pathways that are able to predict the implantation capacity of embryos. It 
has already been demonstrated that metabolomic data does not correlate with embryo morphology 
(Vergouw et al. 2008, Seli et al. 2009b), and profiles of embryos from single embryo transfers on day 2, 
3 and 5 have been retrospectively correlated with implantation (Go et al. 2009, Henman et al. 2009, 
Makinen et al. 2009). Furthermore, two prospective multicentre trials have demonstrated in day 5 single 
embryo transfers that viability scores resulting from metabolome profiles were correlated with 
implantation, independent of embryo morphology, as well as in different commercially available culture 
media (Botros et al. 2009, Seli et al. 2009b).   
 
For metabolic parameters to be a candidate in viability determination of embryos, technology requires 
significant advancement. Metabolomic techniques are promising but require further assessment and 
validation of algorithms generated between and within clinics. The ideal use of a metabolic marker 
would be in a quick, simple assessment of only the embryos that have been morphologically screened 
to have some viability. Metabolic data would then be additive in the selection of the most viable embryo 
from  a  cohort.  If  the  metabolic  screening  of  embryos  could  be  developed  for  varying  stages  of 
oocyte/embryo development it would be extremely valuable.  
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Due to the medical, social, ethical and economic consequences associated with multiple pregnancies, 
IVF clinics are under pressure to change clinical practice to the replacement of a single embryo rather 
than multiple embryos. This requires superior selection techniques in the laboratory to choose the 
embryo with the greatest viability from a patient‟s cohort. Currently no such validated diagnostic test 
exists,  with  embryo  morphology  being  the  primary  selection  tool  available,  which  is  only  weakly 
correlated with pregnancy rates. Viability markers for human embryos must be non-invasive and reliable 
and ideally should be rapid, simple and relatively low in cost with robust instrumentation for widespread 
use in IVF clinics. The relatively high rate of single embryo transfer that is performed in Australia makes 
this one of the few countries where this research is possible.  
 
Culture of embryos singly is a prerequisite of a number of evaluation techniques for individual embryos 
so that the embryo can be tracked. This raises one of the first challenges for a viability marker as there 
are several studies in the literature that indicate that embryo development and viability is enhanced 
when embryos are grown in groups. However, all of these studies were performed in conditions that we 
now understand cause stress to the embryos and do not reflect the sequential media conditions that are 
currently used in IVF clinics. Therefore, in chapter 3, the grouping environment of mouse and human 
embryos was assessed in sequential culture systems and using a methodology that maintained the 
embryo density and assessed the effects of single culture in the pre and post-compaction stages of the 
embryo. Morphologically, no differences in mouse or human embryos were observed at the cleavage 
stage or with blastocyst development rates. However, single culture of mouse embryos reduced the 
proportion of blastocysts undergoing hatching. In addition, singly cultured blastocysts had fewer inner 
cell mass cells, which have previously been reported to correlate with reduced fetal viability. In this 
study,  resultant  implantation  rates  or  fetal  viability  were  not  affected  in  mouse  embryos,  when 
transferred at either the cleavage or blastocyst stage. Furthermore, human implantation rates were 
unaffected by group culture or single culture of embryos to the cleavage or blastocyst stage. Placental 
weights were reduced in conceptii derived from single culture of mouse embryos that were transferred 
at the cleavage stage, although in this case there did not seem to be an effect on resultant fetal weight. 
Although this finding cannot be directly extrapolated to human  clinical embryology, this observation 
requires further investigation in both species. Placental function normally impacts fetal development and 
intrauterine growth restriction is a common fetal outcome that results from a small or insufficiently 
formed  placenta.  Early  developmental insults  have  long-term  health  implications  (Barker 1998),  as 
recognised  by  the  developmental  origins  of  adult  disease  hypothesis,  which  states  that  not  only 
circumstances during fetal life, but as early as  the peri-conception period have been associated health 
issues in adult life (Fernandez-Gonzalez et al. 2007). Human birth outcomes were not assessed in the Chapter 7: General Discussion and Conclusions 
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study detailed in Chapter 3 and may warrant further investigation for a technique that is likely to become 
essential in IVF clinics. 
 
 It is possible that the group culture of embryos with high developmental competence stimulates the 
growth of embryos which have a lower developmental competence through autocrine factors, whereas 
embryos grown singly are dependent only on their own inherent viability. This potential cooperative 
agent(s) between human embryos is to date undescribed however may have implications in human IVF, 
where any stimulatory action should be harnessed and exploited, particularly for patients with reduced 
numbers of embryos or embryos with known reduced developmental competence, such as patients with 
advanced maternal age. This study only assessed what can be described as good prognosis patients 
and ideally a study on donated human embryos from a cohort of patients with varied maternal ages 
could be conducted to further assess the effect of maternal age on the developmental effects and 
outcomes of group and single embryo culture. This could also incorporate birth outcomes and follow up 
which were omitted from the current study. 
 
One of the advantages of blastocyst morphology as a selection tool is that single culture of embryos is 
not  essential.  Embryo  selection  at  the  cleavage  stage  may  benefit  from  multiple  observations  of 
embryos and thus single culture may be advantageous. However, a single static observation of human 
embryos  on  day  5  of  in  vitro  culture  is  able  to  greatly  differentiate  blastocysts  resulting  in  high 
implantation rates of up to 80% in donor oocyte cycles where multiple embryos are transferred (oocytes 
collected from young fertile women) (Schoolcraft and Gardner 2000). However, to date most studies 
comparing  cleavage  stage  and  blastocyst  culture  and  transfer  have  been  confounded  by  the 
replacement of multiple embryos. Therefore, to assess this knowledge gap, experiments in chapter 4 
detail assessment of morphology at the cleavage stage compared to extended culture in single embryo 
transfers.  However,  blastocyst  culture  does  require  significantly  more  resources  and  space  than 
cleavage  stage  culture,  which  is  not  an  option  for all  clinics.  Therefore,  a  scoring  system  for  the 
morphology  of  day  4  embryos  was  developed,  for which  embryos  have  also  undergone  important 
developmental checkpoints such as embryonic genome activation, and are progressively compacting 
and beginning the formation of a blastocoel cavity. This was able to reduce the burden on the laboratory 
from  the  5-6  days  of  culture  required  for  day  5  blastocyst  transfers.  Day  4  embryo  replacement 
improved implantation rates compared to cleavage stage transfers, indicating that extended culture and 
assessment of embryos on day 4 benefits embryo selection. Day 5 embryo transfers did not add any 
further advantage to embryo selection, and in fact were not significantly higher than implantation rates 
for embryos selected at the cleavage stage of development. Day 4 embryo transfer may have an added Chapter 7: General Discussion and Conclusions 
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advantage of exposure to the complex milieu of the uterine environment unable to be replicated in vitro, 
which  is somewhat  reduced  when an embryo  replacement  is  performed on  day  5.  Day  4  embryo 
selection and replacement may provide a balance between embryo selection post-genome activation at 
a dynamic period of development that morphological quality is easily determined and incorporating 
maximal exposure to the uterine environment prior to implantation. 
 
To maximise implantation rates beyond what can be achieved with morphological observations, at any 
stage development, likely requires a combination of morphological observations with biochemical or 
molecular markers of developmental potential. This study is the first to describe and assess a day 4 
morphological scoring system in single embryo transfers. Embryo morphological assessments at all 
stages  of  development  are  now  available  for  implementation  and  thus  future  development  of 
assessment markers will be able to be used in combination with a selection of developmental stages. 
This has wide reaching relevance to incorporate clinics employing blastocyst or extended stage culture 
and transfer of embryos, as well as those clinics who require embryo selection at the cleavage or 
pronuclear stages of embryo development. 
 
Selection of an oocyte presents added challenges in IVF. Currently oocytes are scored based on the 
presence of negative morphological characteristics such as excessive granularity, presence of vacuoles, 
refractile  bodies,  perivitteline  space  and  polar  body  morphology,  as  well  as  zona  pellucida 
characteristics which have poorer developmental consequences (Alikani et al. 1995, Serhal et al. 1997, 
Kahraman et al. 2000, Rienzi et al. 2008). Chapter 5 aimed to investigate a biochemical marker of 
oocyte viability by using cumulus cells, a by-product of IVF treatment. In a retrospective study, REDOX 
status of cumulus cell masses were shown to be negatively correlated with fertilization potential of 
oocytes undergoing either IVF or ICSI. In addition, and most significantly, REDOX status of cumulus 
cells shows great promise as a candidate biomarker of implantation potential by being associated with a 
significantly improved implantation rate following single embryo transfer, when embryos resulting from 
oocytes with REDOX levels in cumulus masses measured at an intermediate level were selected for 
transfer. Importantly, a range of REDOX levels was observed within and between patients, and REDOX 
status did not correlate with embryo morphology, likely making these parameters additive in predictive 
ability of implantation. One of the benefits of this type of categorical analysis on oocytes is that embryos 
can be grouped into 3 categories, reducing the requirement for single culture and allowing for embryos 
from the same category to be cultured together in groups.  The data in this chapter represents a 
promising  development  in  the  search  for a  viability  marker  and  warrants  further  investigation  in  a 
prospective randomised controlled trial.  Chapter 7: General Discussion and Conclusions 
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A field with potential in the pursuit to identify a biomarker of viability is the assessment of embryo 
metabolism.  Being a  product  of  the  functional quality  of  the  oocyte/embryo,  and  a  combination of 
genetic and environmental factors, metabolism of individual oocytes and embryos has strength in the 
identification of embryos with high developmental potential. The data presented in Chapter 6 of this 
thesis,  did  determine  that  there  were  some  relationships  between  metabolic  activity  and  embryo 
morphology and importantly implantation. However, it also provided evidence of the potential limitations 
of using cleavage stage embryo metabolism and individual metabolites as a marker for subsequent 
implantation. It is likely that the best application of this type of metabolic assessment might be at the 
later stages of development where there is an increase in the metabolic activity of the embryo at the 
morula and blastocyst stages. Assessment of post-compaction embryos incorporates the contribution of 
the paternal genome (i.e. sperm) to the embryo, as the embryonic genome is activated just prior to this 
stage.  One  of  the  further  studies  that  might  be  able  to  be  undertaken  is  metabolic  analyses  in 
conjunction with the day 4 assessment described in chapter 4, as embryos would be at a dynamic stage 
of development, post-genome activation and more metabolically active than cleavage stage embryos, 
without the burden of blastocyst culture.  
 
Advancements in technologies have resulted in the emerging field of metabolomics for embryos, which 
uses  platforms  such  as  mass  spectrometry,  nuclear  magnetic  resonance  spectroscopy  and  near 
infrared spectroscopy to determine a broad profile of the metabolites from the medium, rather than the 
method  used  in  this  study,  and  others  to  assess  known/single  pathways.  This  method  may  be 
advantageous  in  that  it  measures  many  different  metabolites  simultaneously  and  currently  shows 
potential for implementation in IVF clinics with a small device engineered to determine from extremely 
small volumes of media, an almost immediate output profile (Dunn and Ellis 2005).   
 
Of the viability markers that have been investigated in these studies and many others to date, there has 
been no clear identification of a candidate marker which is consistently associated with implantation. 
Morphology and cleavage rate are likely to remain the mainstay of embryo assessment, being relatively 
quick and simple, and able to eliminate embryos with very little developmental potential from selection 
for transfer. The development of more quantitative methods of assessing the developmental potential of 
an embryo would further increase success rates following IVF. Many markers have shown promise, 
however there is constantly overlap in the measures of those embryos which implant or fail to establish 
pregnancy. No test is ever likely to be 100% reliable, and non-embryo-related factors in the process of 
implantation  also  require  consideration.  In  addition,  any  biochemical  or  molecular  marker  will  be 
influenced by multiple factors and the establishment of reference ranges may therefore be problematic Chapter 7: General Discussion and Conclusions 
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in a field such as IVF. Superovulation regimens, changes in embryo culture systems and differing 
aetiology of patients would all be expected to induce variation in any biomarkers that are discovered 
thus much work remains in this field to clarify these situations. The implications of this may be that we 
are able to evaluate the competency of the embryo, but need to consider that there are other significant 
interactions which are currently being disregarded i.e. patient factors such as uterine receptivity. A 
compromise that must be made in studies of this type are that viability markers are likely to provide a 
ranking of competency within a patient‟s cohort of embryos, rather than being ultimately predictive. Such 
a scheme would then enable selection of an individual patient‟s most viable embryo, which may still 
have a less than ideal ranking, but is that patient‟s best chance at pregnancy for that treatment cycle. 
The difficulties with such studies begin with the recruitment of patients undergoing an emotive medical 
treatment when large numbers of participants are required to elucidate and establish new technologies. 
Further, the collection of samples from all retrieved oocytes/embryos when only a few candidates will 
likely be eligible for measurement at the time of transfer is not an efficient use of resources. 
 
The studies described in this thesis are the first to assess a range of candidate viability markers using 
single embryo transfers within a single IVF clinic. Our primary interest following these investigations is to 
validate and implement the techniques that appear to be promising and have industry applicability. 
Prediction of embryo implantation potential with the employment of multiple measures from the same 
patients  and  embryos  in  one  study,  using  advanced  statistical  analysis,  will  hopefully  reveal  the 
possibilities available in pursuit of identifying the most viable embryo in a patient cohort. The preliminary 
operations for this require large scale, prospective randomised trials, with multi-centre investigations 
being advantageous to explore validity of any potential measures between IVF centres. Combinations of 
morphological and biological markers can only improve the success of fertility treatments by utilising 
more information about the health of the embryos we create than we are currently aware. Improvements 
in success rates will encourage clinicians, scientists and patients to transfer single embryos and reduce 
the  incidence  of  multiple  gestations  and  their  associated  negative  outcomes  which  is  the  most 
significant current challenge to the industry.  
Fertility has been a rapidly advancing scientific discipline since the inception of human IVF, however 
there is still much to explore. The discovery of technology of this kind generates with it volumes of 
knowledge which can only serve to educate clinicians, patients and scientists. The ultimate beneficiaries 
of such technology are the patients and their much desired single, healthy child.   
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Appendix 1 – Ethics Patient Information and Consent Form
   
 
 
Patient Information Sheet for the Research Study: 
Predicting Pregnancy Potential of Human Embryos 
Why do we want to do this study? 
Thank you for reading this information sheet to consider the donation of fluids, cells and media 
that result from your IVF/ICSI cycle for research.  
The goal of this study is to improve infertility treatment for couples by optimising the outcome of 
treatment  with  a  single  healthy  baby.  Currently,  embryos  are  selected  for  transfer  by  an 
embryologist according to the cell characteristics of the embryo. By increasing our understanding 
of what factors contribute to embryo viability we will be able to select and transfer a single embryo 
based on more scientific information. This may result in an increase in the ability of that embryo to 
implant and produce a single healthy baby.  
In the future we hope this knowledge will lead to an increase in pregnancy rates following IVF 
treatment. Therefore single embryos will be able to be transferred to all patients, reducing the risk 
of multiple pregnancies which pose serious health risks for both the mother and babies.  
 
Who can take part? 
Any woman having an IVF/ICSI cycle will be invited to join the study. 
How does the study work? 
During your IVF cycle you will have an egg retrieval in theatre. During this procedure, your eggs 
are  removed  from  follicular  fluids  and  placed  in  a  culture  medium  during  their  time  in  the 
laboratory. These fluids are normally discarded immediately following your egg retrieval, however 
we would like to analyse the content of these fluids for factors that might contribute to producing a 
healthier egg. 
The cells surrounding the eggs when they are collected in theatre, are removed during the IVF 
procedure. These are also normally discarded. However, recent studies in animal models have 
determined that these cells contain information about the health of the egg. 
Finally, the culture media your eggs and embryos are bathed in needs to be changed regularly to 
maintain the correct nutrient levels. When your eggs and embryos are moved to new media, the 
used  media  is  discarded.  This  media  will  be  examined  for  nutrient  uptake  and  production  to 
investigate the metabolic pathways of healthy embryos. 
 
Who will manage my treatment if I take part? 
Your own doctor will continue to oversee your treatment. 
How do I participate in this study? 
If you choose to donate these excess materials involved in your treatment cycle for this study, a 
consent form must be signed by both partners having treatment and witnessed by a doctor/nurse 
or scientist at Repromed. The consent form must be signed before you have your operation. 
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What will I get out of the study? 
The results of this study may not be of any direct benefit to you. However we hope the knowledge 
we  gain  from  this  research  will  increase  our  understanding  of  how  to  select  the  most  viable 
embryo for transfer and result in positive outcomes from infertility treatment for future patients.  
There will be no payment for your participation in this study.   
 
Are there any risks to me or my embryos if I take part in the study? 
There will be no additional risks or discomforts to you, other than those that would normally be 
experienced during an IVF cycle at Repromed. Your embryos will not be affected by the study as 
only discarded fluids, cells and media are being investigated. Embryos that are not transferred or 
frozen as part of your cycle are not available for research. 
 
What happens if I don’t want to take part? 
Before deciding whether or not to take part in this trial, you may wish to discuss the matter with a 
relative, friend, your doctor, nurse or counselor. Arrangement can be made for such discussion. It 
is important that you understand that your participation in this trial is voluntary, and if you do not 
wish to take part you are under no obligation to do so.   
If you decide to take part but later change your mind, you are free to withdraw at any stage. Your 
decision to take part, not to take part, or to withdraw, will not affect your routine medical treatment 
or your relationship with those treating you or your relationship with the Unit. 
 
Assurances of confidentiality 
Your confidentiality will be maintained regarding all records kept as a result of this study. Your 
identification number and initials only will be used in place of your full name in the case report 
forms and all other data storage forms for your privacy.   
When the study is complete, all results will be pooled together to be analysed and published, 
subject to  acceptance,  in  a  scientific journal. This  will  be  done  in  an anonymous  way  so  no 
individual patient's information can be traced. 
 
What if I have a question about the study? 
If you have any questions regarding this study, you are welcome to contact the 
 
      Principal Scientific Investigator, Dr. Michelle Lane, on 8222 8409, or  
      the Repromed embryologist collaborating with Dr Lane, Deanne Feil, on 8333 8111. 
 
The Women's & Children's Hospital's Ethics Committee has approved this study. 
 
Should you wish to speak to a person not directly involved, in particular in relation to matters 
concerning policies, information about the conduct of the study or your rights as a participant, or 
should you wish to make a confidential complaint, you may contact the 
 
      Research Secretariat, Ms. Brenda Penny, on 8161 6521. 
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WOMEN'S & CHILDREN'S HOSPITAL RESEARCH  
ETHICS COMMITTEE Consent Form 
 
I ___________________________________&________________________________ 
hereby consent to involvement in the research project entitled: 
Predicting Pregnancy Potential of Human Embryos 
1.  The nature and purpose of the research project described on the attached Information 
Sheet has been explained to me.   I understand it, and agree to take part. 
2.  I understand that I may not directly benefit by taking part in this study. 
3.  I acknowledge that the possible risks and/or side effects, discomforts and inconveniences, 
as outlined in the Information Sheet, have been explained to me. 
4.  I understand that while information gained in the study may be published, I will not be 
identified and information will be confidential. 
5.  I understand that I can withdraw from the study at any stage and that this will not affect 
medical care or any other aspects of my relationship with this hospital. 
6.  I understand that there will be no payment to me for taking part in this study.  
7.  I have had the opportunity to discuss taking part in this research project with a family 
member or friend and/or have had the opportunity to have a family member or friend 
present whilst the research project was being explained by the researcher. 
8.  I am aware that I should retain a copy of the Consent Form, when completed, and the 
Information Sheet. 
9.  I consent to samples of follicular fluid, cells and media being taken during my treatment 
cycle for use in the above project. 
   
       Signed: ..............................………………………….......................……Date: ................. 
       Full name of patient: .......................................................…………………….…………… 
 
  Signed: ……………………………………………………………………...Date: ………..… 
  Full name of patient: ………………………………………………………………………….. 
 
I certify that I have explained the study to the patients and consider that he/she understands what 
is involved. 
Signed: ..................................................………………………………..  Date: .…………… 
Name: .........................…………………………………………………………………………...... 
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Appendix 2 - IVF Cycle Stimulation 
Stimulation Guidelines during an IVF cycle† 
 
For patients on their first cycle of treatment*:  
a)  Long Downregulation 150IU FSH  
used if ALL of the following present;  
  Maternal age   35 years 
  Both ovaries present and normal 
  Ovarian volume > 4 mL 
  Antral follicle count > 6 (2-5mm) 
  Day 3 FSH < 8 
  AMH  > 8 pmol/L (if test has been performed) 
 
b)  Long Downregulation 200-225  
may be used if ANY of the following present; 
  Maternal age 36 – 38 years 
  Day 3 FSH = 8-10 
  One significantly compromised ovary 
 
c)  Long Downregulation 300IU  
may be used if ANY of the following present; 
  Maternal age  ≥ 39 years 
  Day 3 FSH  11  
  One ovary or smallest ovarian volume < 3mL 
  Severe endometriosis 
  AMH < 8 pmols/L 
  Antral follicle count < 6 (2-5mm) 
 
*In second and subsequent cycles the stimulation dose was determined by the patient‟s response on 
their previous cycle and modified if required to aim for 8-12 oocytes. 
† with thanks to Repromed Adelaide, for use of their patient stimulation criteria.  
 Appendix 3: Morphology Scoring Systems 
 
Feil    Page 216  
 
Appendix 3 – Morphology Scoring Systems 
 
 
Overall Grades for all pre-implantation embryo stages 
 
Grade 1 – excellent quality embryo, suitable for cryopreservation 
Grade 2 – satisfactory quality embryo, suitable for cryopreservation 
Grade 3 – poor quality embryo, not suitable for cryopreservation 




Cleavage Stage Embryos* (Day 2,3) 
 
 
  Fragmentation 
<10%  10-20%  20-50%  >50% 
On-time cleavage 
40-42h 4-5 cell 
64-66h 7-9 cell/compacted 




3  3  4  4 
 
 
Additional  morphological  anomalies  known  to  affect  embryo  quality  (multinucleation,  uneven  cell 







* with thanks to Repromed Adelaide, for use of their morphology scoring criteria. Appendix 3: Morphology Scoring Systems 
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Blastocyst Stage Embryos* (Day 5, 6) 
 
   






i  0 – morula or lesser stage   no blastocoel cavity seen 
ii    1 – early blastocyst    blastocoel less than half the volume of the embryo 
iii  2 – blastocyst      blastocoel ≥ half of the volume of the embryo 
iv    3 – full blastocyst     blastocoel completely fills the embryo 
v  4 – expanded blastocyst     zona thinning and overall increase in size 
vi    5 – hatching blastocyst      trophectoderm has started to herniate through the zona 
vii    6 – hatched blastocyst    blastocyst has completely escaped from the zona 
 
 
Inner Cell Mass (ICM) Scoring       Trophectoderm (TE) Scoring 
for embryos  grade 3         for embryos  score 3  
A – Tightly packed, many cells      A – Many cells forming a cohesive epithelium 
B – Loosely grouped, several cells    B – Few cells forming a loose epithelium 
C – Very few cells        C – Very few cells 
 
 




  Full blastocyst 
(≥3) with two „A‟ 
grades for both 
ICM and TE 
  Full blastocyst with at 
least one „B‟ grade 
for ICM or TE   
 
  Full blastocyst with a 
„C‟ ICM or TE  
  Early blastocysts („1‟ 
or „2‟) 
 
  Compacted morula 








D  E 
i  ii  iii 
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0.12mL stock solution 
10mL sterile saline 
 
The working solution was prepared from the stock solution and allowed to dissolve at room temperature 




The dose of Avertin given to animals was based on the body weight of the mouse, where 0.02mL was 
given for each gram of body weight. 
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Appendix 5: Day 4 Embryo Selection is Equal to Day 5 













Feil, D., Henshaw, R.C. and Lane, M. (2008) Day 4 embryo selection is equal to Day 
5 using a new embryo scoring system validated in single embryo transfers. 






NOTE:  This publication is included in the print copy of the thesis 
held in the University of Adelaide Library. 
 
It is also available online to authorised users at: 
 
http://dx.doi.org/10.1093/humrep/dem419 
 Appendix 6: Redox Sensor Red 
 
Feil     Page 226 
      
Appendix 6 – Redox Sensor Red 
 
Redox  Sensor  Red  (2,3,4,5,6-pentafluorodihydrotetramethylrosamine,  Redox  Sensor  Red  CC-1, 
Molecular Probes, Invitrogen, Australia) is a fluorogenic indicator of oxidative activity in proliferating and 
quiescent cells (Chen CS 2000 Free Radic biol med 1266). Redox Sensor Red enters cells passively 
and is oxidised by various oxidants including peroxynitrite, nitric oxide, nitrite, fatty acid hydroperoxide, 
hydrogen peroxide/superoxide radical and cytochrome c (Chen CS 2000 Free Radic biol med 1266). 
Once oxidised the indicator produces a fluorescent signal which has a linear relationship with the level 
of oxidant encountered. 
 
Redox Sensor Red was supplied as 50µg vials which were prepared by addition of 115μL of dimethyl 
sulfoxide (DMSO) to produce a 1mM solution, which was stored at -20°C for up to 3 months. Working 
solutions were prepared by addition of 999µL of GMOPS medium with 5% HSA (Vitrolife) to 1µL of 
diluted Redox Sensor Red. The working solution of Redox Sensor Red was warmed to 37°C prior to 
use.  
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Appendix 7 - Ultramicrofluorometric Assays:  
Materials and Recipes 
 
 




EPPS Buffer                   0.75mL          
5mM DTT                       0.1mL                                       
37mM MgSO4.7H20       0.1mL                                    
10mM ATP                     50μL                                         
10mM NADP                  150μL                                     
Hexokinase/G6PDH       50μL                                      
 




EPPS        2.52g 
Penicillin      10mg 
Streptomycin      10mg 
 




5mM DTT            7.72mg in 10mL H20 
37mM MgSO4    91.2mg in 10mL H20 
10mM ATP    30.3mg in 5mL H20 
10mM NADP    39.4mg in 5mL H20 
 
 
Preparation of 1mM Standard 
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EPPS Buffer              0.7mL         
5mM NADH              15μL                             
LDH                          20μL                              
 




EPPS        2.52g 
Penicillin      10mg 
Streptomycin      10mg 
 




5mM NADH       17.73mg NADH in 5mL water 
 
 
Preparation of 1mM Standard 
Add 0.0110g of pyruvate to 100mL of water and dissolve. 
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Glycine/Hydrazine Buffer    0.45mL 
Water          0.40mL 
Lactate Dehydrogenase     25μL 
 




Glycine         7.5g 
Hydrazine        5.2g 
EDTA          0.2g 
2M NaOH        51mL 
 




Prepare 40mg/mL solution and freeze in 75μL aliquots in eppendorf tubes. 
 
 
Preparation of 1mM Standard 
Add 0.009g of lactate to 100mL of H20 and dissolve 
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Buffer      570μL 




Tris-hydroxymethyl-amino methane  1.2g 
α-ketoglutarate        0.231g 
 




10mg/ml Glutamate-Pyruvate Transaminase (GPT) 
Dissolve 10mg in 1mL of water. Store 4°C. 
 
 
Preparation of 0.5mM Alanine Standard 
Add 0.0045g of alanine to 100mL of water and dissolve. 
 
 
 
 
 
 